%PDF-1.7 % % 1 0 obj <> endobj 2 0 obj <> endobj 3 0 obj <> endobj 4 0 obj <> endobj 6 0 obj <>stream x endstream endobj 7 0 obj <>stream endstream endobj 8 0 obj <>/F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 9 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 289.29 1135.575 Tm 0.086275 0.086275 0.086275 rg /F3+0 27 Tf 32.4 TL (2016) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 362.955 1135.575 Tm -0.179 Tc 0.086275 0.086275 0.086275 rg /F3+0 27 Tf 32.4 TL (\200\201) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 423.614 1135.575 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 27 Tf 32.4 TL (WHO) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 503.715 1135.575 Tm 0.086275 0.086275 0.086275 rg /F3+0 27 Tf 32.4 TL (\202\203\204\205\206\207\210\211\212\213) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 773.789 1135.575 Tm 0.086275 0.086275 0.086275 rg /F3+0 27 Tf 32.4 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1043.929 Tm -0.03 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (WHO) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 233.49 1043.929 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 456.375 1043.929 Tm -0.088 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (2016) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 508.755 1043.929 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\213\214\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 569.625 1043.929 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 964.729 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\216\217\220\221\222\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 317.549 964.729 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040Myeloproliferative\040neoplasm) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 606.704 964.729 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 626.865 964.729 Tm -0.04 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (MPN) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 675.465 964.729 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 695.805 964.729 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 885.529 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\223\222\217\224\225\203\226\227) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 885.529 Tm -0.038 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (BCR\055ABL1\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 441.255 885.529 Tm -0.179 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\230\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 481.755 885.529 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 806.284 Tm -0.067 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (Chronic\040myeloid\040leukemia\054\040BCR\055ABL1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 534.855 806.284 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\231) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 545.865 806.284 Tm -0.049 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (positive) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 621.465 806.284 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 641.625 806.284 Tm -0.032 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (CML\054\040BCR\055ABL1\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 799.89 806.284 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 820.229 806.284 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 727.084 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\223\222\232\222\233\234\235\225\203\226) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 727.084 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 647.884 Tm -0.063 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (Chronic\040neutrophilic\040leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 476.715 647.884 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 496.875 647.884 Tm 0.03 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (CNL) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 537.375 647.884 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 557.745 647.884 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 568.654 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL <9e929f9c9d90a0a1> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 568.654 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 489.634 Tm -0.108 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (Polycythemia\040vera) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 350.895 489.634 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 371.235 489.634 Tm -0.028 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (PV) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 397.335 489.634 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 417.674 489.634 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 410.434 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\242\243\222\216\217\244\245\246) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 410.434 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 331.234 Tm -0.034 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (Primary\040myelofibrosis\050PMF\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 251.989 Tm -0.076 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\242\243\222\216\217\244\245\246\227\244\245\246\247) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 439.094 251.989 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 447.734 251.989 Tm -0.179 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\250\251) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 488.234 251.989 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 172.789 Tm -0.032 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (Primary\040myelofibrosis) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 385.454 172.789 Tm 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (\227) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 405.794 172.789 Tm -0.072 Tc 0.086275 0.086275 0.086275 rg /F4+0 20.34 Tf 24.408 TL (prefibrotic\057early\040stage\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F187e976cd-0328-4a1a-9568-d8374593fa13 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2141\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2141\215) Tj T* ET Q endstream endobj 10 0 obj <> endobj 11 0 obj <> endobj 12 0 obj <> endobj 13 0 obj <>stream xUMh\U:f)#&Mfڴ MNDa f=&ҸAA-.,&Eԥ.u).uU:~e4 tB}wy=uX_s]馥I|/ϿؑcQ\ dڲ͑)aR! y@\q ?A>\ssQJ/b1`Ws>[ZVVklK7Nuq &39Z4# B )24LhT"p[f PXbox\_| >h=j'x>}؏ be}z\9mZk/#My) NτΝY 2Aj?nnƟ=uӇeGZ= s`G %0jD=-lF-]MinD S !ɉS񍍮7܌ n݅on_7z;̘--GEWv? %줡։!FrH(>9Ƈ $:bQ`RDxIa)=dgç$>stream xeˊpOeK>"f /8j QxdJۀ D>q.Cc5/릟6M{ܝrLO//nܯw٬~?[|}Zlcq2:qӿ8ïnj27n}r5ӿsm= eneۍ̮ͬ擮_s&zw^xytO-lA+[6@';.5}þA߲ow;=~@?O? / / / / / / / /+ ү+ ү+ ү+ ү+ ү+ ү+ ү+ үoooooooo;;;;;;;;' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ_______Y`+m4M<&gw9oG; endstream endobj 15 0 obj <> endobj 16 0 obj <> endobj 17 0 obj <>stream xz X\յ^9p`90 d!3a( B !X@ 4&@"j*Ijkbgknz9%Un}*^zm5՘Z4׶i]$Fk_wf^k>kk7!Idi՚@w H%;z<#ʱ.l!f,'6tAdUhnw~y@Ow2{` 's3w7o]ߑ'ok(d|¶}!w{n>Ln%dw~BaѨB1L-ըea`0j˛ǎ\#?#"?8'8 G2i'ѷ9PjB ,CJ?+B+J-=j$I2$k9NҚ\>d.`@R[?`QqhEQ,&o(It1; p+jܨ! U|Xv:#3=52@ɋdǮybmR^%ABG&#d9fRFr?>}&h9AN#^^H~KNxLߴ" W-|~aϓ'q?Ay_u5+r%A=_ǁh 'C Q64\PnYmUhŒ_++ yo'-ffRSj1dcAjԼc U5dT{Q24ά Hr{Lb(VT~X$kS(F$EF 8xK8/~=]Rns#߆cԪV%1^..w]Єt+NY.VZ&ߍ DmX7JWmm_&I܉_QCJUDDlm&S.Q1e6zQ(_A|j6yj6Fbt&Q8,7B*B7HWuUnB :=RSa (c)e& gвI!Fa峞=vvı_%BhDv{&<]hd%EJkhZ$|XH]TxbM8mSM9zWOw <اj=k$_JBs5΍"m+JQkzݴF'p5|NV$pl7.R!JCױ7Z# Uv6Q7uelww+Kݣ, UTM Ok[kz<5X[JӁ5TĎ.>.2v|&?.?}?wx9D_oQ^4B Ř/dMP Zf=~<.|0dW mzcc(I8<ѤZ zИOtq EˡR(Ebl!lHCp1ZJv9/q^>leRЎ?︕J̓P{I#]0KvL҄5oV3jxivX1~k s6OZ1yMʿ"/xG`.YJHvKHֻLnR JO"d*]X7<bw%)Т%/8Ng/ߑæsɼZ "^Ъ8˯?7{j'}zfcsgҨ,ɗ~%$xQÔ4 c:5?CLLr2Ꙁh).ΥYQGi.}J3z}>F3zVirή[WYY%%Od٨fg$ok!3NB H؆^aS|m9lWSނڹ1Uʿ]pي(: aO.sw\'w;#/Zx\ߔ G F/f\){O>_IQC}n/? 5'*Sꭌ՟_[8l oZZV~˳[b<$[+̼xkjg}f3!)PMR4j5B0J-Z{QT/QNۛ4̐w{;̬:/[E ^BF^$J- }HFtP7UM!a #LcӇ m:<  B*H %vGmKe3 =rva=ɯ03G3cEKI!/E8;]!{5#j&`3 Td,"DhH%rWBt*wJU]T52f-E8*jNbųQZz!29P߁ hrfa Fh#!}ZS[a a;!fvl݁6@QS03DE[Ō#rX(~q8<=pG]R>s@HO [.zX+ly艇#ad)%ojZfxl͝G &7C;=<_H xX̀I*FiK}S"*ƗM?,蟡b-)\639$ZgeuޱCpǝꞦ?ν؎WN#P웽'٦q+8RWT W_tYi̧=k,`VQ:1%wf${m$Kh}7[ߢ߮KB='zBP]xZڭF ժ^׾DjMBsTk[ NW:-UpbF=iGCeoc cqP_g/5=d/u| 8o< %ӏ8+99_~d\OhZo6 k3IcݼE '0ىQ0#FH8c F] S Ք "!>5s`SГ7u޼3y8:4yE)bedb"K2b9k,|:;ӷʷKjۊ4! 0 ģF$* fXVe <:4_J1@ /FNEv&4ψuv{(T~b2b*h0ᑋFl >$JCF$̀Okoo_X`GL S. 8~P 񔺱:a'2ܜʏ6/=prY {T qʿZ0 g͔AXg)߹p.ͪs2q.C~[}3 F|0=^hB*4JN@ sW1 e$%))^8>- ~#ff|4}4s>ٚ $W3hfSPH̳LQ=fKAҭ @N.(@h\o+(Ф~yjLL0΃( yb^Q;7f Z0cLTVk:͓=ɎLpT8;gu#uH"Cq>ŋ(Khf*8꟎9<WJ4DΆ9! J]S4RR%ԥ,Ƌ7eiD# favɚ^rA'dŖ bOz.i6w8?w$w?㜟뾥G>,__͗'>}Kf̽!v7`˛&uֹ:-V'i=HQm+'>=;99wȑGȿcpzu\ˁǟ{cӋ 棺S$bJenĎ9'Ed%%7Nw4ay}~QQee4ZX -7\0iڎ' r|},oR-aڪ\UK Xu|g9Kw*Ǯ#$rc Q}N@W''x[u}y4)#i9YZtCI$R$ΰ*&J Rm#;L ೘9}MҬ8uirTr#@bpI1MEp" !a-*)Vnr}^\$f=ٺyt:y2{XT} ӞeK-]Ŷ['x4sg cvy@>yH%a0yI99,)E%%!'c))Y,DX'(@9Ƹ38o0}olzz^^~N\v/MbАhNoPA[H'ZH  B!v(4bBT! `4Q+erփwc9zJY7Vj +yHW#I@ٳB޽I܎co=J!T97;,'oW:lxn85 [ +5;s^nob34 y [;W ^Q6wZ91W~A{n;xwGOx`fK?<|衵ë2;.bf9~_~3w50Au<֏ЦfןJgb:1M4b9,[q~iƑ<"b1caʼn%K;e%s/"@nיl3WPT}6hWt'{l :Bp81<}U^nxJ8 I,YȨ8GLGW$#g [gQI % jLIWTf H?7$7'Jid+نeَ*q-@FĶ`!vmJa7&e]}`o2{I<1XTWn\߿u Ū[;oܺP\yؿm]b~ڻM:v-[X lCPW"u3 G>{Xu3RvǛʒ+ڭ(&`/{[;HJIY Cjn^n1XX$_& E߼mKS=X#bWw6T., 󋔝<+>sH{?}uΔx [[[Sbݴ {KMf*wXVס_:–\)^_ 2W | <pYOBXPPILq#ƒqD-D *pI.FHG'4# X 8%`(P H,H|(~?8a9tܧ!,b8x}X? # > ðG0}nֿ>[X߹3l̋l!!h.E66`#1חo'gyٞL, Z5S0Ɍ ғ$H2s֤9YbyFYn+7'kr7Z@27JɂyeÚJ)o`f)oM7߆T5EvM0Ukoh}$ RCROPzHzi%e϶kܜiAM_ 7~sGrJ/GtM͕ K RƆS90U[G96 endstream endobj 18 0 obj <>stream xOoX=˩FsG$,:Mf3KjLd"~xFE|/!|yfxK? ?_Ǯoχaflz^|_qv{^<_Ʒ添ӡma6<0<ߺ[f1[.]oc?o?]?n~vX,vke}ݎkcymSj:Y.tUW:AꖾQw;z^kި7~P?\7&7 oM~o~7&7 oM~o~w.w]~;~w.w]~;~?ɟ'$ŸO ?O'I?ɟ'$ŸO ?O'I?˟g3,Ɵ?gY?˟g3,Ɵ?gY_ "_//E_ "_//E_W+*_WU_W+*_WU?!C??!C?_'O?|fgaZFϫNܯ5o^NϮi^cXT>qitOxt<U endstream endobj 19 0 obj <> endobj 20 0 obj <> endobj 21 0 obj <>stream x |׽?zΙH:eɋdɫ%K, C!N !%$C!B4[ABL6!477M6i.͂`}{ftΙ3so0BHZo:%붻Kq!\zW:zQȳp|~Gz| T %EH{/.}~e{&JPƅ w\U٣%n_NQ_v@޹t]ygg+Z^Yq{vtD@2/iDw21C]U;ԱnDr5K(MbC,ʦvNC[CttFH8T8ƅSfC4GB']Dٸйn tѯ+^x{%nki3qw {3ѶI6<^sE@6F7k\\Gwe$jlGxl3޷`qOпkWՁ;SSݵvy|: . _Ыqq=@{ƅƫ !.Wep'^ ӥ4]ZhQ0+U0Ft5̚J;Tsqwk'OiF'3'Ðv۠߰#9GSnvO)I 'N]ӓ L.o!$ ?%LN[$~oC JL#!ۘ>R.6^xW,ݷ72[0> c>ꃑB.E ,qyϠtA-~͓_uտ|zl@}g,{a@,`u G33=2zsBa7Y#/vܾ].{$Q\V 0' !Lzc0RVla3zϺ7/ҿ9"~||z^_5U{8?fX?O?zmAX%Q)9ҡJ?q2 ʘM:̡cjPMMi?1,\HFK.7b8hdݜ=ǧm#/UJ9~ViZȺC оzBLifK)lt~f7mGSh6we,l6nH[7yuOgſS#?yA!˟,d ydDǿ<]6+2<9Ik*@6y٨PnhMT5q1JiHl$[AX\L9-%r (WxǛ_o=/?sq/>U۹ߋ_G~1$YV*FrRnR0rZtI 6aT]0n9x%?d$F9,|BȨ*5 vL0'Sl+Dx8\3AAJz>([xjl)?E^I4qD'镶KЖ ݄NNeS;"N3ʽr@-q Y L"@wgp`:!M@)횔܃ߎ'\r b@3)l0s\Nf7xH 723-f"vcKN9mx<\y=55ZכT2UI300i-۴W; iv(H;i=2:)9a6&{=%z0@nT)xPAXF0G^&'+XNnMUv4)”ݚljw??5+e ~\P@cUkc="]xefY1q2du.MIJڇjjyőJWrs;P Hu+uu2gV\Fӭ֕֋V5u<$ðQ^NL#׌pW}!2,g/bqd߰+Y ٹS<mU/^1V@%ZgК8Aɤ1g3g٠dh6'g| O6;/y' V3:SgbL&VSb"XXt2t9wN^y X :ͧ?'dwQ j/^ܾgXĹ o Ka{vk%>zk(6ՃVk^"ȴUkٷ*xHB)n5Sk`}$v`l߃;{7s'w{CPK##.a_6P2*SnU:2J,Ҭ%u'0?tjM= })g^XsppM%Vl[ǟ_=T\w7Oıѹe : o*0 PHaJ '^Zr ”]C8.;3ww'o硟l<4.؀sc:śG~?I €A9rH[95t.l4K SDaHLYL'G_j`蚜- =ʓ:0^<| a?֊Er{S:=.dB,!VV+y5QiSI kbP{+[eRQP" z)`89ܡ` hJΕ C'^dG3?{zX߳o7F:Wb\P.jrs-fPZZ~npF5BHe?dmfVoʉRjRGpOYRY<3+]A/'{8zy}w= q\y|k1}.TJ;3$Ul>>pQ}|%e_L|dy+w<8(qs+~'~pl!m(}q]B_K?''d;@ xCE{UǢ&*WɕJΐT5)a2vR6[9A}dvJʛw/QnQWrffVVC{{@۞:I*:cxƞPdPϻſh&69L-[&?$ɨ ^&ǡh*B AGm ÑɓJ&/³^wz2!1p#ɄLx+AA= O?3.=I?_O-zE4 c3I\@W=[=}`<֯w7 _TC!x842/_55[ie^!{F3 *,cze|j Z,c*FU23W"\4ei\N'Ӝ*7D71 Fvu;;ܚљA2چխ6F-JsƇ}Y|=}e5o TgV3CǪϻ|cp$F/DԈ&OF| .@ HəѹBz )QF:`)$޹J%jEH2! Mԋ.P #6L x_ɦ^y'ᒼ qx 3V\_B_wj$U?oϩQyV|!hp!Ιs0F6' i֬,`ܠžI 3}hZ#ՠV(Y\NĜS}E$L8ÒT69]0)'ܮ=uE2znQfnmu2"\YE3{r1ċ3g\0c#|b,gP]J3@eٳ}YʠU&yslW|k^i$wPWW( '*"9rNNfP9!(t8+{GQp%49(Ci[M 0H>Q0+~fM!\!h%ˀ zЕxUژP{m>n:2Scj5}bĚ*,_VX畜ɿ:B>!y%k(HI8U(P~R,Y3%_}dE5A8`Օd(ze\$ݑ'/flmr,]?!;,9ŢG|q}SZ/ w nܳX|✼8'玹8Cl8~l˪sS?B 閱~EVgeK 44d{Aa|ZcM]evo1# 됎ӪTu8=ݡB bN&SLl-X%G8$8I|E%Cuy:tFaY4r\D*5f/o3R~lݶ}r=higO$p|E|A}ĤBWjutN7ʜϫ0 edeYB6-30񂗬Y@BcuZà_v>+A |٩k-D3ĴZU6Z}%5%ւ΂ )`}erU9r>aveNzzDq1]\ ȋ*)nvtrA4v//=]' aR͢Y %"iM)i/ If. ؁ҽJayVIu {r93+'/0X;׼ vgߎok3vvb!v xB!v}WwyÞ1#W6\U{ Ca {/7l Ϟ[5h)Gxݨ?TZ^ jJjhfRk(-j\*B%A3;sܫuL Sx Ba>daqDKKG *@Z4I6e78 bHwVH{ ec0Mj|R^5~X=2u[ͪ[WLc z,+=<[<fs'T1{S̔aWV\if+&3;3( b̜Xu3 :o෋7łJ j%ZAiVYTJ׾qC|57TW^ߗ]TYrf3v{ZIJ)륀\N2IoG.\N[W.wtr`ICPOJP_HwPDz+9ȩf s7I~Jв$x&ErQNdIglb9 ߍtP͉#ξޓwԶ\4'FI 㨢#2o_n~Fs\S==̋gִG]Y_%G]T8U\=S+~h8&~{؊yK A4XĿsr{@@afe8|\D|A]Y gf&Qx)$dTl\vRwق>ǧ5t1BiZ"שHNk^/DY@iI&$<w0R*h*Gvi"# N*dy] *>f'Z[yx69?$^GxSzZ(}˃ISࣨҕ׻|92TISwl'}Թ[$˧ g 0)5!|b >1 "HTƪA2!VʾϓD%˂=DR& 4 h6bԂUTD[&OQzS;xeYY[fNVm+G_sPCvxa<`˭%or9\TZKȼ\(ty(:}s9s:FA5/8҈b $nŒ)DHE,ñhDIʣYʳexWe2S6Pv)L/NFUY*ҙbUAnyc>418iR./nvz?2#^{^m8z"\Kd'|3lU}OFtkմj(V+w)cwRUIG97ϝkmuږ lЁ 02M3MM#bJpv gˣ`WҾS4[N?{(z+:W\{W ƥ" ӡnG$ .l$MOڇpŃㆃ8/%|cJM=wbF8 /QOa!]|K`w1U'>WcnZxTGaQ'yȂ|*G$eʧWDp8_SkLS۝/ٶ<*5C|h?YˠryN0PaMؙ ᠐V^9Pz5ޕg..2-78~5qt=:FS2}5$\dx; BGZYX=DS(m8bWѱw]EgŮ R!|kE5mK ї (2s9֓0~ʆ?vG# A:y(ŞzCiS_`BJLҭ Jbɤ.钓R0'0)QG\<مpʵ`.ger S@N KrK&IDw'@xnY11V~mcbcC9M>1kS*S8ݧF,xÒ.YM} msY{׷v+g41>P-~o+-^anrq,Ʃ KQ&J({՜6)>oQ /"RL>g)q{և9+gP1 rEPRMV˨h`eC]X]njwTJWS+-F`ԯON\:m m[r`>q* i` 5CrR?d}ʧTq$}I_r% @uJOIN@\++u&r|>')¸)!&Ԝy,kFbxo8kq73 O/O_Ut?*R?lb /d#by`>Nl"pUSxv槱 6{➦_vG ȷK|;R5EFL|Lf$_H2{mD%( Yx@o1囹V)È9~rhs% hA |:0Ǧ~:8<_PCYJg*LĜxI!\r H V\ަ *TUD-W~mzP,yrǀfls2|,QCY9UWw1k 5Zp6CAU5ЂhktQE)9;E>UTdo~Uyeцt Bei w g ^],(/"5d !֒Βe%kJ/Ut&SI%%dTV^b2Gm6Mg἞UK{ٵsQtAH> Ѵj:5k44hMf@`͝w1JBN$:@tʑ$G=NyKr4'(%rZxrA^2V*<HA*8+At~y,T4A,QgI!|ǀԝ YyoK7V|>!R֦%FU ڧ^ҿdI겵Gx0S+>Zgʵ䣾G9v25>k+ߋ-hHFVc#6ViJfըU. [mz X^)F򚚚HXSSlJ=Pk |]~( JV{N^2JrJJ3/313cόubs(''d.ɝM>6ɲBzNlr B1,xTҩ<Qqq%WicJFGsi xZmY4 wBuH7?@ 3L} Tf0 ``@)M/%!"ߤTҀH9,'^rQ)&w4Ԅ]ًH5 vbm`ld ё-O/Qqmc1aaZ_}AٶjaݣO/N vumn/S:6SU7WV, س_eW!,o[yGl1ݟ1WxB{}Vk|{nZq Ѓs&9PuM&A)W/1h S* ! N!\!0;38s9\>GѧP0 vǤ_C*]MO.2^zuR F_(yFEUC ]!Yk3?t,NHVZP]&u(D~rQhR,J) WY`_MMͮkkd5'?V#db5v8_[-l!_IR <2\|6p$ s` Đ"W~(,Yx'%:g֢3u˃֢FHFRj61'K,3"G6S<~f qvjشOݙk>>mV_BDG==7>O6|/|-;+ 8֕x856 lTJ0丌;mgrmZf/2iGᎃ<>69\-22@ _/RuKTnFv =`5;!ZTng,cgy)j-,ZVe :x2\ɯϮA]RX;)H0^(40SҶ"H 4"XE[%u$Po MDrutS(1Cd>OV|e rJ0&D;:Q a"7+B`aHѬP:j:ɲ}xZ\8"ޫ#O7}eْs=y=tb􉇳*"l\acF3lg2spEK֒@lPv]ھQUclpZqYh7ʇ;i>jE~///![+'grsl٣6[zzC%<9DKQsҨx4N66O UyT] |;q©awÙ # fFu:}5_-Qx e,aZ UQ 5)@F+9tc,VQh&Ʋ@_C5Ѳh-jnfh_ Zuu7 aJ*> hUhW)*^-VuyūHW sEN3^BeU|r[t9p'7--i?]RǑ`$ОroIĔ>81+ҕ]5/CzN.QO.L%qzr")l.˞"7"]bdn%n]/}+K{~aX~yL|Nܭ0ϲibM8;ZQX7w^#kǑx_Yfo6NmmXwjtE[mRojldFH],Oi3L/~8~0Hu[:y1w$kY{9 ru@!5iiVVM#֡.6H*)viY.c 9c!&I$ƘMȴNc8G-dݕֺ0˜"& s{G?߻Wf:L# ޕ&xFZu$e bh"AׅqrIpj=R6g?I7ԦϬom+^(=b6Ң i2Ʋu3ژK⼵@{WKBئUdu?DE{?]p,t]'շ>;Q1u\wлEg+&$]; g0`D|oG &ĿWsWO9c-p[k%S- dJgBMd:Bu;Z5W`?n?c?kO#vj'vcM'7rIRrWJK"эflHsyX2cjJ/.Xg,$c[Ȓ%q(IbBݵ.Uϰ+ȥ y{EGd=KlζKL{]`o'/XcгW.iЊb {PeoVt&u:]\NLJ >6e8cwTB1 H#m6/9rb CrrGB|0Ww8jq-,C^d{;^L˙;d^b_8ugIF>_BD!,2?GiH#fUP&~MZZi?Gx[xYmn84z7~q"ԱϘہ:W߯0}&b ,O_4FɔW&9ip.$=}׬,%q+gHPoE~p ݪ]ZLߡZΗ).*%0Nwx%+)^SAr9# 4I1*Si0B靵0:-~KZ,etW$I1h1-EXR^_\yQAJƦ᫯ڤddh`+uwSX} Ѳ;NWs C~9oml-CL7.(Z|d4=փg,q,ϴm fL8}]hxr=FɯoC´Xd&!9_aZ'|k6mtDNA@2 sNedE%p.)\Y >jhBFWCxS u$vCLXF % BBxWe*ZyK^Teksg3q6f^@]VbJI))ZHXrZc|Oàbph`*%_] ~9?$gOW|'\JFM 4:@}x!"j^yB$If$KL@LIܤmf1w[t f/= KPYM 9|yLB,ܨ4_] tיw^zX%Y[Ke- -˶C5;ԥplMam㰔RR Y`B7ɡl 9ͦ,-! ְ8gO%߹wk>pJeW'ȳ~=q?NB3=<~V4 %5̇Sпn_6q,5`f}sW<5l4$>dT*fj9!)HF@^+WLӟ܃M\lO5t1 e(f qaq`sKB[:&S,jwFɃåAc>*n?YKbCb-'AwF n%Fנq\0:u)Q{}}:8h?egx{zՊy%CVe]VH~@>q,E4Hq!)ex&.6ZV[(eH85Tvsk9#RsAW1Ŗ1IMDn|m$t G,11rB ">~/`R@p_Pt]29%XIA[7q^;Z'/&t񎌰wCI(?cЮvMm~_П]q~"齳Jq ~]$, sw#B 5"PMaۦ8CVjˊ)2@V+ VCBCiD_= i r8QoZm:Z/S`&^2 2OI;}KJKZI`*%[&pV@Z#\Ue]6^ jJW%1Ebʚv3d>:Me%ةQa9p"O_|o?ᶠx}ew{x<]'Urr8%@3jE6kh1ք4 |l u{;^bq:ly̪j 0\nk"e.;,#C x7zb"\SLwDZ@ED8?PYCދT r5~@f.H-S}ލѵ%3o`z1L (@V6,VW7qd+7.U|VhC24 %AFߔVrr BJn.FӑNx8_o"ۇqqL'q>Ԡ .WT(ɭ \!K>IlWYQ^uD[IW*\JUо҉9Jt[[Op9챒ȵf$^[GaD&D,g+[SY7O;<t$gJS$!28ꨎvi:%tWNm/O 3--R(IQKEr¾W]K%JS5\sQ $t w-Q8$*o&2U\`!8Ճ;lO"q86}[8jʂ {WfW-n졷MmoO1ﵭȎ ű3g{$F]Xxyˍka>baR8N7ĵ *KM\,X"#p 0|4\C46 S)'p*X{!4oW~Gsg>STߓS7yݟO*%eR*;dc#1tJCΧ͇utyyIS;Wnim<"ٴ:%(ECl2$8Oj.T^swc"%?o`bS*V=4!!H\l`=DNs?<0=O"ucˆ0!ؓix: N1Y4e l2:VA>4F,Yd^aaNҠWʛG͔YG|D(3*-Ef"%mnvs9"))Grg9JJ_"wA$9ŰN ڗPHrT0U`J݋ȹVMjHTth-sNFdbcNCeY߶'!{PǑ+\╡7Ozaۂd %;hU̷VgN{7v`Fn@JxFokOXЙHg$y*+Jj =\|q861b}jk>EN^C(Da2t|Un*'́Y</9:i@ W&Cj. ƈf]Nt Qӂ_^/@g0.'"iV j5 i?[jnrw#nHɍ* N(eկu(*C![5""eE%Ѓ@T9Cu}$+NX Γ=7/+!+/῅5~]ټTg7^?Ki>a?ÉOq}p)5:Rح_^t?q,!7jc1YLȢPkQYBo0Fp~*.ZViɰсKE@ciN$9 HLuh2{W7ݮospY(T#$x+ȴ'qM?N|OBccjbʒ J$-a=爬Ѩ1VII Rs\PMTe)'q*"b{ld˓Ĺ&}cIk\r ,"jCfa)'q$+&K~y@cذ9{ZB=U≍J:]B}RnþϪ { ?O3jY`vܰpX}R`n3F~A8tAUxᏊYް6_86RYʑo5V_CTYϣ֨HY֨Dɺz5B~(|bcVqRsiqwjFk'v!A «"Y%;k`(E6T"[|e`&ӛ>};0v&=>.\%Lo`LJD2%x+PAFh(52sTϚU EH64ËJs>2*Һ 3aJSa0|k2Ttt:fV}=(;#ʃdrYfPO@h(t.Ć*DoJ&dkJ d 5:S;S)1՚ڔڟbSFḶao NSrRɐ%@j"V6Fb! t1Du;f5#]dZ$MI)TSb-Sq:GTġSR`뷦X{|݊E,weBOf_E(!LQa]/tEU%0s:=ڳZHw 曉a~Cv<0~)Ў a&ӆ Om7vp1n FUp)|( z_͛x!ZS;wwۗS#ıgyJŃI _\~Ts ,J℆^;J!!W+^DOCk(HCG\f^BK Cꄴ ,:.F0kGg:xOB ǫ B٘ըAFl`- U~,#M:dΡjEi&L W E ! !AIut%^=u򵐒r\>fVèwp^ X O-Bkvh? 2b|M PoRh3E?O_g:E6dr~{ ݊JW)*U+U'՜:TkZ syCr81wY" 6_-⊕%c^n = 7ލ\5ӊb|P ]Bq|( 79{Ѣ#Sue)L/L [2rKrd&D2_.Se% weY2=#1?t?Zu"6^qz(q jVA hV#1_"{w@b<_ýݏuX]vUwW5cjWGV}XGﺎv8~̃2pUpxZ.t@EFBQr;׊y/N#p.'^^^jBۯ,s} }'Q~WF; {n]9*)(]?AH3"$ڭDwDv1v?r1|j/rR9_,OжQmBOnBC8]H[lTa2&M̤fx5}y6sh=%yEN˙kT Pjh Lilؑ[t\c )ʛ)W(eKL)C*/Jq):RMf>stream x}M*G񽟢 !h MB&,NJo 7BiQ|~:not>L}ڏtNQ{ݿ}m|}:/n÷}7_Nv9~cx~6e:?C߯׿|;ž?^nub;B/ۏ2e0l<Y|=Mcr GHNʉ3()ٕ+\Ƀ@~T~$WQސ{A? ?A? ?GQ?G#(?GQ?G#(?O'I?ɟ'$ŸO ?O'I?ɟ'$ŸO ?gY?˟g3,Ɵ?gY?˟g3,Ɵ?/E_ "_//E_ "_/7 oM~o~7&7 oM~o~7&w]~;~w.w]~;~w.zYo֥߷H76(vNnmǿݶ}_6&=~ү5aho[^SϊrߴVo6j6T^V|u]jXWkkWTyYWI3[M߽͆u }d2`T?V߾ژ j֍ 5[3;v[{ozpj㷶z220 F endstream endobj 23 0 obj <> endobj 24 0 obj <>stream x \0~γ;o0l28.ʸh;$hڢBh&]15oYhR+ѢY[fY65o9π?y<3"ҡģQc?O UN[Uц|/r vBmz팹G롫hDHU6cΝ;+*ʜYSU}QgBib.߆r̹'09U:иܪ;jRne׼5Kn2kޫpQhiҾnrqx=R" Eӹ"y_H5Cc\.@KR} R)pH@qM(tt5D1!-p˭Cq@ ) V!=2 #2!3 +"QrhbBrxA (%dzTz>(yQ|ȏ2QF9(|h*]D`4 EE&TJP)h$hTƠf4݂*x4MDd4M+QMCըMG3L4 F9(/UHk?v_뿺Dg?%_ty?߳$v.sp6w]7=nooߟDr~7P_'|^O3Pk | ̲ -Ez{ef@@{3пy|#ZhϿ"2 qBj> ;| vGay;<2*VF-1|XiIME _/?/7';+M;-WJrRb'튋vFEF86l2:FR*$Q9z`+ZԎ<Dfcr{Ŵ Z*ZP w|PJcA>pD)W=aL0jp r_i:h,zS) :B%ukyE08~y-CڂF]EATLI@c!o[ bKF7.A Z= 0Z]ye]  a-`5T VZ k`C[8ܡ4TB3--mGlB0+gs2AipP! TWKkی4mjRE-O:sl0zX UtQraJ<ЙF(Ӿp DzfM%e\m:f ҂:覻+'84bp=Z L7j0ك(IdcXR͈XS 6:[潪]n4:@QY]9e9,gT6-h$6 Π1)@rs4Ƴ1&wRI'5& 0P7:\ TִЭP6.ti@Jrv3mij^ZE h]y^nG *s \89yS*:@ВF'hL +: ƻ&PoQ-zYA\vZ@2;ry\C+s[aP=}؞So2{f*-,9rA=Avx+\}@ZGkk&%vU9Ξmg+P .0[UF퍼 ?;H`Y&-c+XuUBrc{7'vc^֖-c+Ei]Ҝ=h.jyF1*BZ5A[ h--afk唬`|8* VֆSva4]u r]1}V<1%DoEfE0_,*y/Vxo6%M}BܥY<5j4u> '`B"8),< /{1=<{&y6{} J%ݵثK}Æ }g%55`B;SJD8y 1]c7$~d Mr'| "g9(*.:BTcc]3MeK{Tn*Tj"VDb6jI!7p,NeሁebS"-F$TNɓM~a5^4^4̎ pnH K9nCoɊOβ;LIIY9Y~aKJ6)#)xf;,$snjƯ]Čz*^4]M"++%_&Ňbb8á5qȽpE -䱎f$J,c"en6e&!)쀚0 2lV,QF񻄗E~&_ϵ=!9y^!,()(;a#9_|̻;ēk5c{.xtK_y/G7iMc{\0ƵUY &>{Gi,ѓB<鱨/N8N̸³AcʊLq~U!W "*Q4 T@x.?LFًG?O2 7p^΋"U/C_dx00tFPӗl3[gģ{p9obXY::IVyG:~DOr mjBz>UJ(:k$QPTRP'3~X.ɕm2RE-9"; Ol8I>Q'q=*p,9WsM~7@,˼Eiy%dTbRBjʔ󲒗mYn-FF.f62J jq<]9=)OH=n E00dG r߆q#G=-߅+"{ x p lNm4'4/dFv鰬L0G礓_{d@ïˮ)¼K^◅"_侖tЃ}y^zCFq`լFHfY2']&##ܮ؈9|| z<G+>Zt߃VA ȳ,JXܬ0c7($Zx@Z*Pa0à$ܦ fát/Ca2?\wtC'$<ݰ~$)YNuda:r3R+1~oZkL0{.c78+LnQ䖭n;pWC/l&gHyмC['g nlv@hV$&ѵY7#{Tmm*6#p̵bd.0@~j}Ùy?sq|®ʞ|a#k! ɻ$W?|1 _ϼa[~&/S#r 䔂nm%RN0gC@oqWsĂmBe^6W ֭IV*u))ibSb]bfcdfQV3ctݢQL0?V $yY vXqs<|{!x8z; _|`{/}6Bw3~{˪^A[tvC}!}5쭈hyZ ^c3Rmv*wN4pm4\g6IɠQV&y-={aéq։p_cɇO.X~e;+8^‰У0WO1E @TJ,@@^ES(!UJ6$CQea;PعC"~w3Iߍ)C2-Vv^Ҙht ޲RV:+AoEQ7-ѢoQsiBsNRW]?Y,eqwprPYpU^\UyxVa} Jqt,#r3=1,EKe }ЙxHG>[, /]'_K׫W/GX!ixvB޾f9wl3oTw FvR"Gs9g<k,*>LF]tes=tYfسßT9+DX|ww]3YGW cd Z\ EN,;;^yQSW348ѝ҇:oW^W, e$bpo2D6M˭bċ`AR3 "(^7;~ [w{nAww IQ7()Ť [`}@e112 ld=RF4L&G67!X0l[/~t&iǯsSc//Β_4=E>i#HҽDñ^Se憾jݣ:WOhe"jm6RDKEפ,`db}cN%yXB[s}?kzu"pƯw&g$;&ߑ3oJcOL 0TOșv|W>d/p2Fvd:'^x$0Q7yO, #|lhn%Ɩo,z]HPhW7)y?–:Xqbj04Z"T>X$p86#6(hhniF/N@Uw ˡ ^  r >]stHNǸe) rix>Yvv44?قp.d8Sz@R<ߤ H:F݂ ㈋]N"=[\>蹯_q7#j$]h*[ DTeQsvVh t@-36͝7y tMln&fX}m {y5()`ETVu"/I^ćL &5rzPL~҉Lr<Z8'; 4r:Bof0XW_K1V9^#wڹYWwtU(alΖHdW(A1F3ІZ#y-*o4۔f*ׅ' òM39O J#J$ 4QV-`~#Ӥȴw#շ6KXlv!+?uAׂ|dSiDAP֫<ʬ?A ( v%e+*)_~V Hx|Xrc6W_-ŃRtl.C& rcio`H={};v}~KKd$A E{(s6%`U,3Z\ϡ&4<׭xRE]omװ_H#/ aDv&/~nk3{Z$#+EgЧs﹀c1D1Q8iUQQL lvY=M`X H瑁pВCIŏg6OJnm讝nur\K. (f̲1^ox\%,>̪4Z滁>ʚrXlx/|6&ui dd0Tx)qb+!0Jȫ֯[0=&!ݡܒ|.Iċ_x +}Q z@ E[ *7U5|y9?[Bz3M-*YIw'PC F -2DHf:Gs"HV`4ԜE-FqIK\? &JIwKנk07pik6,2l jsc;XGcguA|چ*3'a]&#%6[_OqMh<8`T bΠ& ;fص퀅y _ɟ0Hx.lh@ f0 jEjAЀ9(UtD^Y4Gߥ=@5?'[x 9BEw@Y:ă[ݟLo0>T^AuJ l e?QxcBDxpoÿ(kc0sYP955+Ŗ 8%CXHZPL< diWN^XϺV/xG${lJ8Cq #~!Xx8櫧w{Z߲P\~"@3 $&mhJ(Fl$Pf]E>{GQ,Vtn lϾNda~hMw˯?M8v ֺ{CЖ/;o@$Sd&E΄VsrJ+]HeL ?a12F~ "WqK6Y9E~KcVJm[J"H D:֖ªi<hԪGx̬"1tMEYC^$_ "`Юa] )K`e Ujflv͆?BC{f$ F*VmE^{_w9S/$At-R͵X`e+޻p9`FA1&N!%=CR͕GpK_ ġ@<m341FMa6u|a]^3%k/SFQUowPn>V0g˱j[]swGl 5r~GCko5ЍqLz [> ^rӰK#v|ѿV /akt+hl@?ښ?xwE=`@nɝΧp1wa8G>7OvB?QS;ڽo\MfH|D>J.`Gu e~_ *Fݐz22\rs y~sv:UuϮܚM-܋da .5W7'V<j@ @fRK+f5u(+fQiPȎUɾ.&Wtva$pFRBPeARy9~S;fj`.װ\,7ƃKX=m;%Q{AvBl W*mg ,]NO8z5߅ɒW1ўv1znހ khPUW\ -|6pcv=RIqRֻ%QM bVeNH Š1K⠫:jP>=?4K^xd۟E`7jIOSy/7u@ǯۉ|ߎ93lA%Dl2qz$xƓu:F%,Acee)B| ^ 2&ܯapw_cq X'WFKewq~.> 3  h鴢5@o1JZFa\^G ^]9F2UD$3/k堛ȏ;B8 w۷!u21.(2B>( "_J8\e3\,4&96vVSBpw큎4.|L88 !J8CRəE"Mp 4:#o8(*.)39 Ƙh gUp;䙝;۷Hx .HR1ķ 'ɉľߒVl>mңd*X8 vGvK`O%]{ *3FdKTH-'IDfؓOĎTOdaS9YIYtdup%;Ή۷?+vrVGy܁ӿ+f}'ćy,yc Yh~LeծzYVM&uE{CiD1}=M555Z9I}gn 4K*~` }v.Sv3\T^F6uqةhLb^P;V3! zL_Σ/c1sSx'|ful@uMIݏ5gAg bnGjXm UlvBgfWt"7iדkIW\zdȣoof\S@]`[u^FVؗƨV+ $羜|ep>P6Grp #o{+rx{&Ź(i!8]=*?N4$GSFӗb,!o_. ;EQ=6OJqHg!OOx<\\YiO^@_0~skMr?}ircّoЛ =#}$)Yj.S lHO]~;CxKr|;H u醀DA\3E?3r2>^KpnG +qW"ϸq]Kɫ8qHe4IqAz  $zggeY`}#IXDipnݮ (r8~)) m8Dcbc6Z&d|'x\Ηq58;-& ,tV{cęhhȻĹ  ~ͥ\9%w)y勏M_^POl2IDjc˱;@x4(lY]=v{Z 6^{FbkgI3Ʈ]~ x⧫wwtݦmjlyx6>cq<>|@x}x #+ZPvkEӓ?-]cEx^:@刍U"NgR2*V"D /*DDEcbab~/'$)$;DyP9;n0|CTTĠIѹ?^zOtd4vp9*[[1#8c2M{0&Y_8p!(DDy6f`8; wVFw6_| gS8:3l⤦7]ݱipZ>M_IeA( ccb"*c e8/0.@(lC 2~/lizRK /5d3Fz ӹt!325塔wRP=J=_-S<<##)"\__y/}A13yAr'^6^̣Ɲ~Q=7Q$ڈYeΑ|D`hr^$RgJ&_dnClyjZل-_ B3sԑ iT~ziЕQ|IsIh2SNF~I(m\\^Q@tAԢ@r @-3>ff@{&WJf͋\'3C̼l,cZ|@whZVk~b[_/]aO띘p[o(ᾄ 0~" N|x[esQ1q1~+c@l~#-WP7M4bѯWĨ~ 5#'sN/ybo@c.zsz%7ĥ'49NWTYTe0d RXVԅKEZ2M$mii]Qzw䩓'S?.ї'h}epk+! 3- N9 [CJSεj%rv5wgMn[1kؘẆ/uR)}\Y]~L8)%^kw.bGdlXԺUN =6 '+kvrfNIΜk*qv6poL45R4 J.c2' )&劰/#^1F Ro9R:cgUHI 6Rώ.k εUi\=\ݓI$NZU9,ȭ1V leWKÇkoů|r W[ rexl@^ڥAbP*E#Q9&Jt9/.+UKcSN@yspu^n[4aSXxgvC?dVQ߆,FK2ವO^րnxpf@?hP| ͂n !4ꉓ&9""bh!ž7;˽YQPώҥ^wLqQEeE6dpXB sIt؁ݜH_21T Ğ<BSJs<(u@e ;N.ѧFk[[戅Ȗxó/X 2!%tj;ފ֑Sd\*'Kc9iEZ&??OT| K\JC)9Vo\a755pvƦxihp:mg~ I}'7O<P>:ST,G* q{$j$DɲQ ]L 3}M_ Ӹ߻.@3Bј+;(öAT$7LE&| )Bo |܎mz^u|WOe⎶\΅l%KPj3_~s.L]!e&M,΂N޿x 9t $~<0nٛZ,?@O~@͸<@(3HW8?Roq@ʤzőzv4KK!cҩqVyώĜkdʑ #׏6R ϖTF1)v7Y;1^VNa@&TLR@6G5@BmSb pQH|$ m@iIp\=힚0?KHW_|,>n7yQs0ۄ UT3M3Jgj;^6Tm,jrRU9>ˊ-r{gpu:'(گXB ȷw28.W)/˒)d\nqu{Ε gBg9w7O}tzV.i/z'eW͙Rʌ8 KGO;qٻ;qQo.!J!JDәL& j3!!0ACc މgbJf=qP,r( =EZwZцze3UMY~U(!&.7*cbi$זn'crwt@Eߑ቙;6lZQ'tOݱq7~ 5u ,]c}S J{)`ʽrS4RuQ%oR7ޡNn7}}5ᗢE'JZ.E,E-tIn7 @PRh+ܗu~'Bi6 !@Z iJcpOJe > Z@tH( M@~> EVwvŻ]JT-Kyj64 9 )BQ$ag_ý > ghWQjFTG,&E=vh?^J͂(RHN{@{IWۦ#}~0 Fɘj032n`Zn:n6'/Xz[|fMVZZz*mlĞaCht|9(byďڜo3Ilj쁸] 힨0_[rĢUjLiBy\k7#%9ρoz8#z1z %p^VBaE߰y#)TZdyVW|˫`j <`S8!=_( }DO%/X (UHUH/j{ *Z[)qW+e={Q6G= r ^X fVGÛdcdy'[K3G4ay[YXIoA9-y]/Ӎ[K YUpơ=Q Y/##5bִ O_%pt6\賈,P o-pe +u@TJ@.wXPWnV;<4g+)OEL bRIs]"Jg3:tf]ZRTP_*-pD UT2X4C Z0 ӆ/mXPU6u6ȭjhlPX>stream xuAoV=V]s#EH $jnI@,/^K9|z>/y.n؎>n?̻~s<7ol~q oχqvw^<_Ə~3q;WNon;쮷>~nw$ :nn]Z̆?׬|mZkoڦ6Nuҡ{uOߪo{=~%RG#~oM~o~7&7 oM~o~7&7 ]~;~w.w]~;~w.w/E_ "_//E_ "_/WU_W+*_WU_W+*_C??!C??!o7M7&o o7M7&o ʟSğ'??O)OʟSğ'??O)O?'O?}jgc4UN?ӚT7ӽg]=i^s9{0=z=u}N,fۼܼuN|a6OxQ endstream endobj 26 0 obj <>/F2+0e6d592e2-7891-4123-9006-266432da3610<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 27 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212\205\206\207\213) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 479.594 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.032 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Primary\040myelofibrosis) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 385.454 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 405.794 1057.789 Tm -0.038 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (overt\040fibrotic\040stage\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\214\215\216\217\220\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 978.589 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Essential\040thrombocythaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 449.355 899.389 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 469.695 899.389 Tm -0.207 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (ET) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 492.375 899.389 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 512.715 899.389 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\224\202\225\226\227\230\231\232\214\233\210\234\235\236) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 459.434 820.144 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.029 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Chronic\040eosinophilic\040leukaemia\054\040not\040otherwise\040specified\040\050CEL\054\040NOS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.066 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <83848f9f82a0a188a2a3a4a5> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 418.934 661.924 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myeloproliferative\040neoplasm\054\040unclassifiable\040\050MPN\054U\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\246\247\230\231\217\220\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 317.549 503.494 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Mastocytosis\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\250\251\246\247\230\231\217\220\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 424.294 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Cutaneous\040mastocytosis\050CM\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\253\202\246\247\230\231\217\220\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 265.849 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Systemic\040mastocytosis\050SM\051\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F12646d295-c668-4bb2-910a-4e3b7e6abd04 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0e6d592e2-7891-4123-9006-266432da3610 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2142\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0e6d592e2-7891-4123-9006-266432da3610 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2142\215) Tj T* ET Q endstream endobj 28 0 obj <> endobj 29 0 obj <> endobj 30 0 obj <>stream x |ם(|hFoٲ,ɒ2,ɶd{D 606 J]%PK,M C IMY l6k6< qSF2!4sΜ9sߏcBjԇh|/񌇡C8:wQ4('p9]wuθΓQli]%;ܽK-% t.[\n6FS2hXYvnu+Wݵ(߄Ѓ.V !i=ԝ]]ڠU?X;1 5K5OB}\(v9ކ$H&# Bc_-I((}z8G[> @t"9'T5$"95f&OCdxFHXX,Do_)Q$pk"#R5@]w"`E,fE)(PC-‰\(ݙ( e) *BŨQ2T T ]Q EuMCQԀQnC3P3j9!V3Iocfo'3q{9OhN2N[N Q%$(߇{.+3|ނlL~7 &'m;#dUoMJ/޻g'Z§>Qh2q ,9 A[ay $W A1w_=Y CVa?Ys| xßFC8: k~: 5?cۦ756DTWSJ#P0PLdgez.#ݞfKMZ&AJˤ)5fi[K鈩ܵnSCz˭s}s${$24Ō-GceFvͷٜu1&EY.7pO,ŨL6%6.rvƸhw- 1JOЈ®pKΝ&yw䯦9sGT)51d=n9VG:அu+ O z m%CDIp.ba-:ݝE3͎5̃&x˜ܵYuҷZ﵃&Awkᚼa׈-ߺSC7OmtuTvto"g@+L OVTnMƆN8#+h`]\L ;KٱLy"u+,_u@|5Wg݊Zrpֺe/:ub)^rcN}bpy1̧&lD~QdS,)p;Ɉ̘˹Nõ)MZjmǨ֩PnjٌЧwٖXM3Xl1;AMCdq77\w;; O-v;9w)R>bsc\2\ @&V?)f9޹lQYT]aK7wO߻3x{Bg(M'e-ƅ Lh:KYq; n#Bͬ[~{rCd+ rzdGٚ;b }^]22yt7ynNߊ:/lxo1Y8 nCM+m%F Yevkr¶$g5W8nnWI[cqi^ۭ_]n ~:"%(T}č<-k=΁qev G. 69rZA"A rR@!F. B?F: !3)->G(~TX}S7bdq-<QJFW#|psxrt+`1eb0PŒ>/Qa s?z s< ೕ] B@B8 FDUl2bUXV!ya8h8i}2轹X2#?EǟP?fՃw$|} %SI$Rfh&9tı:}mYj9~M+6țlGRY*Of*R{cq` ^9IJ2q7a!aܛ4ݥ Y)vl٤s\l `JR^%P4Vq kk!4d¿ŀo,gܸܿUx]A&ڟnWrk@>m`$WJFA% ZאLA2&$*%/edegnP+` -\ 336L,@Q{^iL JExDB@xkpᘰ-÷&|U#0C8 <,ARK\=8 !x _09Ψ(JE)iFL'&0&#ʦu@q$׎xRxªOѩ]?߃}@_axo7zIܯҺz~ #si M>+Ntt pv. y"e&ْMFƕ7=~3ţX9֣zLxWahjYkW_ {7fܽVݰVRa6 MeXK:D  UbׄN2%a&.Ija,5>!h -Orʛǜ˙ď6~0gfԏ⫨u/>*}6q~YȁztN˺FQO;qPjc8rv*̬ F6;)]&/Vyg2``Qܬ;#9wk f*>W;[^4#[X?B,;5wmY!aav VC'QȸScq4^^I_I4D'Sif .%;uK{K'>^8}K`ZPoS*M܃"QT*)5L2@D0K"& 7>eX{}G7П1o+~u篞zw!Y x>*~>ŮFa<(b(ԝ3VcX>Bg\ PEX`]91N3?x[l䓥_;m[^_;Yr.!X =JASyT2l)At'w¦0Z)7'0wZ""%JLdqt!D$ S2៟xbDŽ?޻zlf#ựk(|~tׁCa.=0+$?(T*nSXpRMƝH{T;%j`QP"a{DqDa예S], nYK%0擳O?4Y_UVVL =$g;hMi; HD2c,I%>ط3sedNZj6*~2\p/=І}>z }m]7囱/KӡlH͠=$W1WHyIK˭tIs;~g6|H3~#@f%Id{;F->WkT*v1tm",dA֪L~9UIcj#Fy%(~diӴPQCCQQдP]̬&q> )!RQɘ$28B"-=$*e.ě f aqAE_Kn|oGsshT`cTqt%;ͤi ZI1@eu9%`[g"l!dpo)\W=^꾡'^SⲑGY_[;ܙ#$w71s~}Iz<3&^ 1WMR[5У=y&{(;pyOu$cɩ~B@3\R)nF.G?ڤ\zl]F#p ?'֙FB^N>$Txu)Sɴ҄$,%0ɀ,ШpΚ0j<6_`fU->u?xܱkg}u.HcwH+-jKvܻp̵`3UxLH6+12eȁ~awJRB've'jI-*9A]hQ›zWɓrB7PcE0?~ޅ Zxgf%VdVAEZD)'vR_U'Y+pm ͘<1)Gp(#":[yFQңr>+x;p(՚ wSFssSOCSG>K@j5ϣyOo??nr󞜨Wn3x>ksV{501`y$Pȅ-] ';yۈ4E[r8HJ0`0,| uxKDU\qRV]\RBB\D4=="#qg8KN <ba$z2IVCS8+\Ev% / 3(dfK_$|Spϼ0", iaIpq̪_ϜO~Cش_8~幺o%.ҹ+'+un‚+R[@ˍ϶aս#P@3&R*+DPz32 `/NuW0|UJxJ*mQZ%v*JJµnN>5"P wri TQ*Uh1sW)'H Jkmn2~~eOY[OYiʍVV%S(rJUS)c _ e 8OT GmQ5BQ4E<3'ZI5SrH5m@NE0&@6bŷN_YPLݞ`2%RUdI4IDNJo\7 xlr* w=2j:~R|PoسgZ8I!/BaS3i4-A݇6H,oy\Μ1u.$# jļP#QWJJ"n/H9G Yl)1x|vJ-[.Y{ Tԉխx:ʲEj,Iݠ)P1n?(Ge#)vyy]˟^~l,,|zi7e˗G s 'D*,./SPRXH ]sC͙s;|۟m?Z{ퟷ_kq{fz\+bynnn$!wngs羖^rUYŹsr^2wlBnanswy${T~-Bz){7z)y/6]lz?֫Ǔ{@ttE~vz.&U5ky׳]ǻخH&u===_=)==s{~{ilzZ&ҳ'=RdX98pXhrwܓlz/74F#JY~*OUlUMUTWHUVU 鉪~SA՗UJgjy˪Uʪ0 h9PA!) 4WF##2b4EGy$DDFb"|2r#DBlFE~qlw)^\jpEi  6.fA~[Z?]ż3EO#\3/3d]3BLpg] ?$<:<m,Gq~|"ct&z#»xGCTEVLײsʙs e͚bʕ*B]oR٬Jn~eRcYxƲ ˨w:n{t/ %oē.5۞k315f哄^p8L.4l. nDZ~@ 03ϯ^w/([JgS5::#t_F> \sx_G7 ό,') 7GRQRTPpϰjl]e9[إZ=2a4'@MPk%e hȜBs}54r,ta^CmYٹDC ?ufO⊇qh${?2Q[N uAx0GSRTp#( \B_(- :SUjs,ח3+0]$YkA]IS#4i(ߛˉL4fų}+fht[L$'8kzAodd&(E7 6JxfSTQ_f[6.dp@ٍpo0?K9܇~Nm6i9BH4.HэbPC Q( Yo0HMZfĢo- 8[\ ?|2uʴ*KZ[I[%sڳ|ɦd&a\Of6wDq M Ʈ?'<UDord>cA2P2Tt2sSd*.1Ӝ6*ΪQ756rzwLLuĝVs`n{*MʹU.wi!fzcjj١p0LBXvxow7xKlmS0SҢ2jt?Z~n.o/PTQ@}ͪt;RS6lk*bEg )H8F*$}dk%N}rЪP8%$2!zm/^<| o}[$wfm%MӉZ:sr`9MAEGҋLSɏ"UPgQ/vq.ajq|5/8۱Jl_N :>cXyILמe[5](|8;?wի[;9x *a]X/(>%|Ƣ+:W ؞n_/~U`oBxW>^ `E#XixD#-˸̢wp.iiW2!9T雫 R?J4Az̢xJ r\Ri9Ƽ G NA~\}CUV[Q-R/ U*%\hDQ}:MC <(]6FtҴ"#hlRy!-ibYU.nr>p~8-gRVkjD Jq 446MVp*];+RYTMS>T9#g47,!"F𬌬 m݉2,SeeXkZe`:e:ovτE"WhUo*(2IPz~d* xҩSH)b-m#B-#|ScZ  `I ;˸dU"A&/qάz,ƎđHW`Iвn*Zoւ,D#.M~ۋ %Gl%6#Iʁz螔$wY6 ,nv,|xtoέa0ؘ ] s|撇˿2:=>on^ӻi]V'fuuƍ;:n.݊ vTO <fDx$R~@cڥ$gBt3sГ q;NIqz\.z3 abs8 x⊣\pO ^V8HΌlr%gZ.=\夜"w[U ~zӲ/fei) QƧmKKi49 Y`fS;/mRk8Ґ ԗGXJ7RI (0[@t&PրDK_hJL%NFD 6'RlLt!*|Z""Jo&NӂqV)b% .#3OYz79O1 o,]ٻt6n:>K'S__>o 8]8I~5~y-Dg?3uŲ >S:"c ٱ-k[׬|I{.~,bN*iL7՚kz߄ۀ3tfwq6 SUQFM{%@>ʽ>_7?FTom1d56u)XeCcXr*=^Ȧ({ȌaFTlV6[F!UՑ|CQ_NsN{Ϊ 9޻}{pjlNTW?kn:^BarJB.I C3$}9\"Np$xAgxoBpO 1&}O'G;⻄C\N̤f0%57v[&gKIQ)C3XAs#(sbhf%\XmG +G\~6^J3iiR9++ybX)q8lؽ܄M1RD#U645TUfD:'ߓOhKT&")q+*oB| !nzBK|tAQ%rPfGBG>(J\ =ߒ7e:XiB`Ov"u-+DR)JDC[.erQW㗶hS[x~i;o1a;>~i…VnD&` z} ?S D $ͨ93O({T\/[Ә2в"&jK7n:^w82  n/`G UF7hU`"fi4ΚNpj-).T,cMu$1HrUB,xJ} {<J?v~JiWbrPG;m}Xh$t!t14*<vv}}e+[YY{c5EX&2P[]VT=՝k7UfCդJDSY"vZL標PHE)mr4*ڛV5mhz&j}-ޖ#n$Y'Trd[l#z݂bRCs3!9%`1lM$CTBäA\'Se4w6c{wJ B}Yyhm:_t|`Mg6s8+#qfa3*u%O=uv\n2c'*kkK.=Eg'Ƈ}8uRkYdA3hZFՔm̞2%7rmm7wn᝶Twu%pf,&%h +ȹBt.qK8 ܂\UTSiù.t-hqӖhY$M-$Q%͋ü*773b7itȋB:S&I5{L}s}>[!;m2[]A=++y^T@sp0ƭUvTR6,W \Wq{sJ6V iu]8JR%xɒ:C cho/ȝu]n=` 5@@&EtIqL< N d[HRPwBRMD,fyk ŴU$:E \h0u[5ݠNEZDJ$]W$(P0vaamjr34}.]n*%+»pؾ#Oэ7w]}p%=5Ǻj:sΫ]9㌏ 625++UViBJnVې!-n?)&wͯ%Kr+oN(˥\:Q{RƉ%/vK-a>FP<+(.3ÁU+WD.q_$ Fd<'&C>E ̈́oj2}"7)2JKR$B>aÒF|tVQؿw>v#dx9sv(ܲ.o̦ͭ[g`,ʭx+oӊs=Ԏ~@rv`s!g/ފc+Ok1 {{swƦJ\E&M Prne#/bdȦke$HI)S WTyS$E-G>*svGnH&/ϔt7GQ:4XHΑ-ƀvNLUsRWoȧ|E 9Q~JSiО\ی,Nb03f3ٚؖؔ؉$5H3i$Mo4qĶsu8\Ӱcij"B8gJx  H׌O?G}1=xOpB|\h}fQ8=6Q-3T!~FK4 ^/vF^ klr`-3IHNZQ@Xe!CT<(ji 7W4EQ[[uz:wW4jVQt%} `ddIJ*~sD 7dh49尅L'(ٌL$X\J^q(Ԫf BXxz^0ȷ}cB+g'cO'{S=;DkIy;OHoçښFPҲww0+$$SiZ,&` 8rBѻpZz%sqPPS!%bEkuiUd4mMMmmL5 '0l MNs7[ID(LvtFHHN8V| O0?XX j0dX'j $`6xq@ qx:AR3)艢^*ˢE"j~U"\sh2)`7nwݻ{xE"E{8"&W#6'^}%9Iov0P Ȥ^I2{ Ezdd 3w3g'8Wd 8@gU}OonHkOw.yc7(3; Ms[kׅ0v_PSߪfx\}ZZ6o/^w&.gZi̶] 9o]@LO`;Pϳ,Le8Th QDZˡ3FN!g*NMI܁E\ \6HQhbC [pn Ԫ] Dmb*g&e.Pb&/٨6I"Eܷ $vQ>/wc=~jVb>&n өZm޲ !_@d >|J!x 45dKr&5Q5du& %FxH Dh`Kwi FVSs̉K x,fsX1"2OCccy;Q}jqUO%wUG3'2̏3d2{4SL ࠗ| :WtILĞՓd."XDMw`'?7lCH"Ny $:}sQd/Ĥ$~.E$ԗ^|2;cЮWRnGTP+nʭ>G{bc*k{e}k@U|2?p,,is㿧{j=lf-»[~{?c!7J u,İcu5YX++.V1K6[nIYyt^#u|4JK4$<<U5M\YnZ?-Y?W[e[%YeIeL0 d ~,밮M1)6Ɠ0J\Syfaĕa2wowۘl۷-Y\|ɺOj Ҁɠ!ZPVaRU^X{&m 'GQ11劝N-X:CXm.Rk~ 44m1%@NҜ_=1HB!>-dA +xi O4` "NҥIؗ:<V$]er!8OAbo vO$ID!җЕ8HE&rla4Dl%! L2zzXeL,V!.DĴ00 { 1r/n2S Fbf}z%-Љ0wߦk."D+>jG#RffgvΕ ֵ(MBH_|MQT Ք+HQwx6 $?b/|!IJęAS4e1&r[Il5z.!5̓_rLFd-8'c$DƒHYxHKpg\ɁO93dܕstIYQ.K&Dd_ , xhbrFV VH栰IUJJ XG% ޼rT](8>;~&Zq48E)^Xq}ɿnڠ6Fkh/l۹k!C] Owg} +4jhOsUT<on; ċ`7ݛ+n{ɏ;uRdƨU9>q??X:tn_#1ef"ł-Bz(2CUTKMJeU)O*Q%-ʤ_yP))T^P^U~\R7w@T(30τ >w̠}%S 2%o&LCTzTL4Js H~SGL0 n'I@ ]ULHBZ% @><&94[G_{~O#oyC<;^bW*w^:@T疭Sj,.^x9abp3ɪ|2f :c݁ߨzeJ`X8ad _=YجXR*XEYUYUrCLi^tꕭٍxβ`s<0XY;0@1 ]x4s̠!5 \f`(Գeq9[͵ʹ!vI9=/!uQ`2w*4;ݐ@n%XE.5Hbl0q2͑=ι $BQ!B KaxBj\G$|( 2EWJ@Dῲ3<qjmK< 5¢c$*ێM{y j`;{c3S72ƜzfB};?_}͟Rsrmvl{IX?L(b=2kWo~𗷝?vȯS_ʏ^=[wf s@Y}8xdf)K`hJXd4#YS'&o^ SB")hhb)+*"8&xKZKKnJJ\.e2TV&/c|KTXd6l95?)-L, -'L&2إ  " xeE!l'4B69c\|b eM$N) ܡ %|jS&F~5k0:/oeTt3T^4'Z'Wci֬ '0r]| h>tE`l oW2'{,"x7d4iex2FaeM0Xd8Z)ߔ_Td{L- JK>F׻X?%\4D'3A6$$KUMMa⟨ζ n ^#jSF// ֆl-lg( +YixškO>G[{ KaK#Ϋ$>Fp&kYjDN5f+I`c1&9G//<0r 1k3[X.N_AŗywsP\gB2 5$3%yDʉ?e 5My6o$ȩ&Bq,xWCg~IqNG ނGPTbv2Xhoa~:CpQl93ޛǶy u um"_^ࡱo|j(0 xmc۶ ۻO5}/5O s.lE$Cx` ˢlREJ$>W {'zRESb)b=g{ZYSJŠDii^57ddH.(6nv.z HgosPʬ/ 8bEX9k:d{qs:ea3Vds2Ρdx'䧞EA,>*d!5S6PWwfP{ |bj]e|*~{ qŊ6s&{EsCg"浧/:6'5 /y&ͭQoSq?w=юٳ؈"n@(Kޓ=Ük( `H+3IwY&˲fRm!_qYOzlL IèN*`fVdQrW ?NAI GN!,µy}HZTy$gbB1H<*dMS6&~4 ʲٗ鑴쇰}>jd_rPF}yX~!%(&{a-+;33 *VNBAJ2P v`9z.Kr+׎ _gߓ$R;-Ne%qiezc©hVpdfg =ّl*ېG5ԣ"*EEHZY}fMXreUՋ3V}UV U UIqqF"@`+]tIS$lN?TDB$ڕܵKJ`R-$~@ALx~;#qZHRL9? Β)SP<˅WYHd. p5ÿj`9׮=` |Mp;<btCSu1wXbmlPW#]F>$P+*5ʔrͰx+s$st]nG9;r ]ɻUˎطO;DZ[e[wv~3Xg=WjDž; o zhP cRf>͏&!ЃRIm TԦ188"e%s|&Uxo*҆JmRWƟImȁ+*(1bxo~!x?،~ܳS%`; O#}O{v>m,g}^o֍7aٳ]};;-{v}m¯~ۭ{I8>x |=B=?_M _|קo/W<Ƌ*/h߱>;•UJ˿Z.3 GX7_/6ؿ#>stream x}]k2Gs?va Ӗ'=59ȷO 8vWǙOӭ:];·i|O:γi|l~v_ᡛv6}t i?].ۏ~OLq:_g:ob\vx?ؗ{?~]A0]wqڝ_bl<ZQsϱcytTG:ՙ.B誮tnG#RzMoz; ?A? ?A?G#(?GQ?G#(?GQ?ɟ'$ŸO ?O'I?ɟ'$ŸO ?O'I?˟g3,Ɵ?gY?˟g3,Ɵ?gY_ "_//E_ "_//E7&7 oM~o~7&7 oM~o~_W+*_WU_W+*_WU_Rk=~oÀkΥ_7қֻZn}=}[}񗕯Ȍᆿu\-n \55-unkŹ4b_ͯm{q 9okܟ7m}|v>z/g+׿oA~_W[z;ϝ{A6&iY| m;u\1l endstream endobj 32 0 obj <>/F2+00823074e-4b4c-4aa0-b497-872777aef388<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 33 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 317.549 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.04 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mast\040cell\040leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 366.555 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 386.894 1057.789 Tm -0.01 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (MCL) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 430.635 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.975 1057.789 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 978.589 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mast\040cell\040sarcoma\040\050MCS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213\214\215\200\201\202\203\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 820.144 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Extracutaneous\040mastocytoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217\220\221\217\222\212\223\224\225\226\227\202\203\230\231\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 526.035 661.924 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PDGFRA) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 607.064 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\232) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 627.405 661.924 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PDGFRB) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 712.905 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 739.185 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (FGFR1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 806.909 661.924 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9b9c9d9e9f90> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 620.164 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 160.41 620.164 Tm -0.09 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PCM1\055JAK2\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 540.934 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myloid\040lymphoid\040neoplasams\040with\040esonophilia\040and\040abnormalities\040of\040PDGFRA\054\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 499.354 Tm -0.063 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PDGFRB\040\054or\040FGFRI\054\040or\040withPCM1\055JAK2\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 420.154 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 216.209 420.154 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 224.85 420.154 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\221\217\222\212\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 331.275 420.154 Tm -0.113 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PDGFRA) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 417.314 420.154 Tm -0.179 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\240\241) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 457.814 420.154 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 340.954 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myeloid\057lymphoid\040neoplasms\040with\040PDGFRA\040rearrangement\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 261.709 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 216.209 261.709 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 224.85 261.709 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\221\217\222\212\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 331.275 261.709 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PDGFRB) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 415.695 261.709 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\240\241) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 456.375 261.709 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 182.509 Tm -0.052 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myeloid\057lymphoid\040neoplasms\040with\040PDGFRB\040rearrangement\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1e3714ca6-169d-4ea8-a373-0d6eea8e8016 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+00823074e-4b4c-4aa0-b497-872777aef388 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2143\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+00823074e-4b4c-4aa0-b497-872777aef388 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2143\215) Tj T* ET Q endstream endobj 34 0 obj <> endobj 35 0 obj <> endobj 36 0 obj <>stream xU_h[U/ݚQ(w۵Vֲi*&&AqN|pK=Ia$߹9A |}{r@C:ŻW{iiQ/yoA@ vd/VRُ6~2Jiu}4bw_< L8?%)W+C~Z y$8`~'y5װB#]WGH=1׋Z!o=bjm Ft!6=q Rdh,2j0D2lQXbxP_| >h޾Gn |p0K˞s#00.C O6MI< i<ΠX*1Anl%?}ܣGZ= dG -0nF}mlFm]MinFBSG&=3S=tn\_۹_?ѐ7v31G[؏TK~JICCqT~ٍ3 ~wICuı7>/S΅OI,xƯ+,kz_aYP@T+lbHh?7*F<9먣6q 8|Fςz2Յ1Tg=^){ٓy;Z,uV)p3iC%ƨrhXT.s=^!<0WuV s%qct,.0Jβ*YdzhI>nwScΘ\`:ָ)&)"\(*^͞L:){uwyV_43$1V1cb@QǷN>;ϲE#o^š-kq(#LS|nG!\"TRMR]RMR]Rtw!8 endstream endobj 37 0 obj <> endobj 38 0 obj <> endobj 39 0 obj <>stream x |׽/~ΙhF%[^$K^e,YeG6cCK.!4%Ĥ% %\.Iq)4!47fkBs$@ܔ{{[9gΜ9o~7F!E}A-ͷxOq] {J-Jͽwcm {kz*CHr>N,ZؕrZ*T -fw/kMB=6h߿| ³޵pM[6Q;޵[OZ޳[яZ{V-=1Syx><@2=& @É321C'V?t-c\í_BJŏ (^c[9-}3#BRj/'6҃a$q#ۂE:xd@FdBfE߆RQt2a(slBnr!Q*I7]ȇJP*CaAU*Tj`nkQԀnBQ45&4 ݌ffqIx ?IHn`hOvNkr78DJtI-o{~ǒiz GL'(_цE9#>jBv4-O|~Ak68^:q$ AZN؍V-0Cj0/_PY E0@>8I4^BÜ8c1_#LzƩћ& 5UpY4œ<y9nWӑnOKYS,fuZZT9-f<{ʲX䎘U1ћ1d;]G;gRVL!SS2 sbL19NfcJ́qaW,uş_>Mtc$S|:b| ;퉒12ǿC! ;uv,s";g?K@#x3P:>jaC|tư6Űf򍏠 9ҵ5k)hWǵ9M̨ӱٱu!IMc3fT&&/RA AJԴ95XJ͔)0}F),&< W=\1]2<>%MLT1nrLciLXC9lQgGZ8vY"&gʒP_]z@1ec3i8P޵dQ%᪇kɳnjp3xbZ紝<ŶA7ݽlS\4hlʲ:$ޫ&Q.iq:b};')ݘʮeaNY"iЀ^S wϝ=ekʵ!Ng,Coܼy .}pZ)O=39&̔NhDaadQ\zQ?g3P5&L[yL*jj=.>F&Ϯ:otSbl:9j4#AK&3 L]Yq 4nə5& ʽRh<а:!1;wN XzedVzo;\V[74}==o6WIvFfr&f$"vT_1G Hͼq=1#9 Cr H0pe rT5 c$u]?Zux Ϟo0ߑDZRR4P^;5tTt>yp )XB;託:؃.*$Y1179P#pc%n9;9Ka{賦ҡx,N_gi ڕ2ٱD;M]:q}{ ?8㠀es<8s drGݜn6%BTJh)-͠& TXPJRa2DFD?QFM R`)CгSe24UT˧27[=x/E܃xOwR܈ڵJf <4GԬr*ؾSYp6Fh˦-/Vq?4dL[\??./[(ƷK` *L#!ﻘ6n/qmY{)5H"iKa:s{ /Y$_I?K\g3(UP3[qƛ0s_y?: -{w<<vC{. ry`NLVc3X4AD *ɉeQaƈ!Qj\ueKC?d"'kkon[{}W/z?~O_1 ~}RK-ne?\!848N1[z]ѐ4X12#6wV>` )9]qဉsqrF?߻d_2,~ZiƬrkaj뱏Г,5edSZ,NCzm5RI vrXG?$% tܒ-fօ ?NF:c7\ܺ~kO=Ic?N)`uo$~WcUϰ`,5S}2[,&jf:VѤݪ`M[I%LK[X0t,s:Uo交d_ƞ{NC*<|߈qe̳\ <c5/BDJ|i ]77 0o det&zRMT⹉I<&$8_IyI|^ӊ!;yWf: wb:)yjT.dpX@,PXQn8l+Gk$E(ҏUdƟ%nN;(xsF?%pAr\M4U)%SGD.9h)ϓY5̓5MESjjbZldb]Uj k&Vtbb^Uuf'eLygOŘŷ_8q1׊1l#~ߎ[>WLzr9/ҔJ@t"z +R1{JfLH b"S|Sj.C, \ "sou۷oe]W< 33lgH,~(^0vU]r lA>~0mgrd-FhepvlZBYY>kfmY$Y|9ȓcW<}*zskffvSm;  Ѷh[I? HKD 8RŹsKIlu0D`P~ =}8=bewm?>Pc殡Izf[Ӟ~5 dޮKmW GJ3J3Iͱ$@o#uGB>v+e۷e]E@cgcϦF?8'N\?smjW-2*SmW:rNRYKr` O#lT:%:-<Ш)g^<9/|t.\ -z, =LO.KaZ `fRpOqS^D~h2WH|@Si4*^CnVpPێ$B]ի($*x4C"B1ŒeNpJ@[VrLƌ=/{={Z5ѹ]seC9rrR,2/~eyޒ$AkSIzBH;%]0ܰ&tmQ|Y3vd|~Çq[_?Vy( n{[ (O0Sz3i(5, )-X$%2I- }dov[!Yz[NU-WhʠVGnhNbYu<HXS^`jpEyqL6T|StهJS\϶^?1y0F TPLtLhJ!@VI+Qn@Ih'Ũ)fD Ŀ]_ϡ[aPhyNChaXet#anѥ'ֆUam@>Nl{ohxhQM _?6GĚ%ųPљb+HOǎg0X޿ȽC9<+Fb[uϒ/k3KI1_v~}OSpuC|?e[_ݗOă 5؁`pde;hϘ0D:e1w _Ş~ J|OxY|O~AȰN/ꥫoXK[_k~#sø'$A"A &{@߮ r]+򄒤"?!"2d֪mЅ'?|M y~?fm}rFFֱٞFx@ARۍ( F0R1ppmgףݗkG^p}ܹC%Ҹ,yur]cmw2*rqmGeP2Tþ2H O ȲӚ:T *dV-rXYy`mvX} ,f+h{=~*"΃xh!A z=+Z{BNɚI'bcU pBe)VNR(6bQcp  XďY̜ g3S-(Əqe~OzgസmxXƇvl^#-6qd.<"ŋŗifu=~t8N`5 4Bj/:,٬&CjbӤW Yaݰ@ Zq0RTY#,İtk[ in?:(,uA@2 2NsәHسLlئ-Lbvw]X N5Ns(mQڸV{RY`I‹ ً NRbӦLfsONr 9,r/<$3L 4PP&R^|0m0G%UaN)Tq,*,LS/b"u#Xeu׸݌K!duRZR:Rؔ,R;Z֣'@m>Gߠq" A@-$+ 5 dž.7LAÔ/-Iޅם#bqP^J!`+ &qpV]cowNj8;M;?|O&O6tb a̱7iz³83iYgWC;U'*'vO#cxGI!azK4<ɐQiGQ4 JM+NALT`hE&DJ Lc0C2PesT8 Jb}nw@Lsc*.4v05AG 񹳳 yPitj*)}<)MO%xjѢt (I6# %%Y X۬fkt*!S r|zB}xku|} ,߄h]9!['yIB D5)J*g! {!'2Ԍj_ &N"'9 !b PbQo8y.rnBT39PY0LMkg2*wy4Qpr_~OKF331Q,rW_%cn {5x9|NTܬF kCwuq5vv~0Cdͥm EKf&>!Q7~x1^# ni_q{ iY ,2Bx|(÷JլӼouafpR ) @Q:z"FEi$ ļ'  )@-`{@pz^ G.F*%{ MEb}S!}']>.cq]qK';s*Z7ڀ:9"@- 1㣃 c23a"R%dz\ `I (b;jiMNq-s3 k- w6v;e+YzoϕRIץWJR\*)IgpXz\fOg= * 0c{k tV#i9P_i*= Y)!*&KZw 0a*H.2,aHr; -(N@>*dyn *syԃ`̒ý2z%6pӘ@MGh:`8ʪ,ּYn-8xL X9ng0,Ē4>- 2+9okh-y רсl^^C\#o8E>76@L)X T(ē q5)8i" 1GTt:CLvS$a YpL^m h[[i ޸ۘxmBvҲmVg6̥v)'<Htz1~$qOp 8dUb\|SUJ͐}) ICs4ASWw?my:UW-15o?HHh.Gv뎄++^\8?•Ocvϴ~{tC `s7 zje35q+V[.;8cB{ыjgoz!,rIT|1Z-6j>7ה*62u:@Feaƅ[\.RCA\>tԽ`4HPGP P]1}D#؉P{ Āf20BdR5f\h͘R2G/l&q1~>(F#r_w:TS "-c;^#'ω~ p Jv˪H0>?(T}hyѿ3v犟AEv?ƾvº-'+0/>#bxx  `}/$b4y l3mf5[j5@? c5r&+3Ӟ .W#F6E#4}FrxH]ZfJW4(B^:tUeʲGia:25 V\JAGr %Yj*Az2A'=pNN4"#2?> =2,M'|`'Id$yR'ʕVzZp„$$iB\\c/H-O_욵n|է[pU?MGI}2E_ݴ3xn=] .oe[-s?v+ԙAa';I EN??@?B2+HԫVG_^EzBDWgG:R i4mCxdYXedݛPYMVd5e˺3YJo>:J 9Pilhhu^T{g>^˩kP0}~]vjkgJuRͼ0Z(i7 "bQe=-h4GDui̋7Px#D~$uJD#C<,TEfމ=wwst2e&+/*n.n/^Q'[\#&(~oNjuɬlMYl6m{5ݽ(Y')JVh7imv@b흋/u<50t"G>HDCbd7=2=G!9W4=G7V<a%-R'-_29 4n!$N e HѮ kH1?`}kAa_0M~Tal|&~ʝOx)`l]ǘ)gzv6^YG3q{4!X8'~?t"~3g>"E=-URYͪd_:mu]V7§ 39{w@>{u'~Jcs%'C &a۠%^(LUIB|t.+rԩ|=ۧL}='OՏj0X\-|Rg K*m%akKcP(ޱĻ7Q 9 K †f%u'fce;Q"*KHVV_w n ,E&wctY.|˭_/G;vʪ4:LwnIHyeL|FܣKa^&3b Ǟ KRֵHx gnG_5fǿ[[z48׸9ЎvJ󴭸 nΈ?j۰L|LTY@D E`x MO*I;jsff$Wnai3$מ I0\fڗjI-Eõ*@(:/8iRILI903=]o6 L&=4ܶ R-xE!v`E!VjXh5SMa9$ |AGIPME`')-iKF^%'il{$ ); Z/ f Q J{xb67/ &JG SNlJ  Ni]0/g6SphoUj}k3hnvaO}Ā2<^GV9"?Il /bxFT|we3ؙ }kG=٬ q]`Քſ4l~aiJM)/|OEyyQ^ <( |˜4ym1 2 ^( LSJ}79 f!3?hqi~ļ%f; 7o3_438`llL[`͸n$3̸Ì۰@72Mi3 f ްͰ0o l`fVl`g CLa#+`@"(TZjV4!&9+ߚ1WpTog2}`LM\iDHVe2d_92] B!U(K_W qA!.K9|06y6#]mfA4psz{:IO=bmŵl86hV^LSTcV @5>Q}* Qi`mȅ7 X0[ '6$7"WIJ *hQVlp{*(ʒ#yU uPV@u^~΍<'镜DU 4''D#HъEb߼`y$Yvl8q _ֿtl^%~}}6I몖m}|#[v9ܳe#bJ7gׯTO 1?qHھM4 3u87]\ q+saծ d}%b S?^(KPl6Aubʫh;" z5-ӹ!۫=)rFGz5QL}cm -J,860P`VQ4nIY7H# ^Gy_uy&"cVJN~2,R$UʕpHIj!40ucx[>ڰ 9 &WǖA:@?,2}SSrAsJKn$Ӛ{Xطon׮{e#Ow=>ط'=$;WI=ތH/[<>p[;?[F7SdG,s] Zf`iLu62Z<2 TW+d q N&h硆͹tU[œ\96GV|ц0 AGl v{} chPyxiڹza {(/ Sl[|C8ߺn^ݝuqu3VmVhW+33ȕ3omqΨoЌ#3#3ESQ TSỺfcͶ1׸k55}5Jz9RsF!5׻ܫ/n>8wu}qge eK䉬SYreUg3:2`3e332${ .X das;ӂiGNCiG>H;&'i$(MD2:5yԚ4&oSMSsS{ӊM7=ѤGhzoƛ&ߥs([;Xma;VNci#aG)VƤ,NԷ\E.F/^I+I%/'sޤR `Q 0Km  s\B&SoMg›O@rW4 M!2F@8(uYǝ4M@%]4d >nMslCG"`{BU>S{*>u܍G7bX0\7n9z_$ďu[۳eZK!tlVXT3;mj0Gdwn[~SqPPZ- ~Tf[|ԉ@w)4Mt4<36{Zs|GY8`'ձV 2Ԋl y+.9Wpȹ/_j47p)WvQ^Qwcj37-50;q!TUZ3#VSr+1,h r-VuBء/ar+RÂuΛ3)//Ǜ1綒9^*-k쬰\^!eLl#3Vu Cka<l:0'4<]ÃH-h%6[ǣe]4r6)V,SqnI5ESLewYly֛oM XXIQ$.pi '5J:&m`Cږ3 m;yDR4vxbC*ƅD ND.,z3`4 R$zrKN9%T&ȦPN":h: . YԕJl2.}A}۳|>ܦ.߿zDǺ=Zg=gϭ_>8vG w }H~ D(7XFu?PNP`b.7vN+~<Ϗci\+% ͩŒ<%L(, 0H6jv DJ ZVU)uz=`&tU4CRח|OIRGzۦ-a/ $.H8$^i IDB;mkV6|LMxNY#W6!0ZԶ9%/! ~2INΑ MW-| \FC6߻k#>|%^x#fhC7 mZn4q+܅Nq/߂;{6.{~֖կ0ٖ&6ˎoJ;Ģl>7xghx ;|7`?,mWlifxb+P`gy?"2tK|)H`8yqSq(Zo.RǂMūY7\T&M[ ) @`Z5\hDQiv bCLE]`z)ؐ ^47֪ J/9))x~3˗*)deeЗ>_8=k-VS4ȩW"T˄~rcMچɼmʍF$Ln64D&af @i ZsYWW*ި`>z z,[ Z4xK.%ERKQ 5WWz*Y}UjsPRdjDŨU*܇0$i8%y\3*lҾ%H F]鉗ؤj'^( LQ%)o" \1~ɠb^{͐WS->֧Ap%pKgh Wreq?cQC\t2|g-N]rxE1..,I;7wTΧ -='=>4ddD7[ځ~Vǫզ$ШL˱ ` Bu%h =(CAioV(ږ oI& U Ƅ Fq 44A(DҖD]23%.kr$e::|_{; ,[{{ܕ葷/c[ xF{{zp76=!~QTf~IqrճW-ʺ0_ @2~Gou3<(xQ@iɲ5ϼƻi|VJdɒ-dI2e M|\ `0?FH 4$M .&i8PszdL7]`:1Lk%=&gӕ}}o~o3]|? JLl'9380-.gREdj˾ѹ`"}o qs<ഔULE#u78ք55ґQS,դY#j2aJB ] hPC<Q?9kR8E'fL+}-KcIW$n4"ٖlGv<{!aV48l./ɐ n &a0k`.ACf̹y֚o?:ճ`Z5* x̖bY׬F[+ YSTKs!UOԑ4zxtpRfQ~v--dM-uQ5|E1{1IcXӆ~-a|D*̪Xztw6,Ƭ9z<|u7~<l]G G Y)BՀh&\Voh+t8 D)VxccL! }Q$T)]g-LF԰uS ^KhΨ@ny~ss, 3r|<֜=uS{z<3Jb's]}@ll Z_1>(=:1pY*pK`ZrThy#@ 早hpuh^@Q$8B 4G؇9,F[yy9"=^Vpܯ4>Mf/;5mv5 ].nZT\pͦB0b8-ik.{wt_3S]=e!s=JߣN[%"^/2Lr6&txh@*anҴ/U'IY$C*͡Jk  JbVWJcc*M`0~ +* =*!~I58/#hX~zBDʣ99ۀꃞQ+ځ芏y-ZtpݐnncFS#6wo;-[w]==W5f%4N ?8 =v ov8둯4 WJ᯾N]bPg|CKpTL_hSch<_ Ro&g$WwѸY96A-2G}e@~ 2kl-lIVg록]e{{ڈ‹AADŋUHm*nUqN-*ΪY UVqJ~]q7c #|%<[BCPnHq$Mx7hKq7 PNOxרx5 < >5D!6Alۓvk]H؍q.fDLĎZS]BAWmWbl13"Ln\Y]%vJB@.Sg|1ɸ3Ό=c]Fa2(әrPy[!\>Ɉ]'J-ÓuÓuѪOLrzm1*,_oVM U+W8V-/+ۂd{fI!dC!d,h당g.Kk|myA8@ꂫv.N# endstream endobj 40 0 obj <>stream x}MkF?-rh ,n[nFqp T`H4gfzZ?Ont?x:>r:B}_w6>C7~6}t i?].ۏ~OLq:_:ob\vxؗ?~]lA0]wqڝ_bÿqnl{ʁ#9)'rVdS6rQ.dWvrܓr%QR^kFyC*o9 ?A? ?A?G#(?GQ?G#(?GQ?ɟ'$ŸO ?O'I?ɟ'$ŸO ?O'I?˟g3,Ɵ?gY?˟g3,Ɵ?gY7&7 oM~o~7&7 oM~o~_ "_//E_ "_//Ew.w]~;~w.w]~;~/ =~n}ӧfM6fjn[{e}m-mVǖ6Jv}<&f{M_֫v=qyNJ?o[ͩO_CۊfVoW~Vy?iͷ:~+6mZ[ a +shs+ va>MC۳ [y^7# endstream endobj 41 0 obj <>/F2+00ef34fb9-d4c3-4102-81e7-7ba2f8d771d2<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 42 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 216.209 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 224.85 1137.019 Tm -0.104 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\203\204\205\201\206\207\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 391.934 1137.019 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (FGFR1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 458.534 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.215 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myeloid\057lymphoid\040neoplasms\040with\040FGFR1\040rearrangemen\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213\214\215\216\217\200\201) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 317.549 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 326.055 978.589 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\203\206\207\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 432.434 978.589 Tm -0.105 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PCM1\055JAK2\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040Myeloid\057lymphoid\040neoplasms\040with\040PCM1\055JAK2\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm 0.764 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220\200\221\222\223\224) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 302.43 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 311.79 820.144 Tm 0.722 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220\200\221\225\226\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 459.614 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 469.155 820.144 Tm -0.06 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040Myelodysplastic\057myeloproliferative\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 824.231 820.144 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (neoplasms\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 778.564 Tm -0.06 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050MDS\057MPN\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 699.364 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\227\226\230) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 236.37 699.364 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\055) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 245.19 699.364 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\231\232\204\205\233\234\235) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 387.075 699.364 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 620.164 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Chronic\040myelomonocytic\040leukaemia\040\050CMML\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 540.934 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9e9f8e979680819b9c9da0> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 398.594 540.934 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (BCR\055ABL1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 501.015 540.934 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\241\226) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 541.545 540.934 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 461.734 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Atypical\040chronic\040myeloid\040leukaemia\056BCR\055ABL1\055negative\040\050aCML\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 382.534 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\242\243\226\230\231\232\204\205\233\234\235) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 398.594 382.534 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 303.334 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Juvenile\040myelomonocytic\040leukaemia\040\050JMML\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 224.269 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220\200\221\222\223\224) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 224.269 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 305.85 224.269 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220\200\221\225\226\206\207\210\244\245\246\230\242\204\205\247\234\250\251\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 731.265 224.269 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 145.075 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\057myeloproliferative\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 535.283 145.075 Tm -0.033 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (neoplasm\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 650.245 145.075 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (with\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 711.753 145.075 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (ring\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 770.413 145.075 Tm -0.072 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (sideroblasts\040and\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1d770a156-92f0-4690-a853-a4cb55832b4d 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+00ef34fb9-d4c3-4102-81e7-7ba2f8d771d2 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2144\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+00ef34fb9-d4c3-4102-81e7-7ba2f8d771d2 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2144\215) Tj T* ET Q endstream endobj 43 0 obj <> endobj 44 0 obj <> endobj 45 0 obj <>stream x |SU?;;dդMw&M4sAM Z+*- Pv|@A"8:J0(2uu<GqosϽI^[ka  <&H~=ܹW1M[8g|1}z[w8ʶ"l}nk)AH1Bk%.\@B%qi %wG{W޲p6;j ##犅wM wLtXM{Wګ۩|ȿW"RvɂPhNe !,|I@F 9K| (a銐qG = M򏅱pp#(S!5RR ȈL a4JJGȎ2QrBnA9(=|T Qb|RC~T(QQ(DUՠZTs[P#jBP3P jE t=P;uQ' B7b?4г?z 9ىKߙ!yr_3W̵1nhɐ"c})T~(Z?-N ?6Un(u"u9Z=g97JB4-bjهEz䕄@ $ՃuZ6 ~ f AQϿfvFz}ǟ@AF{ 10acfzϘ^F*¡`+-)x.g#+ӞnY&Js2!c[8{ڲxzcO\iθf82]3S*y4=nn} 9q"3L. gsi]8^1߱Oρg].{·ۺй8ηC˞Li72IQ59^7gMaMzcS#'qd"(^!6cWqlc6A8`eiŒ.:cu9797u6!(uzz U[UtX5M*zcM-D30A -Lvw- @99#'BdȔ %;d'K8zyĦ-j{/?;,;mIgOJrq2e 0-snzViЀ^Ӗ5}Oϝ=mga`rO7mFp1>eȸv/4ƅN:5MsRIsc4iWrݡh\Yǹ(ύ$()1{Z]}4ή`_dl2|9~g I*X2yL20Zy(*/==65{͛z6-XqM5MzcHa{ypNY+a)5wLnGٹdaRXy\0gL3x{gQ$LH{P64f ǍPr 3'wSԘ"*nHB%.塇G"f'N>֮朘̱Ds&sZ٦kyctF}KvqD'H\I-q6c'34[҃tN@Jn=γ8gWqoļk@Df>8#HgȜ"M=)vX)x?=0<{#|]i)ILyJhQy׍J诽qp R9͹.v$9kG&>ibLSd ~SP, E0gsvj"ѶZP?5e;;k"S9;읬'k6^vd6HwS-APaxaoqy06v"449yw"$HDq!۟ J oHJSLatIid I>&#69="R-o!ePI`.̏Az vq >[ąH#+ku 9a4Tmcp0jF+ZnNONH`0(]P3f&P/5?e~%`Ds/:hls6ĕ `K)f0F) AWuA7_h qer .64w|2C 6!߆m`ӡӶ0$ \Y6`θλN߽~iۺ=/Xm?8=ӧE`ld!k-tw&m1V%iyvÒ'C,bRIsbLm ִ^´tE$ތŢ}\N`Q X-y) TOxD\O9n{wbB|>0}t拿(~.>̛Y72et&:RMT$ INp7Dɟq>.>#~i۠Lټ+pv''9s^Eep,\.Wd6#!(1$Rbprz .|)Rx4K\'I<0ɫVhWc/xެڦ6!Sk)БXO14-K}玉{HceN՟ω`2bdCPg&Mvw6sGwo-=/iq~Iw-[w۝o|`myv92sךZKv8?N6i5=Dq6_ɷdgyPqCo6̌lAn.Bt2VOf*e1t y%u0D3/[_+qDZx.OD׃0`)?(0.۶xx2 niBM}՚m2Х2v(xD4fRkIʟ`h=Fꎄ8 ɓg&^wW޿;wnMMT|(>ۇ<Vg`-($j bT;jw4i֒::S@IuǍBVж뎌*ع[~e]`.Wf}wйٕ YZz 5Ch& ͔diyHx+ S>Շp]y[`'ƞÿ޺yx-O_pIB'Pj@le/^xޥxpN?ݎX'V+?8Hy9uCȂ^!NѨx ^eSEla VTHiИ^/E\0cY8<`\+9_!`FLo ȎeLC7ѹJ] seC&rs,2?~eyޒ$Aݩ;i$3)[$XO Z~]w 3gv>gv峗`Ozf󖣸+o~\5*?* #_쾤4g@қIx@aa]UHi.v.}Hi#{oYwm^<lVqVt fM?F rXVOf  50ϔ1A ( z@Q!&ƿ\WjszRnu͡i.g;<d:(&t:}@`4Mh;oWB:)('Ṁ)foE $nVC; 1aHtp- Kbn\°TСQ4fIi`f,TtY r9;|ɿ3 ?V>oNrmJl"[pՉَC޽*̒dDvWiGdvo}#?7ClsIxڠ)Fc~cq8M$Dep+`[l=8W#)U,,;ڻP$2?%=C45A/__kRzi sm8*>z,9 bo)`** .';B/O*I*R8)Үo+f]<Әllǟ/顝UØhPY֭r:-6ȷ9FZvd#M@ARwQR/a1ppOFV|{~tO=w<*mv?.{r;wN|J^=p&VMS`,DZh|vrJ7&v]Jا䫱@NP!&w~oI:L-dXU+<$/<t*I99WP>i/LiI M deWz=z4~h3PB@~BX~-˨~ Hl=%u.NJv* َϻ i4BD:}0]ȳab6z^TJeeiv=gҫR7&MdVQj_IVܥ^4e#4y"?б,cxJ~O*_|S$")zPQƔ> I}ւ BMQpզZSW&lNW`263IOM#@´tK\PT NGC4$|l2ΈKsrqLWˮd)=hPD_Ze4u[h% ݃̂9\W/Kfͺ9|Zff3P6 gGHEEi<+D;scZ6xby5$<ȭ+W/(-Ƴ[ f\A YWu׏\4sLsǭ cՋxtBע5ΑczIR-M[ѥO.=w*>8=륊Kc-esʖ졲ʸhY2故˚fV&++#7,2k֍uWnyZ7u{h^XY–9K U|᫅~Vm&0\\8$ t£G 2iYޖ^ӻzeyͽ PWG[/Um*VK%ׯ}ҕ"eŏV+xl{+V,]ϯVCKMGEߕ>FٗW7G}='h_T¯{セEBdOgZtd=)ԅuKu4}6)Bv"lζg{~8lg˾#bEl]$ҤDyv셉1ilnh C^?{S a$=^bXEYo<-%Q^]?yv>x-jrP9:.!U7фh[PQGy;D>Ux~UDˣMNөDU>i싰wH΢YTQ>]jbeRB٥mݥ+Kוn)[ :)1tҏJ,(%RVeٴ݅ zWR=I9uZ\mvkikrV-OwvBZ[GA'N"vC9"~ @9K$NCZ5J}pp_= h&w JQzYEGA_*bU]QRSSAA0VuIu ]>_(\ Bԝ Qߨ7^hz1Fi=R)ȧ@uыG A 'xLA(.VNZO:U\0s99D9gH.(yӠ5d#IʼnS/=E1f!6[ q;:|R ^3? g+ڽOq&5:ĸx|EW,'ӻ |}0*?'Lp+nel'^"Mܬj%y34.\|pG/B'Qk֓9ƱȌP`hdc8\rv ygI{! |ՠFԊ >_^^%v״D)̈lM-" eQK^AP/TSSqIIn3Ӯkiih>mo"N7k:qXE8j |.u$-g ֧Qc)F&>>SБhU=.W NgQDOFAV @_G uh-j9natP=}v캊0󜚏þhho)> ^jy>/1D;.%&x܅d"isB&Et2!#!,WM9`VF]eK& VkeeA8HsUʖk"7gcsWކ }z. =W_ti C) 'p֋T,Us8.?2~eVZhWsl\r[[T9usNVց]i]ىw|T C`FLQ_2 JevVRbOC[UYY B8 w+;|gNVpf\0?R)d <[6F-DfCf[ь2syW܏`.363e?lffxxdAsf|x10.@p@ u}4b e`2`p_ZaT,6lO 7./*áWeD즇MM/~obL1rSiiI03q&Bee*ar$ίJKR~Q%*A r"\XS:sq.[И:b0Dm03 Fmc=N;mݙ$Sm-L6֚l4FY9FZEڡZ Z!ZOԞ>RXE>ޮU뺬ы߮ #/P5z!h X#Hׅ.1PbKgj)^lJ%]zUǻWCʢ]I#&/R=y*Rh+JҤ^ $9')?2Q v>ar -hX*$m`Ҭ72RI:\vt G/V6=lpەؼZ?p흃kj{rqVؼsރ(^߈WlUNǮTO3x>=|@k4 č\).qsq޵Mw'Zpjot+eӴ#x^tsphe#FPZ`ؐ"#&fZK4>T D9Du`L9ة-ϋ)LCZ.yHֲ3gdeFOoqq3e}h#F!CƄV{BȃP:l7dT+t:^OXn2Y~U 2h.s`.Jva\9D~?h*-ajrRH֣:BCLUؑ3(Sy^3Uqzz* L1I09>vCVg?='MKˆ!uK+WZPՠ4&) HZ^/H`LUȤ&(Qʷ@r7Sb(^A]HF jNȩȩ_![N.gae=n '~-|9MwewψilS+>;_^< ķ'";rf(|gg0욇ZœoDLHaaf{,2Qd<~(Dm@&.?O)Ȍ|b\sj/vG[>}D(c>!ӿg,+7hd=Y~E☸dO=y=_ip%v~Bޤgň8&xoA*9  b@e#(mL'T ԅ:JPRd%p)-r2j-ܜ@nO PIԦjD3ZJ6Ado q?bJ!:vNq:mnBBX% H=VCp?eq~'|J&iE'ETXyVQIZʔR$8~wHK$1)|RůlǯlllM!&@|0""\x Jj? k#=+=ط;JSq3fhWJbu) _ӷ_~B!Ԋf4 E=F0{]hkuMM7eΚfQ,w8$it]Q>""K3xP/@s67466SVhL:5GdB7[NF-O}uS^i82 )b ~ьOsX cVy"=Q̰Qs4'DpZmbK:-meCֵmiƴ ű6`ͼo,@#7 |dd͠:bfH7T "Rf9[e9o-?QΔ rjWI5fXoUy5}M) ӒB^~eƼ;\yW B%D{nSۀ܂ׄnnS@9lOEWRWbTie<|<m[ic6lQj7 ff70Y3]<_ PrZ]VE嫤)jB* _Lހ $]ݽ:5WuwuII`wwuC.ʢ&Ob'Y\%6).B y)Qap̧Knk(Q\.gl! ኼ|꜒%Tn'KRᕜyeŻ*U|qѬe/qt{ZN^<3>PxÜ'4ȼ7T ̜J54\O:چfoHXk nړa;JJo+)WCEEM•8vd(}]ݒ&)z<%&ٜA!}usiEyEa3VkǍa SO1i@y1z?jsҀfqaRS+K8>C + odF@bzQEcZ g6yH<(hH{0iRFzɵC]ҁԨp6" FlI/jVݼL @-MQ'Y#9pOlܗLs;Svsόl0;$;ő-&31&,VRXr/giGpHH3|`{KF H8BU|A!@aCf0KX` 駰Y\i0TاSbs0돨tEfBမ4$f/:@uDҤ!UFM7SvjpTr§l!*R>~ ˪߿%)K 1%F^1@ /[CE!r%&풬K}'r &qn dM1 ! !ćN8Ǟt o;#c[Z!4E ݻ5al>з^3ɮŽA@E ! ?h>Ae[57M}]ׄќSh*S4Fv W~\[Q pUU:[ M13f̼#jl1ᕩ!W¥QDkh(R)Js魏~VbęT%u1EK!(S +2Q+4&I0gŚ г`&U !Z{g1Y?'>IIFr7@+15)i5`0/i/i'CQI0)t4J#hҤ|)KJM!`((IO/R Lm)D@>z嵭 /w(~w+>oknz } @ V x__>[~Ϻ)\yCXUŘdLQ3HL:#uqsݔPݸkܿ9T dYv$ǜ.C&dB{ʩ:ST\1 >ҁ=2ׯy;se&9(X bFAJBUA tu%OJ'âIQ$D:6HZ IHOΑ QFeOJ%wr ,))3+_'#ތv4տ-dnj9s\h=`)x~x}Qb0s6+Ŀ?7[;cn_p"Qg( d |ydJ,*%j 䯌Fp§.**.*Y,l[iU'|-Hl8_+P_vb6̍) QVTi#P"Yx,FFƯ!N}Wh=_s}u$\dĉGAh;P7> h6_xћEro%VT fk(ZYi/bqEG#@p4|tkEL $/F].Cj)w2E/=*M KdwAhj$-"QQ0RqPB7CAI< BȖ V&ϡ Ӹd<4$JrdWbwLl|$B,;TEiNTszɾӗXΦw->(64kmײKo?Y*GQvSkv#}ԱVʡʰj.]^!5 uh6 F8F76VhdAT<*d:3㔕ZA﫩Ce+?; )4i&#˱ 1[eeDLP^SΔe2&.:Y(HJ@ms1R$/FL~R..8 d4NJIRsڅfk Bf@??Y8S, Ŕ18=EwVYI.iGx tșy* h꘢Tk C MIqc|A)jt1WȚ$^H%WOUr.ykԉǶW. xx)M%^ X-iH^]Dؿ?>vČRv/ 2LG|Ԍf`8yiKq8VY`.RdS*zW7:<0w#ȠF@MH#(;<^V"lBTة| =9sk)*K(ݜ\V45硱gάA...;cQqx|S? ،6 % =ޱbq\]d|xTo[NaOÌ>Y(Nc9X),lmXs[l=1Rk>\L`22[p6 Dj>Z12:~`eM[E"_*' 2*;,,2v٠ \uE_*i7 נ3C0L)O=&Ak]+`%.jgxjf73dX܅όЊG~]b`H>4 =?`ȘzzNwN`E:]F%0CeZZ̤hAizֳz5!,mdhDfe2lo١el*+C>A@ v{!qn-h1Dz^з['g땽~LD/a$iTiC% L||D3H8z1y08}w :^fYr *ʩ9?hrH+fn3]ydɞue33,:$f&-~./x<>>]unr:W`IkZA×gֶ>xi\6`]◀A~]iiIqZZFVD]SđQKwu E(ܜ 5%rഅGq~_VxDv1W /(,{e98[ƗQX192zj9"J WV#",.p7Nr0`5M5 d+|-C v& NssmqM5 6QQ#?ȩwd;:9;tp0Z={2liiz@2GQPraTrHپ*ʓxŌ)}*~4BSWqjz4ig҃ݑQuIG!4I0H;"ιmɟ8eǃ0ȿV˨0߰.dאmx{%Ί?m; lًOl-[1>TâHb/O'͝/l[l[LGglܿB2+LZK3r35 spęp8-fӨ$b(Zǔ{Tt 0 \ކ:U (*ɥ)N,v.|%%ޕu^J#%?YRɤ(^?B8 ɨ/Px͐.R? !fh(.(EDFNDPTRpCSXP5W]a_]]޺/&duBN~Npbuϳ|Nh:|D$2 !Z (RVŸL_&9_gn$1ȕ |:J:'=Ӝ6H:Q-Kà 내ZBE] [Yf58Ƭʚ4'Nʧ$6E@I05w&/h ><[ |KIcsb?+ΞZ̭9 g?$/L|[LE"Xq9$ 3CO8t%-8uN<-^7nb࿈c=ׇDZ?>O2/f7wZzos62b玽Ԝị6=Gؠ9tP>W?}i1W>Ѐl 򷹇ϕ5S JOV=&jjWy`Mk+PPؑ`9"[@Fvܽ7g&o};h.As[yZk(yE ˭ζW.`R @қ#-mZ 3c3hWx(& Jrً#ڔT[SK0B]K-LO i)o!kdb 1g FТ!EC鴫ꨝ={vr|cS晷+A^MNyG@eHy͒~ItWDPx-z1$mɋzu˔=NQk!L\ة\ p|SÅ%6y2qQ`9ɲxV\8&ޭcMߺ`Aǚ[e3y7ï\~AGedm '+-dN\}O.'~jaV@_l\ceIy}.1%~3_;@ i%=R)5~P`t1Zx° kj@z}D' uPH2dYQDs5Q AI]Ui9,42xd,+yR-X8g0F*\,+Ȝ--r iAW:p( 2H1fv:TyQznkji:UqqGETX!)IYI}Ǖo*I$JoYL( %؍tI[Iz5hKSkN\HFSȅCXS'a#sX%?FLpDh:1s{^.kG/͸||p^nwq|9Sǥd&)\Wn}M.v_I]ʒu%[J,h&$xS:HT&8ʾ+gFے,d[eKdٖe[bvxH"93띘vIRݒ1{rDH/YdwL3pG1,Av{(׿s] |=t 6p&9)ۙL!uVXKTb#x9 ڵk{ շ<+%n~"-0o^|7^cjlh_SS[/-[VC6+9ڬ<{r;eeQƬIx谋>Q3)9ٰ-DUy oQniU5GSdLM&z6CccSSyP__,2(R0]!Kx⥊*\ N$ ~kF{~H P~>E΄LF/mUJv~-Er_O!PˮӅ')[%d D5yw?P]?J|#R ciQ1uɈp!kYKKSml{xDb$Ό 5/nds~8po.n:콧_<.Ÿe U ׮ w'GkAFd? {mХw c8``XbaLv;c15BEIZT*àzMž&SU}UhPUQT&5YS8WHIY?N>BTKhIQ&!d!@guqI$1<@ϴZ_["$bA.p %*H+3=p,^l-SMgVN7߽rt3q!>!ŋʓ[@VPϬ6ʡM0[fM۝2l|-` qJ9hpڛzYWg3(H4RO rs|9Ui>?]oѢRb{BK7K:ҼY:]0ڵZӻ) 5d7{Xp hl6ّ }FdS::3A9?gMADȊhKG2IP FD ۑB el#:x^4IA!>+Hؠ9R;Y&aipb|RөVK~ߺ{;wr7w=NŤuT xccDVU% z[~nWmYQD1lLE}όZ'Clr@D4J#C>Ѥ ,jhkT\>٪r 9 hܯ(]}PT0NdnhX8S]QkXѭ"c`q1D[|&N.A&o uG|TJ} K댳> ^]}QکNi霫nj'ۛ'4MEm8ܳ> A3'0.s܋/Rg)Բ smб o-k/ui< `A2to:݂UK̃HjbP(G֖|_]cQQj}:QG&UqXBx PKuuI *:쫴ZW{zyJu$ ꠰m,WW[l_y~7VS&衝C( Q>O<^ Q$63=1&zGb020'kzPpӦ@ʝlSNEJb]kAkw}TV:y1YN^9Kk@*7BZE߾>$1HeA^JyT%6=S˪ِIҕ轨fȉh̋͘\DR2,1w d2i`Y(N,!g+ꍑ !mc/pYk47T5xa8o #v;niyl3R-s,n~.\H鉫3qٖE dџnfs©)nhՙ/MɄoKm7kvEތ/j2ۭ- ௕WPΏ ZqZ5Zis\bSvf ڬ,QkJMY 1g0?gXg{z.ʓx\H -MbjÇZ"Kr6 x0$h`>L|/ٱ84uN]{\f/ &Y2 숬Y5w㶑3rNDG  e#Og6EtM.d6šC*WRd A׫#u( L^GoXBK7SٖH@Bjk /TZԂɖHF6D?RTDq{9tY>;ݜ\v|K }:!]BZg5Ziz` HO7J'fUe8LpOILE|P@MFF08Ep7~:,Uu%́( ޮHÒ_rjt%:̙k$ȓBV^]j"րh.9:]N^g| ~\ow\,$Bl?&֐e7CEyYO YQ-m*I hԥdl96q\wSp%BOkD~++\BETcK%X n)Gaf0f%#_R-J撠@zxob,54y)fuhWZ|o e[HTIjL*["a.OTuUXg7bNM/Fh11rrۊK[T'l.q(7<9St CDC'ĉPb׳NUuK!Auei4MFϣjc}jOp(ߘvl 91wšjxLhJ&٘`Z.Hm;p*Ɔ08Xo9iέ w 4ĨZ-)? 1ˠw^fS~߾{1eS_^r.eֵb0k [_(?4iCJ`V=B~РT(: F!31 8@hL t=JtvSMBl&vE3?_ Ԃ{jQ/5A-nY+>"MFvRP'SqVv`O|4Sm66cvy؀߸stIo_<~\q~^@ֆtdp7qzht`j^$DkG؇'llVSgnL2[AT h,d)UY8dYfe."@r: a9S0@Nе[:QQL4t[AE "ZT+lzkA=3f\wl5u\·:;Su[# =Y$w݆eAyNT^XHU >ܹѨwDZժ brnXuۊwQګ髨*-* 0tEEH lxJJAh55F]"R8Sߗ b|~FцJ"JCB=JُSJҤPأaGTXȴ("BJ"N#ޑL|貸D6.[*4д/JC"*ɔI&J9 t(qЬ]̫)zJ+6DȤx(\h'HpNd~}n|sdR '9ub|b`ķÝ==={̽ĩi~_LnZ~xmccx2snJO 6 8?Ko^\9wb)ӂZboBd ^,ѬTyP^$ _Kٞ 0mAѥ@O0tBQ C"?wDVn_8U"Ppn /*d =ِ})v _O_>D}FT,G5dCȩ}7:GtiEޫ"hEtcQ‹9bktEƭ/n ;9|Փ23Q!=RH^CIRxH)fRx}?)NRbR5{h/9OxUI[@^rHR+a CEjxn0L?汫Myb@Q[:7'2Ujj\uWVoQROi"!9߰o.U;]C9wwr/ #WBHIqdste;tq|9r]UY}x 5P$U'W23oQd@G6?mlIV |(y =+~mL3r%EMtmr6Ou *"R6NF%Fd=#}sP7 }Oƈn"=ϑZ!ԣ^DO!l|uȶk|Xsk^5j๾_}ogxBWNe$_!MNy|*E:Q}y#f{u?~]FȕRKɯRJgJ_)NPsځg|HW/BzU%x,_R{A}(!~8i]/˗ř#[wy O\lwxl^dw)ϑ#>y~ڗ]dy!ȦYW׻_ؘǤ'H, fc6 BCqH|w7`0jMW,"`n9.Й9.*NS?)wʙ)CJSl ʖyZa ceoX<`Lݶbه;$c$%c$C*s&!ct r:sHΓhX1w~Cx} +Xx^Go= ;#;Vkj[ܰ`Lc|s$Ȏ6= endstream endobj 46 0 obj <>stream x}OoF=VU眙Hm.H B7ot+UU-^qx<\iχ2/i:aw߻y6u~xNnv;v| ߍ}aw9?i:|?rO<M:,f~zٗ4?~8OCAi?=L~tX(}>^>.n-@ʑ9+g)ٕ\ *WrSnQy$/V^- ?A? ?A?G#(?GQ?G#(?GQ?'$ŸO ?O'I?ɟ'$ŸO ?O'I?ɟg3,Ɵ?gY?˟g3,Ɵ?gY?˟7&7 oM~o~7&7 oM~o~w.w]~;~w.w]~;~ "_//E_ "_//E_Wm\cjy*~_zo 抿>/F2+0cd00717e-4dcb-44b2-bd40-15007770ce8d<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 48 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 1137.019 Tm -0.059 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (thrombocytosis\040\050MDS\057MPN\055RS\055T\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 305.85 1057.789 Tm -0.095 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\206\207\210\211\212\213\214\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 548.925 1057.789 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\057myeloproliferative\040neoplasm\054unclassifiable\040\050MDS\057MPN) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 867.21 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 887.37 978.589 Tm -0.036 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (U\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\216\217\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 899.389 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Myelodysplastic\040syndrome\040\050MDS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\216\217\220\221\222\223\204\224\202\203) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.934 820.144 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\040with\040single\040lineage\040dysplasia\040\050MDS\055SLD\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\216\217\220\221\225\226\227\230\231\232\233) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 520.094 661.924 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\040with\040ring\040sideroblasts\040\050MDS\055RS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.079 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\216\217\220\221\225\226\227\230\231\232\233\234\222\223\204\224\202\203) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 661.965 503.494 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 350.962 424.294 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (syndrome\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 467.592 424.294 Tm -0.01 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (with\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 529.1 424.294 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (ring\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 587.943 424.294 Tm -0.059 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (sideroblasts\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 723.469 424.294 Tm -0.013 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (and\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 780.299 424.294 Tm -0.013 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (single\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 857.672 424.294 Tm -0.066 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (lineage\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 382.534 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (dysplasia\050MDS\055RS\055SLD\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 303.334 Tm -0.079 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\216\217\220\221\225\226\227\230\231\232\233\234\235\223\204\224\202\203) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 661.965 303.334 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 224.269 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.457 224.269 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (syndrome\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 476.765 224.269 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (with\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 542.809 224.269 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (ring\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 606.331 224.269 Tm -0.072 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (sideroblasts\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 746.372 224.269 Tm -0.013 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (and\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 807.88 224.269 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (multilineage\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 182.509 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (dysplasia\050MDS\055RS\055MLD\051\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F16e5ec3dc-0ef1-4835-b7ff-8991656f9b16 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0cd00717e-4dcb-44b2-bd40-15007770ce8d 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2145\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0cd00717e-4dcb-44b2-bd40-15007770ce8d 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2145\215) Tj T* ET Q endstream endobj 49 0 obj <> endobj 50 0 obj <> endobj 51 0 obj <>stream x |Ǚ7\Us_=H#ͭs$hFnj: ,ɀAB0A/ژ82/^ba8 czqbck;^B|:M}{đ7tWUWwWW=TF bPgPї|P!zwQL&{ !\ wϙs!2 ϖ}lBλWܷ$} O#4DZE}Gzw"t'Pb)pɾGh]w룋+Vݹ twݻh]v(䟇g{z NȿU?X;1+5w2@~3\ )e;eQqLړflUʈFwg@m3=#τV!=R)DEnz!ѻ!sX"Er"vF1< B(,D*39dD&dFd#X2elH/<ȋ|-g\Q*DATQ 0*EEeUJCqTjTjQv=j;#΀';-]60=hvz霛9'd7I?VEω+OEѿ?߻;N?ޒ~z~_zwryyS|^#&_>>>}{^ _J[R+z]ot!9ׂAO܁xe@6xŸBGK8i苋c0Wff6}Z[kbjKcC=_W[S=*(/FJá`aA~^nNzܮ,gfnZ&#gJX`TIGcWdFcoRos}P^ -NJʂIdtvF|lnR*I& '4'%gty9sdfcL!-%N(:$좿щOcPb޹ѕtMfK| 5qMId9&V$N!īP[Nbs[o&z z'}}ˠGzoԣ^ϐghF1 IӒo:Q7RC aJ4.kk )u}&f[ o8CNLԈ1Y%E'6rhqoP[+, ӼtV2kZ<([wwi^< [[KޓΤ Ic0j/8f2 ؓ ͽ騗nAf? .ּI'"OrprIm~с3]׻6y"=C%>f@^=˛菞ҏu5/7߸!<8$??MfCCʹRSp11wh8pG~QtQIj.;!=z1v@eGf.IM,IUv8߆twhiZ4:1Cڡ^_~ܙl<7.U0TZfLKoOųtd,ޘk;Y:3x{gC%h,B(XgQ5zp(c&\I5Ӽlf@CRKuQ-Lr.)A#az鑓Gw#G뇱rLy7y!Esۗ<9 XRKqt8R|U'AD'`%8?Ʈ CDj Xѳ71%quh9[*tׅ<ԛ+g:)7 MZRP]rzmszjKlm]Lx=K`'=M뼹xt&jɴ3-ְVYA jʊ~.kW 'V ʃэTs^<|^V?ҋDžݤ1\.W2~23 n3G#{(#eUlPOXJ*Fiϛw|Ƹ1'ɬ.lbkr%aЪ?H8w6\/vm;V;J8+slIއ{LlLLd9ZV0M&c-OXQ#1h3-F`\8)/+y%,ح~j]jaܼW--|m9; /S k;?_9s?ç~|{?h.=c}@ !FIJ' #ch 4!Nl-^f?k0qQQMG@eX-#cTO3}غ뚎9'GN֔z>O&|i*r?BȜcW ru|=*{,]ϺϹI{ltosnk;}Q:mr+n-! c1L^mv:i{+T_sŘX`o}<8^~xϲ/ P6 'M}:>F?JxmG ldەnSuZrhE4brcPq9?8u}? jGv%o~e.] g ppKczûrީXGdV]ޮ4mZۉM5_:ht*}CVJ )Xc O÷U>Oܟ]0Cb?4@gh2a茨)NgR$AW_m(gWbx;%<4/}lK~>^|7鶔A_PB5boϐs ykn*΢qOrɑJ+c* MSeWe?{'cL#ߜ›76GapLM :!Ї|6 TjVimj6jղQãMX.Tv;厄blR5G@b%?!k{VDv'fETyG8kv3tmIdQY`0s8/o(SqcPUx9gb=u ܰw-[^oF){%?zl sF[GUZUTV,j^Z$m1}#{?~ۆ/ɃYY5(<,4ȀG jk:=M/F&]ϑH #t :3,T7`$*HA"ejЌZVZ^b?%{ljKyYsk3xFU0½;7M:xOD҇A-)63}&>3' j|$۞9l0YՓ=]KEHԗoT+5i6;YNy ;﫞>'|/y3J x޼B1-nzL-7SVv?~W]r8!_~x_>xV{hz<#&Sd[`pb[3ӂ 0d,;wOH&T##Q*1,;oR!0(7\O+uo pя_J .R^Q-Taخ ]) yQULFv^ 0Lcσ}cك|e}jzbbQ8Dlw 9M)aUËhVm}ӣ+??{oK_?3} mUqZ2y]ThNi JV.gv C/߮(j$9Ӻ Pګ#j4R,:U:mJ5~J6Zat_j s$]xggH 8 Π40l.\4@͋w\&3g *51fli :;ۓGzr3^lLH`5f5ɽ<&{C=2+oG7LZ"2+V_Yʔ:PTŔmց_Bͨ4GFr5h4JA\kPngD(C CͦaV"xK:碂zDkYц;!p 4N!枷z*ʃ&O;D_d^+> @p{Xu9Eȅ,3ixшa|"^}&UQ(j8ȫ5A4FqՋx0|=o0| ۵ E7iG[Q㍈E,g}Ño8̍ nf4ZbVOiqP;E;_8ǏI_'FprlpnGv[_9&=C&[Gke$+)^U1|p$LxI0KIrNU9:A^}{uZQBk{AtPUFi2({οLma)A8F/^br Er- y k/ɪyնg/mkߐxx -)m YiHFz볝߿?>m;wl3c~H-|#24ԃBUGAf-uS`9srLm{(;P: Bemxx |<>mQܖDb$F.]g3_>g( ]GZ{C>aeƫtuS~tis+sN J Ƹ^^+4K ŗ2۲eO-{vٱeo,;L9le.S.[i-[ҟ>]*JY6tvRYi)3_|j3!۟yK=o|y= [q UV Z ,+yKo|Py܂OR); N=[E/o'?_?2?uu:\.uu|K\שs׵uO ?XZz7ce|eV+|z+ʖW.[/|֚gvˁkj c``}?xz@A3?xí>~@Xœ^z=s\ߪ'sIBLH˧ܗ)77ָgr']ߺt_sPH~!*܉'Po'i?Px3rM~ ̇g_uo뿬xM:Vya۷Q j ]@߀n-u8;?&A+_2~- MYb_ r.,&ſXbfqe4Jb(qt*PdOJBD;%|U2Q ^pz [9w/@%bGu:\6NuaWu,Y FNh:{t*hG=IE?IvVR\ Rf5-dҹ(Tg+^_.\~t AQ0kŒ(``~](T͉]!$~inLqzPRҍto5+].n 8LWQ79r'W@Rs hzTB:8Rw&}7#YgMX^GKܒBO }]>|1I Wq'xx]}p%$-nYrGݟݏep}*7^q#3AIdrcpi?n_zv)9w(CY",e(ZtRΛrEIWqE$+RX] ξCͩ^µԣF 5!CJ)QV4nZhJfa8:#Yfpn/Z5La ՒLP69nkٹBp}G"5.eeupd֫q%AV25**%9-wY:w.cy<  dllۙ3`@ʓRc<3}c YVW$-{:-m33V,KGz{ڂ[(m> +x|rIWǙV75]XN9J*Ň_"7s ʖɸm.Fָ\^(w cJэ;y^vm1MIo4%M'Mc&KԙɤP׫ tTu*6V|P)U*]09Z"Ks8 &rƙZNvDi -y1VhCJ-4PJ/0zYEfq\"N򙽩jr*5/ pc18\n_ȷc|֐<6NàappAoH L@ yD qNR&}TR_R%4#*Yj\! I,UA{,7/P cV(&)dswf9,mrMecמ@gw^ŒƟݩ)\79<Vg5Lh!k(fަ5Yk6}lZ6a%5WyPů"-3;Z\)(+άUSʬ3`-saWM> ?G9% дEp^<\ZZN96S*P`yUE N>ðW()J)U-\YJDO4 d4 V`~UŠx7Ze n"7y×i!̪a[RnUR`7d8%(qwwwNQzu ax,۵uuK>O1g:l6mB}X"V:Y@R7n Im 1¨яjRB? +jqQ.Q`D'/ RPL2qJ[q8%?i1Ȼ˨1߸%^!%}dtS Wo6=E{q[mkw]u쒭z5$^HZfiWJNVfҾkBa_ߊ/v?_r 6!|([Ʌ9eN[fj]`Ul>r)q ĠL>ĕދy0\G%)R]TTBIN(Krs5U |.1=S\uuBlbq,r+()\UȂ S B[VB';c@d(f b-2EOATɋfG鱐(BH{n/5Cd4r b|q$!FtCBaA^ըթ{O1.D4-dO4> y!rD3EL^%2I x0'Cr;ɝdIn "^&  ^CWbNBt4TI;|i^ABT+䒾D:V~L?~}~}X8M83%-#JnmBۄ38Rp&UI?o֎z{ٱwU p>FZdo >>hFs:F-‘HY[RoUQ'U j8xF'2l-$-'-cB%7 Pm) WbQu_q «/EDu ꭦG+t@kz֤͢\rOd>t@nJ4N*hDB4Cdp;"q$ Lv 0ѡҚ؇䫩mУ9RIRȀcn1@]9гm^M\U\˿n[6-ղ"-YA22SmW >)#x0+2gxxSYVT T0o64\%:$f0 K68WߍR1ON ֟޿ddIa;~_QU(6>L&s 3#pR\S.;}"7Sǐ fHxҊPv7?" -pd8dsV|1Cpm610Ȕ@ߦT:`$GIHYP(W)7(eRyBcW9BLÌkXl8_kTe!YC#[% *SyzW2(C:z9rĢa8J)%r(iB47 -* _cTRr( ޢ0SHBE:4mC{QpJa/fe PIyz}^xNGjAob`'g/\ds"؅Kq4<cW4Oxsz4 3BS(eEAYfTn*'=sz^|P'^ͷ#棈8G_$\M 30Yr"\w4 wEGTBJ46μ/,-d K|O+ 9f̖^ ͗rY@XQ7Ȅxa#1yzIsOx3OJZ-u3wu~' Yo=3k͜YF m rRXNZKyj,*R !*bS1ER1rP(jŸAk;=H,zp+i rL61)pDcRyO1T9vVfDoԾrS-0M20" ͤ bNw -/̌]8 W^YspzNΔ0r݅0O8-\X>>Zrlڼ".绖\Q\]y%ϒL燞wte&% ?wG~i}K#Uc̖k^DZ"_`@+R/8l P0ynvwL.92s=9Μޜ9?&~x>ϗ{<ٝٽLvsR꠨!wf> I!ޞy=@YECPվ ]}Dz sQ.1 t_Q/Ci$#tf/QHAHJ+ a;%EplQ-i L=agY-2NTH_=w0 ChgͶ8SyKɦ/vg· pIߵ. ŵZ,*~$/+GSub/YhBpUvg/* <ڰx ~5h r׹Ya=˕.~GG'>iKD#H<U)W'NShk%]h[K FR@;sz=f#>ӹIƈZkK.Ӹ"U-o=}usC+AIz|Phl\onX0iڗM|gqm5/q?&+?KjEd& 6 öQnVYU)|0ZmI/FmCu6*RoĽ(nO@ !_o=#MS*h̰oFlRYiІ :C(-*fs`^4ؚn2^p[2j*.I'֨5VNV`Ep1K$ZZ\|55Ndi7 q2mڈÍ|cg#*h!,eY64>}˙q44:`4bZw-њOq`;8c1&FJaŌR+ ' Y[@ p555wNzd=b1Jx:t.==@_%'PQuஈg_ZrϒsO `I3Ĥ#jQ)_Ԓ+ob-YB&/K\Q)WPb;m"y얘dkLO:Q~[NУgKjg_ kwlƱ=fl&é3>bֲqq"ұm|˶iɧ M[ڶ06> smZc؇T ; ~M}jHB>ݹfipyǟ GpW]'F&A( yџg0Glc۔mdN(9),Ew ;Y'ܧa7; =kŒw}H՝Ա:aBy% g%dE^Q/NzA)LȨ!JjrDS "!hYI(#%ǣhe1ޠ._Vo8CQD lkg2]aNk=ymW帚̻v.%cK6 )W v%]4WcZGR<) 3^+jɌ3M׋bHx<>a1ݟirb0;e|bs^ j2+nW=lm6fӈ6Vb2J'VLc- F"tḦ%%vBbOB4ڑsL /X\N'IdQ1-9a^`a@xf^z}^( Ճ86yɚgmqYt̢q$S}R^5;̵?Y;Q_%|tkO<2j tzSϡQjet#B8Byp0[Aan^!|ج nlk; @Es6 V2kj•ΐH:=UCw2QˣAt1(΢t^ؑ^\Q=FΔGoXdi)b`%#ӧWԤ@4H#0OlЍa"}ItfI`/ n]걽ͩ70]gNX9JJ©>t."wҁqr4"Ceg2.yVR;=7_iZ|7҃V3A0ٯj0j<:|V ]*lOq];"+/m2 9 oN `qGNO *Pb9MS##@^Gj.,S/'\D D:S*pVNqM.W*UqƤquү\_w!`H4/S\_aN,&֐]>3:]f[+Wサ?#34>k|%ERU0u:)it![>X0?> pH˄Y1*ՠFԆC܊ fD^5N_fhj54V [l /s:*j95榢 `^SY9[W7lo/-{g]~.ۘ..!|O=,SKRwv8.>6.k1ˬ:-_5Scj/mL+.AnyQU=(|ʵڶg^0>kAW܊_<.\r\?BRwɃD/Q8Y/W9M,Cτi$Ɠ1 U]Pbg08&%^[@.,`T1X(Hф1:܁$ l I"xЩ*M QR- PF.'=160$EߺH J@q u DmOf?M/߾V1Oku0J#y{_˶>]+d e%DC޹a39m^&WX",} !Ȇ2]. r: ́|,c`q{@RpPk|Ngl6XG}}ؓICC'@>`> $l8;Lv  d3FƠQnȦgxb&dF^kM Bs1$BLC=NLc;U!VJF FiX+$n/. 2aN"יB$$ cګPUM0ƛCi4ac쨋1?&¯v /ba_ NrpJ v| U ZxHj:=<ļZ.V m$6^(lNVc9ށ?^ƫj/v|VxJwq!԰ hr" : ~ocZU5SjnovvfqNN^^HY]ԆL5UgM!ԓ7{64]2Mk٦gzeuϪh}w:NV7sJUq:)lݱ;*@PњS(m*Zi"JuiSūsr:Td鵳i|]S3;p}3Z_鎋C |e: OFb+TҰBb,4.IFi W%Ryc}1B[ƍ(VoZOTQI-ZnL2 H 5%R.Ӥ$i`|D VowF.O SX% x]Ӄ+`tyΧ~wenYOX ##Kv oג?3m p!^\{?E-]|% f] ]^<8x=-؄nP$,nW!D*1 =oцu 3TxMnnR^oҋa1 @ʏ idaD@*z<)^Cv3,%`~N`V8uY*ރeJF\m/7e,8b@@z}15+LAShiuVE ]IakU7Gq-t Rg9өԹjjTz:z Sݫ&@H,RUѨGU ;PCX^D\zźE,*#[̚6U_NO Ipu-MbpDY+Mfα!-Fs|['"ђM7۵csO*Wm?xbpzv㦮-ɯ,[rލ˟eL%rSۄͲӛ7e B/=vX!\h'^=[pfQʷj/07Mw6߃\5_Ջ>,*jG55WљpdE,(yssk)\ї^y*-kn¬37S pAca#fyy@f** ]}TkH4T_jW\LƬP$s%_gѶjd((aLc#ő1rcJrVe_)JJ>HZJL*+rܺED(;ҫ!@:$-zVHL+S6i^Q59}c Q<$0rпhga&j{%dF(lawL1`%ĤЛTcH~ApUX1l cM--ض*~]o88e=bOpZطluaM85KKɯRoGD T$εtkJ? .ovƪy <£Vh$b9`{%Pg䴺 U75U`I@G_ X"lVOC\Gj^J<5DTc?d'T$;E U[:V.['a[YTKˏa\w{ayaY2<&ARZLWABqzE0hExSzLZ 1&eh`i $!;TO"Rҥ<=HWIu;a3ǙGR }یv!#;/i53NQX+x.Kx`>ȭ$,#b9=;v;UBq7:S;,Y5B&73G ՝ؓ8NAveۆ jRש;ԫԬ:6CbM:tMtrL'1eL^'&H'$$&+`+"+9R<%`tNa4E qr<n?~Oވ᫿uT_]kL>w^a_zX6,0zpNe5I4;``eSǕ[rSIXBe%Xf[ J* r%R*u K W-Uչw}pݙ;}9Pvf\mpaoF|Ӡ\vr,ddeކfjEaW+1g(o~ Na;9 M(lD PQ|((!&{2Jxъ@B(uP1d>H`5mZmo '<,B5&<\c{NnC:¶یD'΃[XVAU(jCPQ];+}n0@+L+x@_AmtF('ŽY-YseDI8;;}/)gK>,z>yrWPV hF0 .oM z[> #8@UB Xʌe`N믗DY~x?OUϏ°>[r99?<0!dvK˘4պzڳHc.F߈ig<ڗZǖsR֯_ɣWz,h mz~(+񄜔fjuԄ~VAN`t28:v8(BF0 "7?<JKi' Bq3Vi-Sw)~bb3"H6*WC/2i8"VA',p[OZY؇|PMq($WY349(?F94QF)}Mx 2U~[XuE] 35H+)uk*-l%e,Ǘaʂp֠iZD k҂O5욠h.bx:+m留Fc; U0왝ݗysl@c<;vv<5FGz0w1TCnk9.n1-;3;׵xrWvMtQ҉ij02&դt endstream endobj 52 0 obj <>stream x}Ko"G=ԩ,$Ebf8,hPϚ(H^Lutz:o{nxڏ6rwz>>u8<~x<ϒu8ݺd>>o/_C7~2t=Bzq{z&ټ{Wp`U|;ڎkgA討tR':3mjЮv+ݫ{z^ЏGz^+^Fw?A? ?A? ?GQ?G#(?GQ?G#(?O'I?ɟ'$ŸO ?O'I?ɟ'$ŸO ?gY?˟g3,Ɵ?gY?˟g3,ƟoM~o~7&7 oM~o~7&7 /E_ "_//E_ "_/]~;~w.w]~;~w.wmb5^~Uۦͅ/s*:{l{iUſٴ붷Ƕ~6G*~_Uzӎo͔~woxh m3ڏm|( endstream endobj 53 0 obj <>/F2+059094dfb-c250-43b9-b9d0-47649288109f<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 54 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212\213\204\214\202\203) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.934 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.049 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\040with\040multilineage\040dysplasia\050MDS\055MLD\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\215\216\217\220\202\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.934 978.589 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\040with\040excess\040blasts\040\050MDS\055EB\054MDS\055EB1\057MDS\055EB2\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.076 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\221\222\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 444.135 820.144 Tm -0.086 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (5q\055\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\040associated\040with\040isolated\040del\050MDS\0545q\055\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\224\225\226\227\230) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 459.434 661.924 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myelodysplastic\040syndrome\054\040unclassifiable\040\050MDS\055U\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <999a988c9b9c9d939e9f93a08f90a1a2> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.934 503.494 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.049 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.255 424.294 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\233) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 362.594 424.294 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Refractory\040cytopenia\040ofchildhood\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201\213\243\244\211\245\246\247\250\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 345.094 Tm -0.057 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Myeloid\040neoplasms\040with\040germline\040predisposition\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\251) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 200.369 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 225.209 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 250.049 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 274.89 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL () Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 299.73 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\240) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 324.57 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\253) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 349.409 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\254) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 374.25 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 399.09 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\256) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 423.93 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\243) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 448.77 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\244) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 473.655 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 486.794 265.849 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040Acute\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 561.789 265.849 Tm -0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (myeloid\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 652.851 265.849 Tm -0.106 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (leukemia\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 752.903 265.849 Tm -0.02 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050AML\051and\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 860.848 265.849 Tm -0.133 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (related\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 224.269 Tm -0.041 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (neoplasms\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 145.075 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\251\223\201\213\240\253\211\257\260\223\261\204\205) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 499.934 145.075 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040AML\040with\040recurrent\040genetic\040abnormalities\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F11c21f2c0-50e4-43b7-baec-56d27a1586f5 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+059094dfb-c250-43b9-b9d0-47649288109f 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2146\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+059094dfb-c250-43b9-b9d0-47649288109f 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2146\215) Tj T* ET Q endstream endobj 55 0 obj <> endobj 56 0 obj <> endobj 57 0 obj <>stream xU_h[U/ڴQ(w۵Vֲi*&&AqN|pK=$=-{Aw~w t,.,wҢ^*T>HS^ Ȩh_m dir1y@Dq?J>RW.HpNj/aGrnj1[ Y=zbr߯}C;5{0@fAXЅ5Hb6GG[2[ȄCxhF=r7p?H?o8qXZܧ?uцwRx oOiHqx, Ww|e Rpc+s/d=r$7&КQ&;Jmt3bn[f+5BllJs3b]-ҞL=r45s__HΕ\M͌;"~Z_zPNzhc nQWXk0O*#] vaMD3 [HOa#;>%}udqCa}_aC"EQ5ژXGPfOSXYD_F[@/5zԓI. ~¨=J˧Ξۙb!{JIu.1FeFRt  qΆpb+\6Scq11VpUz KEM:qp\uSֱ-/L1&OBVjdI{<˳!񐈱„jQuBD'?&Ŏhy\^ơ܎2eNaHdHd(sHRK5IuI5IuI݅BRH*sXG?  endstream endobj 58 0 obj <> endobj 59 0 obj <> endobj 60 0 obj <>stream x |ǽ?:3c-ْ,e,Ye&!BPJ7!8B(GABM9)IBsypRIIJZ߬dkiwgfggg~3+#ҢĠΎ)#/gJ>g+?PU=xe[o=ys{ѕPۅ΅ġ}."yw>s6C<(o!^«rO~ŷ\z?B_ wC޽hwy}?X66w랞<\C. "7 )\jLIK+8BX |}dc 4FrV&GJŏEϱeZz7DGK{4HJ<H7'AH)?iAR7^:ұ5 #Mz38ؐt@N(@nAYȋQEy(B"4#? D!TP TP5A0u5FԄDC-I&Ԏ:P'MFSTt nE]h:nC3Q7z`(S4?v2"k<-co!Gca6v\3dCc?HMfwORWH'Ђ2[?{4=W ;SE 01 glẑO|~@MUrO@ 4/Ճ-~ZZ51? ;f@>8)x_y1?c9<2,VՎ>uMZ[bښʊh<\V |y9,ەtmVd4zVV)r2"lzow5#7x T8#S[ٵ q﫴Ǚ\|gsmϟWOk ]#Nr:;HQg݆>@!x~rW,,HQU<!%ql&Mql |-e#` xÈ^ӑz܃]$NŏܵOj6ܡ$}*5i4ѿkj })0|F&- BgL ]{)LTqYC\{~\G\;̣9>Mo̮83*CLNӼqg[ ([;M((M܃u{amDoMp)~97ZlwOz]lݠ$dO"lw|`΂$^;A>҅]@`6}̦uht[]MMn &xi>z`>}pZL8|J4UQ8=U0^F6NI9?ኽAڢ<'ncp脢]M㤡qmW ;c6vs z&\^Np<=AMne#GBOn9]Yi1wPIa4͟ Pwsx =6,9ܕ̻>]/=stzf`{@+{۔O_σK/۾ѩ"qE$EnSC q04|҅tL@K^IoŹn CJ hѓ71՝qU[i9]*tW4؛+eg:ϑo0z-i$kN>I;诣 f)nrϣĎ{%50q}F˴#ְO퍼vxPl,|Vc2Y0͓jPQ'urbyxycp+p .+f¡ d"k_?঵_SO7ÿ9U? ~uJKv* MrZPS=T' zdP'mi'0i~'d~[Cp[c3dc{r[F#1 soڼKǘ~-r>% ((M>8 rz=41 Έ% ђx/3m W28WEln2 ,d'%O* j%V(KcFL'pk|m0$d e[+Ua2ϑ)rL;$=܋]cWb°%|?q2_j? ցZc_0H dzøy(APhQxվS3 7er( c(-LdBr1\YċEbtTGYjZ0CEWXxbT.^!6^#> f|4G f-{Gk( }qsVK%vd5 ('&ګy; טx!oj|qbr/љu}Μb"3hBG&="ykfvg\\5*lD]v|+OG<c*z73fq3ᩡwC(BK'irxܦp-ʼYẽ::ox_Ƌqvؚ;gq[<;:_穾X!T n=b29fޜ&ei4ֺYϳ֔?_UWI,1"J-C蚜- S{D+Ëڕ?|ފ7?{'`[/T)* qjI.HQd%{OCMṼ!foFE $q|%qއl)܇A!xKtzx$p-'igjX­3x9}}zk01HʣyĚk3M)1_w~>paC|џ%e'/>׉j`Yeite3߈uMTR t1{/ͿwW-+U,og. ; 쒞8]t]zů򿖥ㇶ%uPe . إ? :Зũ 5à08aeBX"DDWT}8p+_>{{ؖ=;@K5f*#rf됗Z^' 7UsqTA%Ӗnaz!_{',<ݍ& k-_~7^')پ:'7ԷV4m{:kY:lD\'VkUaLƢf0NYTr1 $jSHBIG?Brsy][ÿ&|;Fޙu|> #]/)w#r^3`|^eqB+sGc2ǧ{_@ =Ԩ<0! _2j=CgIar (Pl}C=uJɣ_S'2s4#&11x=WI2eh̤W]ߡN;Wl>QE*.@CRoLGYD<':e*N/xV%SGF֌~}};G(/aJF]_TI}3&"`42_bi* ,5zI*Kd1PzJ=.j.c梸} .xwMkɉO|{Nqq.+߂i5YzaVkijIm' H8e< G  k!Qv4ZH-bcdF\ '/Xv6WSGyUc #u|L8-Wl̐3j2f=mk?bg24^d#&@| =O`&0|mi$@I((! ;*(scX׽|7vKvwg׽R<^JL(DQww7EKxJS}IyjM_0![x9OxlRpCWF4h+<`e縪^nŻFxd^s"YӒMUb>qXz[k.|+n=Z/fFF3" @sghjC=tZ~~C+9`V Y|nu:oM״WC%+2acNEԛxPPpN|%73%ъU1"$? {[{b竤Q6=1s^Ik]pmߌ҇^Ӆ2⣅;,{|40%~B&ŇCãwvy'SRZ%J[VN($R&d2yqGq8V7VՀoW*zT7u:0/uDBHr np$U2 MD,X<}?SYve&0n/[La) Yd&v=@FFLlb "N^k'v{z j$Y *BKBƆֶ^c]Lrc1Lbͱ,l.?P*+X!LW*WU={+T2Vbee]˧Y-X_*#eRUf)PGuO#VsBZV:xɁUeg[uZ56⪣*FET*z[/^ Jǥ'+r T_tЄ "z5*2u 9J3qfMdggs ϫQY6 ΋JJʨϬIWgȱ"_("ơ99%| u}3L*#jZNj}apE+8* =|Kp#J.j _a7!._^WØح1ZkḨ3f:S6OIcDH[z a?nj{ :g;1¨IR%~W$Ԣ/,rN* $=NX҇X*mCn]2qUOA|6b {f雹4{ݟ8#qROl ށ[;wmZi||e6n$Hū1,$yf᫉8deK[w-w>*>HedG ؂€zԂ:!ӟOX(IiWdU@ЄD`yJ^3PpX|. x&`-a5B3̀bB׊tWcE!&ot͆Cx.m`&B%zP@&L(ȊL`'@P?P4q}4 LC+SF<2,b2rS{k6ޖȇ[ٕj3LJD_!55_053?V#,0/4D];a0 7T"vC$b.;0V΂R[ ܙølA]F~!C0H瓴crW%r!M/ݐ>!LI`:$1 ."4V$w*[4姀cA F0(dn2tUFR@#m:)9,re:6XƞJ\ZePD15xY,$^>{L'34*ܤM8r=[y+Pm9nwM7jx)4anrx@j¨de)4& 3بFrpfNf-`VjUK:P`Vѡ`:xqUC;Ǜϩ!9Y9YւܼBδL*XqzD΍A{fje`u23Mjp7Hǰذ34@Gӏ$oXJeuP)9 $e.$NCtc*ʓ#qy0]##PNzSɲ'${ɆÊĚ7k׌m:mqb4{[ql 9pn$^%x Łoa8TkQh3HkjX P#1ar.(eYDxcg$:Jw!Zc1g2rgebnAvvQeO^&pb\\Losci8- 9ytnpr;w8'v6@}DzX:^6)iz9Sqsh"#`f!`HVh`)?>J]\j@0YSMD[T\oDZ$yI J%!C/ɑL"'RΔ< 7f!$r";*;w~,ͮ"Eߚٓ-, m8[޿/ѝ'ϊ[̏gtnL47k.vWfw.]8%tV-\ֵt3'vV_k3ɇewjԀZ>AdQ -x[9G}!KH}]]mMM%@MQRk65M6M[ZFw45F]gƓG卍-Z zC _3Ku-fKY²uWp4,e10.{<Ք1looG3(J@-1FKKtDT:>O0󒚏|g .$L Rt 剫^.#QI3>e$_K${QŐI@CqUJ^c%rC1\eDrΡ Sdʭ<ۤv>2[9;TzeitՎܼ;ʨCge3bXw>s?JHyxxCcHnY|;brZ/֜a[gmZ=Em/^{77gΈ!6quΙ]S wY\8SB*EaQT DerkU˫#m02*ǭvgdI2X]n5O]Z5CZl4xk5i2 |aec$F#KC.Cv/NGa@I jg2uN^cn)Q̎+?f(Xz LiirLH-N@ )ϡ;;IY\AYBD qC`*_z%R,'Dy"+r#dbY.g5j8dOĚ?NF4qs1 $mD63xi<KqxlaU*q2#~bQu۶ ʋGϲɪY?o$JT"4 7luEQ< w0&d A: S2 tezc,} TY)`Xʪej4˪Ѫ2&o<_tePyCBq0 (Ѧ (*;Q,B]{GŁ_\a@!= Kkb<ã$̗VצgIx2\LIUN'x>&q[x>$R=3^ e-9h񖧦R!f< r``QfB!y qݙ }'`G.mëc;7qZ |rbc 9qѷEa昗{bp?wﭸx)SV~eIC 1hȆJ&zj32kc[ {Ӆ=~Ċwe'0/i{7OJ,$mms֐F_O^x5aXoz_ޔ8+GYxw@P ?,Ϥi:ItS?mRL/}L+_%{ =!? r2 :^/QӦLfsF@U)ƽs Y-M̴<:\ i$Xiz(.|N:KSh ʛG(3#o+o#-ȫx}Qm"&*JK+RlD|nvmvG6]ֳ RgZ]H=h1ZF{)!JŴ)NZ>5g-DWffBr!:&$A0E8h6QK.":4#co}}ȿ}J#_w?s?ih4 Ԉ/੣h??g#_ffOoy;U5Ub)]hxl}I3}eS ڈbh *]DT 2% M#1L!y>d*}1uJ6K(U4zT\t0t>FH ;+0V `,CQXU[pK:O?mk#I%;W/ DҲ)k3 9+:+v=k|@tz$G'\<0 䲒%>iW)4JS"O}:^,ObQvMUnt;ϱS~$N8 o ,= Z%j4b{hQ8oIsۻa+s5\AV|iYlL'ň8"FqPo87WVÇs:6X;KWxTNY`0˳<ROhq![X*zD].DaJ>/M ~<. ѥ~TΤ$rr\M'ގO1KK "?INRi%D9i_/MA'gВwz?XOD<ɨ'Țx*⫭swn*vK|?ɤ[kyUBxjU gl 𽅃[+:&ή;unZzʍd~#"2?pSГ!?Sː fh' ].IB|V!oߡO^=axD V+ᵄpBeVn+\ i&IbJ8k(U|Z1ЍH&ʕ&\,ME99`/xSv\Mpr_sJ!-mN+ OU%;)qxU&y X%z.bH> %#uS+礘Вl&%%n57p1rr/M{w,{A|N krh#{/3}G߶=sJ:T,b̹8x nG6'AO`ѭ6ԃO JU-oUp-^VW+Ѣ =ԛҨWQ0H-uStlK 榛j͢p>ʁxm&B 4[[kQK{c/ֆ)7wv Laaq۝G-cG[b`è ݖ6g7: <$nC@ !tG(FKĉdj2E"¬ӳI,o)SkNRJ,rM1KIc 4t\eЩY~R$aʵn3 ?5IH! Quf7"FǗ^w|I ()lf74Ej) iU'ƁmLAIsD 3yv e98w.SMš36lq⃩3#'߈TW$ďlf}[ХH gHxp /<tLψ){z޴]}{Fs7Ų3vVm9e2]Y:CceT$^t8q˹<R݂ޙҕf5=jG>=ם9x6} $?_q3:3z3 EUAH=(/l1Ya=fLI98E`ȏ839E"n@}&YLENYk'FZ`I@9r@)a7T4ͼ"[ĭ5x ɟq gO ïhN8]z[sy&qVnV99pM2TwL0bYa8Ѩ<SՅEEZ9Üfey^Ke^6 eßL0X\m̉i @nYYZ5;^ZX5nM@C^}5zY^ij]q/v3Un<pOff~>~Yv l8#4xX_A*-Vgi8 |(Qg}QuߝTF%It? ;nC oKI;<ᥦs-N¨h%qkZ*Xri*- ,`߲ψ$MoX-?_X~i(];Fd^Cc .tnabY1sM*8y;_9P #64v9q {'?ОC'qP<~K,X,odAr4᷄ :9{BW\\滳g[U:jiw:@+3mԪ[etFJ ]YyS/0a\Dط\.Pe%ڑ5MΘ3f>3jl1N72Fh£QDi*R)9֧Zjek鋘`Nպ"u̡ VTsr 'jokiƂ|: \ \F[w>qs$JpIҋhz,9/yt.|҂ϤfL%hniɛdC҄ ]JiyЋh2tLp}9FuPrB2[̘]^) {]F҆6q*7mÕ6T\Zÿڬ`7?XqVs3L CF|aZp@b5Vr#G]]ܮMVlV[5* ;W,*~U!/g]/i/+I3^\z:J^cs"Td\YIk9zwa| }tA+#^7~F.Ұ4K&N*+$mҶZ--VkSI+EM5Euүy|EEMsxݵ yMWY:33 Fn*7Aw<̃MMzȍ\P؀ښarp^^);;3Q;#E}!+P6v28ScNϫ5ѕ|CU@(&y+=1CdYMLc>)\VNĤcNt4rLz76K~G$OёLuRg/ YQ:JgMԻ'q9k]xMqDgR`?xu1z\4.f034LiRM :G\ҋ|s+mWe_T}ι7_7ih4MmҤ IX*Ki+jaLb8U;02ZQe]_םuu]Au]sm3>ﳄ{ϹI{]"֬Nvlԛ >LBy!$nZ斩ZɷN{i7'R쭙OL:ꋭː|y ߅hgoPN=WfSDܽ_d쟅kRN#v X;p W_k ͦi6MAwp 1((M5 =?D5DCQ}D#tA_ Wױsݷ?mpTˇWڅG7kZҝ;wk;G<ɹOzzudz6_¦a_yǛ lXMVA?7%<gtfFɤEV ak5(rk*V+\3R:[STiH ? 2}ެ~/s7WU3?`,z /h QHۥF;2A TF >'1ᤉy)㖈X?ZQDeZmZ(ZC:ѹ7G%7p+6Rf&fߛ`v|X<gg; Kuߚ})Rv5G/#S.;76߻W~D8/{UA6YL DžֿPVB0Õ;Z#{ H[Q'X@92%̭ c" k <,(pd$jk\&SfD6cW).oI D+\/&2Ug2]""\o5"Y_<;qZ G_" N1Cwxc ˅Pqli\nr܅]p mV6[c.0wԐdiȱMs&=7:$ūԯ\5`)& }IAf}rz?\a~lpU]V1'2brµC*S1p=m̢lVqmmw-ohǯҕ%t:Ye.Wc[Vg/:buyRgQ[(F.T ?RYIGRs55h<2%+(y>뢕%9#E[|DBgtԾFn'nᖸ 7NHUD_\f㯉 ɔGSv4|&OKI8ML H#fl/Uf[lұvM!T3^t ٚ}ƾz,۬\w-[Ѷz ypv/wnt>s辣Gkuv<Shr27"?&.ƨ#5ӳl^}ۼ~gfr3;ps zG+5haXsnl˿dZeFؤ=4?+`KPɤL nDY#c4F7Gfg(Y%h]|ȌiM,]1b3+ 7phknfx^' [EǷdp~I*}o4IuMHĖ-WED}T`B=Wo(-gf2KAs8XT HllNNĊ'sR aY0-’Ua.2eB$+KR-"LؠqRtD21 D5,FOFgkah|-.PiZ/KmZb=ekHܹ~BaS. VixDν zι#jiaLXI74W`f_M##yIaqtpe2xX[&L57?c:|3?E9w Xrִ(*Zff3i}kM+㰌Q%J-MZ"˴: #Yy#cWTڸg^Оu-Ԓ d!f>x7J=9GB U1<A E'EE$"Q? /'dH^>0Ϛ-;&+蓜ٜۡ}>^֥Sׄ+ZOƅطw1c:PK1^e4.Ͻ~]n_ M(+<ʕ1>8So'r  Έ-%/( dZV32!S/X|#3zUIFQ&J uuTJ$CSdkJC,h¹Icrb NtiAU^Crfx3荎Dn\ul}$'î_>f@ݹ‹qj?Ut .jlwiPH.+ }qї'ļ_r^%RB^bdv{A 1 'dlΫ\Q]-&(}b¶Fp)y5)2)t YGK=NSIDMHRN'R/;;yCAG.ܑfR8=7SBlX2ǎ&.;ffs, {/#V,N|\$ |EXyCX{bw } F:m巊qxD_+j#~]7_mul%V5 RB,J=6߱8@']p%Xxk=zk)aA>XEkUwku^ڹu;Ⱥޠ&>p`W)p=ժvwo{j^}CmYue\e tt; %`";kNɾ$ %a2=uY,f3@Q*C`/󔖔xֆ]*uAk6TAߚk aVYS ޏ1/9v-)~O;Q_'l՝0 51L1l {mpi۪^m6i ADt 3֦ӵ:= лaj b{J3f.!HbrzZ!ΜIy] S!(鶒nSB#i7ϗl I)L2ۄ/IViX:F{'e5َ61QyˡBjP o**rvqCBi6[L\rEM^2N >!2 pž86SG4)Ѐ'-+i\µ'e`,SZaIKK/& Rf[\ !_ ] ]na!&$! 2rYZM4|:aQ&DX*Cv}}wI p 8ZoƟc!BX_Q8l3N/b:51Qm(cRHw]-*EŎj뢴Hiʟv HIy"ڿŒ]| }-HIR\A0BBCmƻ4Z DnЦ{rmriZVZn\AvGwO6 ;evn߷՟~%Ӓ$ fwݹ-f w(,̼pwd廟Nt rϤ~4_}"ob΃/CJok_ŭKfn __#=>,C0=`#"sy76L!ZtC- ܃΢sKm,gyR(<{g+Gl7OyrdQF>4[ e % _ٜ.u@q0TQWE|ĴT%%y|M$~ǓPVw gaa {I,A;SAAl4D:77O3,^\755-<)7:@yM\:C1jDq6jT/d0h^D!?]U>mD.lh 9kF"&x]D#BM[n[bRډs(xUhcLDlKLD_B!|6j659E\A\4/ITۜ?IS@ FsJ||.⟟ta_v ԪD˄s&&zɞ,н; n˩!evZ|{`dv?scr…t#L3ʻWmꊌN[vQ UFnP|C4NZa@*{>a? 2ҫՖ)˖Pf29T2DtPsW:p-u/Œ3KQAPsL;Lɉk)ʰK}FFuz@ͪBEb@aQņh"l8e$*,Gn+1 D5G|%q`,/d`yW''<(7 ­-^.A~'lv7=>Q!J^ő7-ga hD<9!l/l~^fM+{S—pϽ!Oť#g)9E֤1)'Xʐ g;WDe 'T:JάSg#_L-o(uf3n !\i  >dJ{J^*e 0XՖPt2XO/y(JGQ[K mp$TWR59x$Zd&IJm%H(| }FNɈDcs>TuNӿ$@avMC6>]ȜF GF۰ю;~gQ+pspH&_RBBy/j`cl. eDZ`i]xr slН8{8_! 8XV%eIvowjjOPET*&R]V]([2QjQ )P3I!1P'vJoJ[͏ YB|NPI[~ ܊ }x~ /~[4&YM*e>/x<,EX o ZKrnqj*+[!2Rjj2P*^Ј`>ḡQrj]R=nS\Q% [*oy!F7y{z/z/{՛Sz6z۽"C ־x*Ut:BYDJjD9(i1oQ45r,P&};O>Vz [bE-c#զcR\ԧg/Oݦ*{9¶;1&t1dvrD[. Cp `1ာBn/A~cqwjW?,\{Wh,yN-@-cؘ] Zo%+ >?,@:p' wZS^)^Sc-M%EEKFwRgK9Dp: TpuO~yZ2kh=aYKtv USZ[peCS%X$Enw &fjkw36fH@1Æ\H/5ŭ2L tKfZܙ @Ob& Vn_/3˭j˗\Ti_s@o>oF.I{KdOH>sZW<^RI/Q6><\7sCQEoQ%5oi VH%2qAa|~1 Ѿm ޶zsnahm_=ێFcNpqfW?UIQg~} /NN Q)݅ӾߌNg};;R0ػ}qp/8C\e+UNVdwt'Sj4&Y笀dN<9,tie2UxR\xȇ.(.ev+eĎΛȑ,;yl{:=磻GFu@@/zNx7N?b.~τn^DzM6XIƢD|(ʹr 5iǂ@Ǿ* Cɫ*B֭*^rɶ*/Ҫhewh GKY;|#u$=Y:yǃV1Q tuaњLzL=[pX2[  Lg7{Мߧͷj^C`׿HuÄTgTay./3!XGECRTgHJuHu9cb _I\ < T~|`1 t0m F@~<=~Z˵܊} H}<:?^<0y`6U6nt>кG݃k];um~2㯐0>@97!#RZ*r 3Q軻P;xم#/E[b-E, [@_B[ "3jUjVPjViХ): 3f]y,HS7N)[ʒ2 )UJbR -S`T=Xh)1 -ReW|Sh˧ؑSŝV㎟P5շSî2,=(N?L-y`|Io;ej?>[E~S#tJف){187xC[Sv endstream endobj 61 0 obj <>stream x}Q6w~E[U홱R}#[. }_ΜխTUE|qx:޺iu:߯:O Iḿ}~XO~xͯ[vv×z~;?~c|~z4yz\_ӭ[-0?/ewy:w>V\.w!z>o~N/aZwC^/_I]?w϶k},ȉ9!g\ 2+13;reȍ!=< #ye"O= / / / / / / / /'?O'?O'?O'?Og3 ?ßg3 ?ßg3 ?ßg3 ?ß _/ _/ _/ _/+ ү+ ү+ ү+ ү+ ү+ ү+ ү+ үoooooooo;;;;;;;;W[ߣ*7pV6|U)օ nYVĜ_kIL߯k_F_snǧֈZ5jg_ ~}86)֗,"?Zjآ ~{om>^ZQa͆po>טˈce}wK-E}bn=ijO>cq/&L_b 7q!!ųum|.;ϝ&f}߯(bxm. o&N endstream endobj 62 0 obj <>/F2+0fba8698c-d80b-4b9e-a600-6c9f17d74b24<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 63 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 1137.019 Tm -0.035 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0508\07321\051\050q22\073q22\0561\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 512.895 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 533.055 1137.019 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (RUNX1\055RUNX1T1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040t\0508\040\07321\051\050q22\073q22\051\073RUNXI\055RUNX1Tl\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 978.589 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (inv\05016\051\050p13\0561\0731q22\051\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 534.855 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 560.265 978.589 Tm -0.04 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\05016\07316\051\040\050p13\0561\073\040q22\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 754.305 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 774.509 978.589 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (CBFB\055MYH11\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.041 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040inv\05016\051\050p13\0561\0731q22\040\051or\040t\05016\07316\051\050p13\0561\073q22\051\073\040CBFB\055MYHl1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\212\213\214\215\216\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 403.635 820.144 Tm -0.071 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (PML\055RARA\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040promyelocytic\040leukaemia\040with\040PML\055RARA\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 661.924 Tm -0.035 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0509\07311\051\050p21\0563\073q23\0563\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 529.635 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 550.005 661.924 Tm -0.155 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (MLLT3\055KMT2A\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.071 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040t\0509\07311\051\050p21\0563\073q23\0563\051\073\040MLLT3\055KMT2A\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 503.494 Tm -0.035 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0506\0739\051\050p23\073q34\0561\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 501.015 503.494 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 521.355 503.494 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (DEK\055NUP214\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\0401\0506\0739\051\050p23\073q34\0561\040\051\073\040DEK\055NUP214\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 345.094 Tm -0.039 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (inv\0503\051\050q21\0563\073q26\0562\051\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 527.835 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 548.204 345.094 Tm -0.038 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040t\0503\0733\051\050q21\0563\073q26\0562\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 729.285 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 749.625 345.094 Tm -0.363 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (GATA2\054MECOM\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040inv\0503\051\050q21\0563\073q26\0562\051\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 458.534 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 478.875 265.849 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040t\0503\0733\051\050q21\0563\073q26\0562\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 659.805 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 680.145 265.849 Tm -0.348 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (GATA2\054MECOM\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\217\220\221\222\215\216\201\223\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 504.975 186.649 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0501\07322\051\050p13\0563\073q13\0563\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 691.665 186.649 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 711.825 186.649 Tm -0.048 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (RBM15\055MKL1\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F14d42f4de-d41f-44ee-883c-5c20c818e16c 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0fba8698c-d80b-4b9e-a600-6c9f17d74b24 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2147\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0fba8698c-d80b-4b9e-a600-6c9f17d74b24 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2147\215) Tj T* ET Q endstream endobj 64 0 obj <> endobj 65 0 obj <> endobj 66 0 obj <>stream x |T0~ι3w$e&}Bf2LfBHnV1bXB$! b(bH,TEť2Ā4.h-uRK)*.B{Ν oɽg?9yγ3A!C_o} _.|a*nx !r<ux^u jqm[_GHHWQ 2n>һ!uiC> K/Dkqw<u내s;_қ`w/e t+B3shynHCD;V!%c!E}Jh8!rOlԱD"r9H$ 2v!9,"v&60^)i`\zzxj! #2!3 +ǎ /%!JF)(Ri \rt*,9(vsQ|4 /AN!*XZQ 0*EQQUjTjQQB|@x-_agx\bǾzaֱ3X> ?8vK,?l,=)+;6<8 +#h#@<ĄO;_;yt~{bu!)h `]?50QOFm0-Zo Q~tA/·gaa=/1b~i3:~r]uUXQ>lbi8T,. }ނ ܜ w˙HJL۬(:FR*xeF8!PR$XѺk܂3vo.Κ<d4@bhVʴ)q8k#l&wDrf)ǕY&Tr9"$;;"Bjj'!D!,xh'gw@=0>6&,jC("9DF_l`5N j;k;F;ڿF]>gߌc2S"׶Ш՝j@r:@f@-=@R3Qpk$"nn%JƎ_]xŀE 8?6;Ђv1nK &9!-qTv/ /OYٷSj<5WgІ@zh=]݀0q0?lrE=a__-q~@ <YP08fV<+^a6mFKkfrFpngQxq(;6!ʌ<n4+8yG1M=tڛc\Yy/zu׹κCcV]w>Y "Sz1%bv]:gpBqx8π>lZHge/C!D)@r} 샅2/ASY#1N0]υN\.6h$"mhc^];-96^b/Ҽ k0> {e#rM( ŗ\8H.EYtEqljD.6at~|/׃JO_}oՆD~O^*}~Jzso,0<1WԺ|/MԺ.w.*2]i]@ wDBzCHX1L184 qΚNϾ=Ks~|;_nKރg=-hlّ7N^ Bi W XL]* LA3Պ? @ vFW1.cQW`K򫿞`Y){Q'vvֵG&:PP'&6w!r`F eOq@APH [貺.J>=ȥ 7MRe>WϘ%5r߼3QM6؆QKsoJJg9w)I.DiO wYI2ptacdq0@Dc rr^tۆW$ܲzQO/||t^ru#[.WC_0w=a/n+JCI̵:s&5Y9vR%$}٪v:S]Bb.N!o w@(0⢌8 F N(2<Ā؜asEc|% OŻ/oQ/k/WOw{$i3Fzι޵zW:o>[nn פV'7p^.553^ݮB]Ł˚eP^(P Ĩd䳁"˒mjY~o,oN"ҟ~bŞy{}B^Sgp4 =*]'=~b!tzhu zUTʫGd*k^`5pgϋF+eO'(:g2gџ^7H6]SCa%$ dڔn 0)6$nn#50IdW ]2c(10k_n}E/o{Tpϟ@粦On7Gl1VdFcrhUZJ6Y,f6%kFqvts&r5-GS$VcxGbgg\܃+ޚ+=.} }&tx)9E[כսHRc*6n ?a!0> Ois^'-AvJӸ9g*ߌ:`< *Sxu/V*K:jϫm-,em62wV52}EOxݠ$XYY?*߫) 6%Q!p{-XL*7'z)#ckQjEn4k:`e5G?.n8.朓>߉O9*E!\;I\?MHzLgWpu8(P/Zrj٦yNçTrmLƃkF*ƅHL#Ѐ1u ^far4ZmE>ߊ_I{{:ָn#ZkŽmjfÐ+c|5q*ūG{IzTG_uoJ&)'·2$1,PTWiYJ6l!oc@ާ<Ⱥ=.Ȳ\4vͺYջ`$[}j~ǭUK휣6fK{߶I[YnhZY*% #bg*_ZnΥG9׳7k/]a e Ǩ cL>p5ѧ1Ʒ [Ws%/~9&5ЯVi R0imT Pzx\M+[_T8Q'4_HiIvI)+w87&%ɖ2eC(l5z[D^2^*@Á1Q$aa2uRyU* F24!z3Fgy!?󵎝eNK4T󮄻tΚLÏJ#5iiJmO#4|[NJF  @%0i:Bn]a ߘ+#,Mba8z'W}o}/^qn잻1Q =l@6-3u̞qh0a~V5*YvN=݀R@\  iL ĥ*Z5 ރ;}⢯ 2W^~w/&&Nm4.b'm _C6pd[6bΑT C[)@Fj @REG>x?/I{_?zʆo#aO/L? ,?{= t-ZFZF8HeVe.Pĥ"XwlgG<7ۣ?;%'It?DavhQ'׀M FrlH Z+PjaJw x~hp?\TP\\g?ν[4\vg8.7Xz)$j2zoLS+)_JZb~w^=Oǡqd6œ97:<7D#:&PQHFu|8߁fPkPmTcƍ&n EpXu `'K寈 _#Y5^xVjt^_t&On Ln?}><@t3;ck>8|Lcv #Ć3Q^8O3{ӏc\Ee]{: [?rjø1-ow}ȾG_&)؄'IoJ_Hps/W'0~a`\1AsݞfF,z,1,\9'yev&+% +;?➹kwdmGwGo䧿Kyaϑ8XaI)zEv.`I0@0)FƅbrUJ+Ȇ=P`W8X0]~]%Io]Ɩsm'6|jXbsF7FvHew9ѷ[{ E j~0i 2L?bhΠ™+Zߨ`L$;/_`sKE0 u:Mc*YgрEZ0b Z5ZXR>*)aE fT-4滰F.Kkl@ZrIXP1[(4Ia%7a+0.k( o^v%p p !iW٦_I+e*)=p@ŗȅP)D)-͙Δ cⰽRQTP9n( W%:n{0mPjD6Loc, ?hbĆB,bY9Y6>$ >=SIqq1b&&ԵG/#sF嫪f޸Md UB Ěib u7tHg-qj0E흣Ⴗ;; ҧACxh+pmIL-)UPU!`PϨ(upAM5LKEu> Ւ`䒡`7~y(U|+hTes2L^s;Mn'v:HFeW,(]7=-oyF+LL6^T6)Q~2z}Ɛ0ah+V΃I j%*?Ǝik!쑗->Vhz>y?d^d-q.j]L2 QϸW HyAlVzqLpCXxg$2i]w=ptCl.+$ K/&n<$Ks:#[d.Kh1ސ4a5hD7nAQ/g-['e 7lIiBJ fL5b,) gpxJmMakmnZTbUnnn8!wV'r侚^jru3sw}/[;'K]{V?沺gBn{QY?_}y5QƹëVZx~u]Z]zVgZҕ,ameZ26ne=2~]M=䃞{.0ĞܞY=۳GAឆ+Oy罞O{ч{CxGgd==G4. 9m$-i7 ki6=Ĵ)isng=>OπLHXW7IWy+WGʛ*o\`%tTN9`󕿯JWYS,yJrrt\NFE;fp?QVC3*Ì&O =9`XI3.GX>?TXL+kB-w^e=ʹ(@l$B+tum^˺7u|nn٣ú-Ox*tBD z$n! |<<H9#n[q> G yS0ery`r+C0h291{?ӓa{SqF텤 H2i?PV˲STdV6a6:ulfV6%6do8Ta|hBjnGDDž$w'5NHHLi0䱄TUVV@F/@GEU$sM AҹdvrCCPCӎZWCjSstEMMN`0 CHT %,[i{Ń rhA[Rr O A5 Qm[7SRCN"WAᢢpkxnA4UBDuUdѐV?$<AoVtp8ߛpɃ}bLU\B(SEG>(Є ʻ tH#WVtFhɻ/te U}Thrmb#hʔ32X$XrYvL3g`Jl"b!*tWҧQ f/ =#=ۛ/JOH{6(9*M*NH_c8k:څNQ\#|q1,ktF ag:oy:!cêK(*e4nH 5ѾniX<%zj֟yΞ*)6fPG=tA.VPN[|U ;?'zQc׳ Ƥz1Ӳ$r$ z'jBj`G29NP0|pŸU~J_#Ɂg&{/ۻKt.pw=`uc' 7L,ksNDwju lFDՕU.1 ,ELof''| 1@;/ݹ=q>tMS(,Z%$9\1,ǝ0A,rnLsݞduBY0aBɩ^N|7\ jESc4N( 55E"0$՜J;J%8Yɯ?a]qja&.mfҠyOcq;+ $eԃ`vQK,`rdC }\G2("[6ۋ,~?/\*(dz1.[} `Y:=Yyz({Kblk9SUf<1##…qB(Zb(=@k|+4˜ VƸ@7el(qiY`K!`昬vu`7Gaeck8şv\BA)!$J& oZƘj7,kbʾ$[ nao_UF[ע]MeXʯ>~\ZD4Uz#T1k[.z;at)ui(ypXԨZ%3d9:Z `4 yM\ x.B6PT۳NơO) snsŒD3ӝͬ$ܼ<ɉv/pvبǙUO 6k͡ ɔ\40Oџr@qP̩<"EPsqJ[wU$F_ UL&=^+0:%/59˲r,LQ͍ۋpfb6T$,ag.yr rG#˙r Cə訬BEUNzzͩATƘ%8/km ydU *s ^KoPmR#\- ;镹% Eee\]h:K4فBMfN6TPj\+22mXQҎ.ru ^̑ _w?f]*̨J_ >rrԴi|'YDX\BԄ#dk#x?dǟ}A 6kǚmPlnyޮWwњ̬ig>جyV'S6?x9[f̬ғȩT)$ 8|`AvoRa!$oR[MHԛt_Ity"HK-I$H^u1$E<󄧼ihBFќS3bHH QMCWuEq75d+0qRB,|c;W|zI;[R3F[.='wcҙR9~UW:+h?JE-2_y~%LO~~-دngEunnvm)d,<F'h$q+rh3g(h;K,% Y s1S]  1Y8;WcJ*ge琇C7O|"NeXQeL4&Etlze(v@_/d@NL7Vl(^Ԕ4tѽ%| VPX/r(j&s`RRλ˘>d},;!If(7ض.@)Ņ#7d;Ch@=#N._7bDQsYE/PW[:[`̠L)@Qad免[Vr@yM],4V KLZJwRoJZDI.I=KlRKRO {fF'RԩP;v d476x}訔_U7wE?7Z Iߘ6 LSHݹ&*I6K;+B[E֧SjO2'ee%)J(-`M!2 F.~MTˆ :ۋPdGP9zR䄩4UH­:Ԣwb.Iȧ)bcY1AYI Rwpȿ܏?h*OYuy)6TKM 0Htс#M5EݤI*61at :?Iݮ&X#9KUJҗUoJ֧|'T {OB#oZiFu\IQ,]Ēo(X˪Ҹz;'P縎Ve?1DZrހ_uYo3w7. Nv-[/H-x~φ%Oܲ$"۳ۥ~nd]Oǟw~ .`kq5.pQ?(3Lt@Ic:@nØzX6/rX]lEڼ `΄h~ov+S0g&J +[v*zSQ姦xNt$`ȯg|@ CPG83\|fNFsf-YLCLf)c lfwE(4~"Ӆ0'\2]3ƨ$b ΍] P`ĥqgdVclWvKks3?kwnaӁ%}#S.=G_n<䥏}\[cOR3M 'u'ˤS F;)!Mw!qZS}ąI,K@k GSQ^/!}#T&J&@Z9( ;d˃xAlzy=QUԔ!OQYu-PAAdf:i# SA02O _FzzQ 0)jLezzC[q6$*p'Sa~;O$9Y))qUhϯPP>XPҦRtL>|O5}[}||'}\wG| zO;o"/4F=#1Ǐ/<' !(=T9S̘/fec|g"Wy&z:dBe( OqVTkG-%-/ɝKc$%קgQFZ< h㝾'H&&IeїVO}(+ᡖ 7Ko(M5f|R IE(~(7R|w)pK˰qH%TBUuP\ĝOK?=nG fѿ?.^\qql%^QRi4S^[l0`fR!`6[B! 2|y9/B\T m\QWR3xL( }(0qɲPR<rG_ˑQN]`YA6?Ӣק&OX^/,TC"+)ZMqf ԂqJEFW#;(oMuuGߟ^x"'N2ji ude96¡窵v;E n+ńىagxzu[jZpRخΙsr,M:Cx5t!V Hx5<j |y!kh7  @ص>Y) P㞼.G[+u#׎⿫J{xyEtX`_bD/|"?QlQpjiY4nԎ%#Zv?Y9~Ptک'ع̙u-رhSBG7=߭y57pŤܟ_kgTZ=Ӣ/foVK{.]dQ6C:1S2a'͉?cAXB2$a+sg8^9xGc=.B'EDIKk.G?K2#f(ʙM䟕|zkvNjC:?fNyk\ԍI,%ti ;AyL t% :h]m:4.Ga28 9а-4 CEr(}٥eP'O\g9|Fы~Ά:dSQ'˨wEl1P< ZQk54'D[ݢ}W4L},wl9v>/1+nkgS RgO{t]'Fub vc=@;EhI< |{8q(go9q?U!P>s( <俌rBP<`x5h1䭔-GNT [~χ[ -UЊ:!섰P,u} W.eU+jeʥK+ص[:Wtv@,] W52rjZ7H\%+Ny0S'Ȯ?ﺏV7ŒnUuW9Bb[hv bhf[_`,SN~|fO~;z=nx-]7-]GkKh1:,ή+oNtOeׁ 5:Vx(ÊxX'É4!$p 9F0#SOg<Fz[ƒ;qvrs.p>4lak<b(黗xH>stream x}M"W񽟢Brν $!M=B^7!hݪ`竧xuߦyuxm4B]{ݿ.}mx}C7z޻/t<>Na:/rkx[-a8Oewe:tU_.A0\/0ƗaX,>-gx׶zMkA討tR':3mj]tQ+ݫ{QHVWVzCo{ ?A? ?A?G#(?GQ?G#(?GQ?'$ŸO ?O'I?ɟ'$ŸO ?O'I?ɟg3,Ɵ?gY?˟g3,Ɵ?gY?˟7&7 oM~o~7&7 oM~o~w.w]~;~w.w]~;~ "_//E_ "_//E_W{H j[kYm9~_⯵v*bvy~vv6\Kofv/U[.͔kz>7}Ș>xot@8|p9_؋ߛ< endstream endobj 68 0 obj <>/F2+038da6c73-1295-49e3-a681-7ee2ae78e2dc<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 69 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.03 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040\050megakaryoblastic\051\040with\040t\0501\07322\051\050p\04013\0563\073q13\0563\051\073\040RBMI5\055MKLI\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.076 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 444.135 1057.789 Tm -0.06 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (BCR\055ABL1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040AML\040with\040BCR\055ABL1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.795 899.389 Tm -0.088 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (NPM1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 408.314 899.389 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215\216) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 448.995 899.389 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.056 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040mutated\040NPM1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 342.615 740.944 Tm -0.483 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (CEBPA) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 410.114 740.944 Tm -0.122 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\217\220\221\222\223\215\216) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 551.805 740.944 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.102 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040biallelic\040mutations\040ofCEBPA\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.076 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 444.135 582.724 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (RUNX1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 518.835 582.724 Tm -0.18 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215\216) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 559.365 582.724 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040AML\040with\040mutatedRUNX1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm 2.092 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\207\210\211\212\213\214\224\207\225\226\227\230\231\232\233\216) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 579.885 424.294 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 590.685 424.294 Tm -0.025 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040AML\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 652.01 424.294 Tm -0.01 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (with\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 704.162 424.294 Tm -0.065 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (myelodysplasia\055related\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 382.534 Tm -0.056 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (changes\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 303.334 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9c9d999a87889e9f> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 303.334 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Therapy\055related\040myeloid\040neoplasms\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 224.269 Tm -0.066 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\207\210\211\212\213\240\241\242\243\203) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 418.934 224.269 Tm -0.065 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Acute\040myeloid\040leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 674.745 224.269 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\240) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 695.085 224.269 Tm -0.059 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (NOS\040\050AML\054NOS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 145.075 Tm -0.066 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\207\210\211\212\213\214\244\245\246\247) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 418.934 145.075 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1a9bc812b-cc3d-4698-9510-8e0033bd99a3 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+038da6c73-1295-49e3-a681-7ee2ae78e2dc 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2148\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+038da6c73-1295-49e3-a681-7ee2ae78e2dc 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2148\215) Tj T* ET Q endstream endobj 70 0 obj <> endobj 71 0 obj <> endobj 72 0 obj <>stream x |TU7jNMJ*IUP!U)UOF1 !"b҈1`. MP)\gg+N(im[TRU9{\k}0BH=v$#R>_۽萇R;s}=G;{d"$ooCw~ГisfhOCvVdM9-( > sXs! _x~#/XڡZ@k) f<0뵻[!uŸ-Dhe\X yQ!5 "FTJP)*CUjTjQQjDcXtƣ&t'Bh5h j$*sx3!ގ/fڏ$b%yzp ֟=&Y<$Kxt'x~? }q:y cʇ7qc46ԏ+JK#P0z=y9ٮLgnKOK$[I&AJˤ)%jnMn5NUEzé=G%(2!><9*qqQ:aF,:gGs&4;֛'3єf8 a4DQS3 DvLhHtU# 'RqۧJ">Y=K HL@JHQȢcVc1@jQHӓ֒߼(d5opp/!xl$d╈Jx%s(zҾ/dOfUӚ ajLiIPp׈2x9{!9ڈ6g \W7?8i\չjM켕̵hONmWB`:4Ȭv^a]hyqٛ;".O&m=O+6 ^;ȃ nxzJsg~Mv{zjIgCU OՍ>Q~xB15Iȕɓq[Ҭ(͊ݜ\;9*̄(U\vb1M7\h]1wƥ`ȡmb|S7GnM/um==uN{]O[όN;٧RtԶř!h](6 y0&js*:qp:Vn=M<'󬇻 uS"Yu^Q.L)f2+`~[L'gν+A !wg"2q8zrG3!9~{0vmɑ+ɕ+7osXYG#Emm>mnT"DYiRJf @i?r([|Z:0S&P5L(.$KEHaxSx=m 麽Y >_ Z`Bl؜襰51HY )?~G;fb+^ ߜu|n\n ºh Us5w񚻦4kþfbs?궪2Z;BJTH"vAc0OGxUFL`$F0wq#i14^LIܺEIkrdLˢ\)mCSsE\o#䀿;(MNMy(^'̈gp?!_oAv7 G o}ls2S)$'aiڤڢUoH)HQW+Ώ()y8\3C7b M/}dc;/_ya~d/' ~ϐ6$Ch:+H}eHV9T`[EE [n 5=q-)"T2+NqE*ɘPs8~sԙcMdDΌu;N<&Lrs?~ ~E?^]`#^p gam0 >h7j#4HN>Hނ-:C:%Ŝ٢@Gjr ]WHؽ:ɡ2PQGFm<痦n^'[ \c. m~oW0a*%y-N^6jJGiNNYmB]`Cc#/ơ}D"mXezF2Dqd][ 0 4|lh *řI_ /* KojYʭTafX***jYDÄBI;h'hWS"'>[ 5jVw P#vG+0&~f+POUHKcWM0B]Hf٠%s0Ů%eG>"Yb1NA2zk$ >>=W~}*ѿ?+>=;Xǡv0L9T,`L&LAfAA6P zZ"萺 fIvYM. _XOɟnxBL8]?OÝt_ >!"&~Sb>M2b`V7H$ vE+6[&›o:3A1tzT^}!_)HfeDuIR ˟UДYVG7_FjM_4}}Fs1ǞCIPtQjT1j ITChiB*؋9EAtP*~& WcGӕӬBNfb:mMvƒHP. LEZօ)It[|~z45WRi`_cp]2/ќ$)x" $a[ȲC( EI&h'I:IM1 x@S%X_  Nߑc.6gjq@viNg+Yu4z i[*InUO* +C:٫7B F*s (mj' sHsढ़$+d 76`&̎#$@xq0!a*\,u ?_ Dž:܏ _ĵ8:adά+` rxtUBT*J)26W& a]dDM='xi#a7_ĖHgO XkC';W>Fn0z} R9*yJ ۠'F⪧7 8]ұ  4~2$&cYhG+{q]ݲ_nġ_}9H@aڷa,oX9%37sg׼ya,;Dh2nд89>{A!T&T3cC^/5H'ꂩ+bT4Kh^qS:1'c.~bkb/4^:M=[H-84Mo 5r>ݤ"hD Q"drYwފ(UB`dPc UY*Cv׷g2'KHFKe c=2s |dαI$ˣjQmlY66zC6l㊹Frg8d>EĄFcF}ʼn }e߲|t!.tQb5 ~^2s9sޅ1YO ?{@rXZ8o2yb\HfȦޢ|lX}$6OpDcY&;ٴ&mNbV^?p>Xyt[tǶm̊|Y(<ݫ w ̂~ӪTGY*JJ A}@$$*M`_p1s|Ac\e|s|cq[;B/OL'}3 }1mGeZ %&j5CYÎ8LӠV?(T*PXpPC"ۃXcZ"(E"݄z, $zn.b/['iP}fOW2 ,( YYI&\m{cά5X(2O$R,Doo0Y`eZѠt֠f3 c/G>9u upKl/݇w/8;lQ$ފ=33bӡlH͠=&W10 $7aq%]|9:!ࠎݯ|ߵx+ciVtF(#roPz]]Tۯ}L50=Pwm4q:qd0HUr,4j!vA?56:l| 0.>pcHBUO8W(yѠ9Z bG7pַ8[MpU@qf ]? *$u|#vC [ (O?mF M"3Yb!q2b4bu{NIfH > 0ӳ}iդpޤi "1S%>qhmL:d%_螿?:~υp,?@-?=j.9{es>o$#c%;ċ71^B+:N}W' g#ᣏ>(n5ܦ fa]{htNPi|e;?q쉏|N@3PN/i)K7[K]$6O2ć_ }p㠗oH@]&S4v`/tN# rY"&ܚm?yh{8S؀:J=re[|î]+)$I} Q!.ԜL++nsdLI7BL|:^_{bg rNm|Ye nzTJQKJK-JmN'i8NE߮EbL0 " d/oXá_>wԑ?Bo4nW _jP]X\{+٭FP!:I}1 p.O*R>N$* (|K "D_$_+ N@u=3]Lϊ-0wxfB۵"+rZ$Oޛ2B"DVgg^|S}i>) RhX&P\EZL N~I5fW!aJ@0U+?q4" ;s. Ni ʠP<+Bi*U+1hZPfR[#qd3(Eb-/ kc9K¡7?0 mpO^=xQ!S+f_THY_L:TghGRWXVs eDITZY- 9Rm&u"!]9nDU-;,D rRa;BҶט?MӕDX!SO`yP5Q1sT]P+s\9pZj}~YhO?P U4<*p3D9x\'O7 / C7I-4k/)#Uܑhq=P  FԀ K%%dH7bȥG zZCAC%PHdf4>x^Q#eLũ'+59 μ(U RQ;fj5t oĹ*99~ȶ S~Ox1< x|eH.ZtE\ nыE9E{-ȫ-zo#s> |\ G"OBBDXlf:LNXa IH3`n%R,Yf5ɮC:C/NZ*dLӽ_ò캚wSʡRcϖ~ s^x/ x=FE]7.S(J򝛵5 Zm~AӸKZ KixQ5+ u`FI=K$ 06U48\EIfiB(RnKӸnhtЛ@eX$)ůwTm7m q:rdpشIxqТЍkះI4a”yĠjΡhShCbt@:aY&iJ<ݜ?3Gi魚6Wx9 ՝c^*+XKY7Fy;g܌unM*)vRÑJ`D*&Y C;mG^D٘VD10Ì {$bg0ba:W3ū2](:t,sդ֭Eu'ugt:PԜz"(&۝qƸR͐]-ACcz\*> "B#IšQ#J$XIף_g;|E!@XNGH?fL(KF̰׏uߝ0[׾{ ʴ96gɂƪe|jYjWל;~z?6kLNԨN^:  cM匜3á gEּyL^P{PZB$q4.{  }7`yFXe_@7q4Wtź$</Y^!7vW:E>iI`7 Q70T4 z-G]7*JII3KJQkrUU!_R@)=FbEj#1\W_?Ü9q8_*U׼E1<vDN)D:n&\܈(3#HMdxDEdC֙=TgI, XX (OAO:QNg_ h {QiQO2Y,KtjlPdfJ 5PW'%nz5SϞ=㮠S8NTFB'3RI rS8/ VG$.aIl{1'yzQk"12pS7a(|=Zļtbk$ bǾ8ڧKbȗl5,E$RQMgCֿu8)6!q[OhM' 9 (̨K_ܩD?$0,9;Mp;U5=jեTy}}Tx.g˸ucqx$=_̡rx9<}h4W޶y\ĩC.D3:̬`mO|`eYx8 ZES|A4:C_hU-k-g^Jk$JqM|~S+]oRg6/YIz긄%|L&.朙C<8lHGe5}[ r|Ã}GFFYC,6D,mCQUE%;s#'Pf5*)+jkG74p5$nj5M5;kԜ40/Z]9W>d 0Ip)dX$2HJ HI$c2DضF'RC< +"D*tL^ tѨB`*FZ[sXՇBWdp(ߓ#ʃy ." 宆ԸE'-nb򑈛8i  ;Dw#qG?w5B* YQ ͰDִ3>3BEP03,|3` .Jb,^fcUUSힲ7wT$z®sB|CsNM}:.*^'V *j= :7W#Ⴗ3·'4)Byq~>ަJ/XB6[M nKA WWٸ63-dsyV&uZsZy;~1Oa4_r#`UgQ܎~l҂{rQ: +75H Dx9 !.# C7. Z߅\ގE.XGt|wF9b$~pbr%@7ĔR)v]kk~1c}5?b;ImWHߓO9=үR[D+؀X< I F`?Mj;hT 6hqrU~l6~X5%aYY)^6I>4G3AjES)Y?<hȊ*9 ])x1 gH}!a_wm̼zȘK$QXV[R\ZRu||9KH,lN1!vJC-|>x,QRFP-AK"5v;ݭw܌ Žȟ@pſ.gws-eiw q7@NYgCYȍ#RA,:/EE' O=hX́_4rQ6\Ӑ %{y٥VMAdPkv:Gҍp[Y OVE΃n6'I$I)-dD<@xc\YqfJ9Cxg>n]IdT#d%w)AGhUNn.Uʢ=+:QCR) pw6bXJ eEpgy 3Iܔ|.>9s=]\󷄷SF+i X߳VpNM&F4PS4n`('dLQ Ц3adaf156i&3+̔9Vo2iIP+xm\f1:rM F\{s5ZBHq5e?݈~J$~?<7OP&bYU1*dSO˨#JziyXAIԬo/ƹ4CڭcҳYW&[xV&z]a\EvOh{h>sU;Nk܈2)̛?n=yzl\Һ-k7=_(s7*[Χحl^4GTʑK.zZm2߼??d[M&BZ9 r|8zT~Cٞy9zrY x2o)eg*m}f&Y: >8#E4U`X b׋]y<:O\eD٠,iDXjEF74F猒q5&c2&D_MR^i<]ťeQ5:|M).M?"G?žpR%/m߾xBޅʊSgo$O"D9!CC\q4VMDžoq-Ϗ]~#va2<~e[[cq1<v=7_UK){zjixmquS ;;&mY{ʏCW.[KK_.8 fu<>@SEdɍ]RIuO Ȑfδ 9 NQd *iG2Ui~(EӾ(o4HЅKa4l-nTbPyH #k4RZ\Jӭ.;rFΛQDxJyS>1x<^⯱eDcJHl# >Ok@?~GM+#檄s P8@ -eL-2 ; {xg֕ s+:/ z=rಬXnZتy (/Ǒퟰ^r](Ly롷/bӃk*ͱo ex.~!!) +7 a{Q)Bhe-$//Egj!Gz4Fp?7t P! e@IU\%'WsՀ':b@B^SVVK dH4 \nǍkM( (5a^T0a,SDWK$%%ںjr:RWHEVy]Na,ܕr͠ArFNTb>18s^:KlmLs%)iyUm9֜9]9;rȑg9_09+#{rpda:5y)) St!zPTdA8V>88D]eVqZ%B (lD#r'%6<7)L>fw 5lEi91FsC0 OHž TMlv綜FRb1}{bcYdd9mo\ϙ_CՕ۷|uW Q3kS޾[:v;'_%,f9ڦo31Ͽ^CrW6&cv'43ٞʥT@Rp Xՙ^0`8 V1Xjg*09F}!U6 Mt*IR%%GSNP)DȬ)) RҒHG|: 6y!5.B~q,.,0; $.8ms[x2SvR}7H)*_:gIOqSu9T*4H=u}Vm{vMz-$2ֺ^TJhXMg0sja*+pVA+ɮTnҤTƤK䊤\9E!Hr R'D,K0,٤UjikP\nSCWZ4V>`e4t rxR]KQA ֐}@6S|,RiV_%Av͡l`GŃelys0c[bS\'YO92D;`NI+e֨oV0SP+3sJJI4J|_#|oR!:R]q~["?G^XhE  wKǗ3ĥ8ڼAW6\BUV!0; i=enК76u>\8># ht R*0RLj=m11Tj)M;tJE A7q)-/\ _[)_vYz'e)LrV*A;4EnO=[mpifF# F85p|ɝF⦤űɎז~O;-WnE#9ѐpG')Įݒ=;?S_݌ c YvARX P"qzwdަs#_]Nl, Pҧ$ io9v;4Sӫ"'莉[$xtJ q[2ם1& f%[]KdfTڤ5JlWza(i1|w ܆y( Xp8G4!>ԴiOJ0§Tح*QMUV'nubpR"Z[Z,:זade儅NS9ł4vvWjp=jЌk&L&^qdQꤸ'MVNDHWZOlYLEɾh1_!!-?_}7:_IȂ FIl0n\iXr-nxPnkn\VC$e++ysje5U;.ŭk.|n=Y%⧉Tz^adD.ˣ:4 DZb/H1敖bQp rVqu<U&65E/ 1ܘJ%\hD$41b%eVG15h ;J:/wS!YEfq7-#upzéKXR*ra1+9~ 9NWrQcT30Ѥ'*&'d2%u%%Lkޒ%g%XkZh20c$0a k R%`FFД_¢ee NSƖe0E+JT"KbPWD'H#+jaKT9(c~O,.>jvCw|EHDP)XBdD'!or.0Qi%Rܾb0|LNgư <<|6\E|O݋mM3[=;Tx i?18-g$ua$*&aܘK Ʀ̞Rsxz‚tP[tkɦܵCfUd}Rx8b~focՒ{0) #y3bmFmtGb'Y!rR=mZ!=Fzޫgl[՟Y=w-Bz&%H#&gٓv Ug͵gdfA5V`Jم&rƞJաl=ջ*b<")+vRWϲHGFq^p|akp!3pGL*,D96A&VKFz-Ó#ޛq" :P /^-mvkkOjhiڨvPKWhk)H)\&ZB܌X"i#>_8f qm4ɉWdk/l "TqK0bzc-ݿc,B oROcӞy{黊0CmY^AT=卫yL=q\ vS߂ X1^SP0*?))%?j2##Wj4|dseBJ0foaaU2=W%šs 'E`؋3?UZ!t. JC)J)fITUaw1K00$ws k5~ ×))pXFS6GNWtiXFs2l Gcc-9ȏxl^ ؠ{{O.֦La>Œ&C6 3,(,.݂ޢ]Nsy9+<8qg '6ߕL6 /e˞q_ w +~_Ź}/P#;0ȾY櫶Qo K737 KOJ_63Um|?76ڸd|zu6vXTX?\&RMd9 3uΛ'l?{P=t 6vGƫJԪ9ri ; f5#/خi*Md2ΨVNr ld()i))F#=ބM&ڠ*N;Km]K۲[wd͐eWl*;v gJM`PqH)idGkY8(qs#J\Ky-e^ wd N]܃e%o\EGkG(ⷈ ?z>9f<-z g 7,`S/Rc?^z`h.^-우y+ =3I؎W12;6Q;]zV{'K@:@gi2Ж4%C:~^:Vf dhu!&S5L(9redeV q9oњPw,7&qHw&yT~N>(g$*D\/NԬ&N80=F~ȻJ Ǹ?}#MݏX>NvQo \ ˖t=K{Poc| 6]_ٜ?:1-vpy ?6q \.ֈz+5VT;Y_QbS''FF\zQ y9-BiH4i,b+,x\ ] r1Rxgr:sR,E PѡhlaFQE6EBɊD]YUsRY65Viڻ{'_ۇҽp^5_s**&;j%s-˒,J֧e˲$ےb!`W;@(GhB 2(cM3%!d%$C;iBML.v<bm Nyv߮j/9';uH q]1#Lg@\'L[aNIQh.2Z{ S |\('H$h9S2ZeN,(c >qб"qEb1e~CC`J$'oAlcWυy;v93?>_zȺ.]}!~-57}cG r#KЀE#bPIU"//Z}Nf&b2w6BN)F  4 ڱ摤[(p!GZ9nj.7 aE0\.x zz^Z ZXLBTL~srsd H9bO{W* جr mw9X3Tk:K! H<3AZakX؜M>Yz*VěTk^H%'[qW^={o|cYxgu5Ϗ/3gOY/$e9%9Q?_W_HX`䃃#c=i&nX?K?OlD él|wQ0I6; $<X/b1OXl7i4x$_nn,\)<>"s3e>rՈ{WX5 ذ-h"T&YB8'4 ffYN4جVQÊpH CdZ3"IcbV8ʡHvi'g"jyaWYX͆ )oNcą;i:׳'IYx<1V־u ۷%WA~jiN6w|VߟO$/Rmu[`[_$+HR¶efr,O(jlфZcYP=ra((TZ&r.^؈CW 5zRHI hxX\T!&jkX+[̒,kY Tg-87A?ia0 t^&ed.HrA>,Jql)v`dca$,8Rl]cpyצ! NAx1_9_I$vlBƌuwNE#_ +;"ɂH/:b/5rzRxgcDKi8oMς6F 6zI%Xee\mn[xcK4 hE9D# 41&DWi\B^ں +Yj&ںHĉEkZhheIYOqN7zu)C譇z(*_0\)j 0mFʣ0? I*:0 XVfudM!𨥥e$vWY?w1<:/(ܷ4F\###5S]ӶRR,Owln7;Xz]0kK^ANdhh HO'ڪIuƷy{ :hqz|õQA3<6U/S2'݌,Lm7sb&i,6A@&vT}j/=~[ JrdYJ2XV&H5fh46kfv)`MspWYHk_nDK}&[bN y^^G3!5,9K*2#9aR`l5fCo3_3qf拸ٔh?u9yqHė)1yxDr3o?a"rN"&sc4+\nڑS(;R^ {h^4>-%pK jŒE<$LKQ|y vJVWwEvr%7͑4!y,q_cc[y0-x^^"wo]klfa r41(hSkVe qlW;C/݄0(_>-ZT&܌?\R,zsrAS@4bxY=x F%Hu7/EIe*ϣF; bUdũDqA80;tco?'s@-~ǂO΁h1N}ddFP*W"~ٖ9~3vݛY0' eR\};YCʅF)p9<1s(? d-%F6v=Nec# Vo%Q/_u=F ߞWY:9֒u[I_ؿQqWP|3>18q9FKD tݜKLߢ.-FUU\ѧ [/&S'4ᾀ.t|9B9؅A甹W0+pXbs5k_l圎Z&cxa^4X ʁ AG]3c[`Oh 3D~1AtGNq+YZ;B)SJq%mx:l͘u2@ T'ID"4Z &"/J zHm+e% uEOD,_XN6 ̬a]IeI.$N:c4,04XXTwk$,XZI.`0H[6#+M//_*{1Ot+GTu:o)݄>y(#œ<ݾN;*ضO/"eG+RnɓM#f'ʳجV ٤RL:gE1Xgu^uJ|az=Q63ךכG"b~]@ +o3Wb yb[a=hqF""[?fd1s Kl 1z욍~w爸0"HIU,!M9Q={HK + uF~I%s%#K>mr?Kl`d,>$߻s "e?o+ C ^P.oO\oX\3@^J~]nN~_JWt\@>?S\BqÃK)6Pd|,n][ULZ<|O، ݂QZgBS5N{}Ԟۧj'ZvL* $˘vE~nR(G2 v" c1}T7(Gk‘wn:*Ӭd?C ~Lo-DSs*Hϝ89b'2`F zvMnB%m]-B;ڄ7rgz|&W*^|Ӹ뷹NMz5/& d&?J;n|x<΀r+8G$*Qy >|\ 0H$%$:poKPك(u$_$^`6.H'>j/#=N6SjPDfiE>&'%cOS!9T ȏ*?@#*Tt\Y Q=0#6?PiAG-d)'iYBЎNЬęOfrT5LMQ*QE,]A?OIҭҋ2l JI+ FѮثxUW.k0W2 moQgoMrYvc{|yUvyy h^x裀.4" Je`T|o;f XY4?5| b xMl~/ID6-*ئ' g6D}\lh%Idm`ؖ A'bF_CZ?XDcQԺl@67~`6m3 ʄD-7=/#}=p|hv}s~>6DMhf}#wFIm~x#o@ܾ{L9[ؾJMl1>X/֋źNkźF9*Eb]!QTE?!|PÇqb ԯ_X>؇+B5!~H `XwuXwj! TvTv?[m,.ֆ5le0;$dr=nMO]Վ|Ūf ̐+T$)@B TFITZJ*<1Wؘ%3Ʋcژ&cd ZCḶ 4-ς~v>stream x}OkF?-A0NDmiVRCcY׿y-R+43z4B3g}<t;ϳ][秏xz>/oonh_v~b|<_.Mڭuwo7{<?n?ͻ˴[P֋t׵U}>͟mWc}A9r$'DʙlFve'Bʕ+Ay o7||O~P~ - ?A? ?A?G#(?GQ?G#(?GQ?'$ŸO ?O'I?ɟ'$ŸO ?O'I?ɟg3,Ɵ?gY?˟g3,Ɵ?gY?˟7&7 oM~o~7&7 oM~o~w.w]~;~w.w]~;~ "_//E_ "_//E_Wgo1+mcVVjDZ{k{6/<m8և -3uly3˦}S}h}fqܫ60NjϜ mM=lN{nm]vo=s㯫Ml5|Xl݀/~:fZ߶}poC'[S P|+4|AZ JiV]z8 endstream endobj 74 0 obj <>/F2+00f3c16b0-6ff0-45a1-a562-e7436bd88e10<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 75 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.052 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040minimal\040differentiation\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 398.594 1057.789 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.048 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040without\040maturation\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\210\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 899.389 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (AML\040with\040maturation\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\213) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 236.37 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\055) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 245.19 740.944 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\214\215\216\217\204\205\206) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 387.075 740.944 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040myelomonocytic\040leukaemia\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.066 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\220\214\221\214\215\216\217\204\205\206) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 418.934 582.724 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040monoblastic\040and\040monocytic\040leukaemia\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\222\223\204\205\206) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 277.049 424.294 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.037 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Pure\040erythroid\040leukemia\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\220\224\215\216\217\204\205\206) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 265.849 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.025 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040megakaryoblastic\040leukaemia\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1feabc8a5-77ab-4d71-abfe-342d3ad17c3f 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+00f3c16b0-6ff0-45a1-a562-e7436bd88e10 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2149\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+00f3c16b0-6ff0-45a1-a562-e7436bd88e10 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2149\215) Tj T* ET Q endstream endobj 76 0 obj <> endobj 77 0 obj <> endobj 78 0 obj <>stream xUMh\UI&bZ_@'L^5eĤLKD`fc* Z"&J R(.F+@ᄍ .\蹜{9ݹg  K⽫ ռw ԃ;2jlyW+~'?=6M>BX._W~"ȟ* NG 3#VB I^_5Hnw?-R-{kAGOLo&wț|&348Z # B)24sYLh[T"pKf P>XbxX_| >h޾On>8A ae}z\9mZ{/ gp44xgЋ'Bp^xLJQ u7O>Rf#GrcylDO7#ƾeM]#Ķ.ͦ47#M!cGS񞙩͞:7܌ {@vO4zo݌lf#"+DvCƐly$_7qFq^a> endobj 80 0 obj <> endobj 81 0 obj <>stream x |ǵ?>Zz޲dOٖ,ٲdX?y:ơalMlqq@JsIB a 1yҔ%m4Mi 7?JI Mwf%m;3gfgq93!@4;:8P>K{Kt B.9Qຼ'6AQIBqy+W"TeG6HS>@z$W }ΎkP?Ϯg|[ "^ߣ#9\Ҷߺx{[;ـ!t9ޣ~QkQ @$<)AcѐA˩dJ!))i2&y6_"QleA J!yL"oCdxGHX\ Ɔ?sKe`$>/E2HR!5E"#XdFÕ(%d-T@NQDY(PEyͶAU:o4j??Nf;Q#0ӛԺ?ä3wt#ŽLbMCϋc..\cq'ncOP#~Ak_;w0Z > jه6pyN@#ւ 0BVbvWfH܍U'>hFh}?>=)E0a,.A_|@qil=k挺ڪ dZq0P/,y=WvVfFzӑj$'%Z-fѠi9ZTdRVF9T5լWjg +\#|Ra+3ÆÈ,oӸ?V[MIcҶpfC_τvkJodwR[[ԅQ}&?  NJ.Xyķ9rUad8@aTtAC8!w06Ά& 35m+5m0mZtDA`CQ3çj:W9@@"+ 0Va1B)kSHӑ֐kE"j7<1tgǦbh,ڈ0[Fa KQCcZR9ږ.n KaDt4g/ jF&Va4) wG5o:[ VG5U5}~AXֺ*(ZJX:m$98}[x4\;X5xTVLִX&NR[x`ي(- V~eف'cCֺ4yR͚GŮ]~լ&y O/lp~!t"tڷ.` i6h}ɐqdMX]S5soV/bHNkCѰ4}:bӭjT,FYi@|.A2& %9#̹’֒6N Coa"; 06:Y*t[clqם݊)7(9{hyAz(b:%=ZbƂxZl }`%Fl52a[k(X$M^h&bLXcl ~9|8{C :|6VWKcSl*"#]fQ*Gwf7Rw+n-Ʀpkhzzg2캩l뉖Pavao8^mM#Z+vB^qBHIFh&F(Xz,(2"AL3HM0gҸ)4&JE*t`J0~Bql/SFP"x[IM 4ަndY ZZFBPX.%+YZ:T^^N]DVJKÿL(ԗUM̠̮M \O_KPH&Lɛ˱{\Gڝ>>q4ɪnk $ n%7U0ᦑ̍LHYW?cR%:^fWm ҍgPMRI)~Hixtpǽ$9#-2Fʠ>Ml^[_z]KUE^cUetBdO.x_%< ,M$[YnyHe0)l:1dg LQܓ܇gQ2ѰƐbphA7Lq0A^w84ZڼFk^C>Zvܜ /ߣlQ`\.RF zSxǛ..38ޞ2{ő zp'aᄮmܶm+<4ycOByEٜ2 MaG#Hxv _2QM3:|~Wg#5SXHe'7Uk$~fWa#yck:{iva*F!hȇ J AF~2'Í*BٽfҞ"MG iX{w;{MY௘óo7_Bt'VS40 .aXbU*  8GP~ Bj>?'˙??4g_vl{M=7ȧokKţR&z5?x8x61 k8f8 azXnQadpVFIqM _C {Z3OozKFX | IrR)rnr0-^ uX4rE>܁q.ϭqRn2F, ۍvXB_a𖙺TďaZkmJ^Otx_XEtXYPLF5..#!a8Ƙ8Ap *tJ  a &3f|67&GoOjy18w.~%s$>iȋ;#O~^|໿_a+.E!gwiQo Wʶ)W93bq]tفmɑ6hcϦeכr.`J _;yHfDU WJ% qZj8Yf5GB2A(8wO9irG z230D4|R~‚D| vb8(peyg(#bc;w72~{[7^=:]|Ea^էOϱtʇdqP DًD ʠ{1{[wO'?}JW*"^,y߾?FL;pl>(%gJ5rq.!-UL#*&SB/*F裙F{wBT9cK g ?gs!IlƇ[;HiBldft;U(nx;22^hBt6*Ħ9&cXc?ÏO8]7TU(ٹz hkeMɓ {NhJeRh22e4lSaB*K5, XtDM1) HKĮ07o_X/Ϙ_p:j~,/GY$-OoLCTviD%*42 $[ZrJI+}Zܡ12ݗuobj`"X &72W0$hX @td9@@ 1DN.?4=ͬn pdR]|voÞv(f?Č˒6,T>+l#eX۵yHYOO4qM&+K&]ek+z%gZ?*}uPm'¾>}v['^64.,ox<9yOx`޻WlӻGF+YOFx!JqM t)!Ucxو#(ҹ1HZJj^˳iyV%y" ֓E:''xO\O^zB&3KsU*Maa5G cM n3`TGyl&;;Q9ZP7~3C t}@0ך^0>Nxc7wsT_|ހ+$y>R `+B-r0Ȳ] vЉ,D|bmG2̂Skm ^lt<ԑ?KB5v;fl}-NXOY_5x}xL CC҅€g7Lkt"&A~= 8$墙0vh%}hzmx|ZȔJ,L 9cxHee>ao_?HG3`pQ>ٸ`tAm(Iءc9<1r;Hn:޽{/D ?G q*sʧNR V'lR.`e* b#3I]v̏&|~m|;c]O͟?ZA˧-[ܒ y,̪Zՙ\񬷲>4z2=˟U5?oY #K%`O]׳烞O{$==!H'(ToSq8?_׿o__?'b#O㻂]u]w1Y] vvzx)5Sշ]}7踾}=D$}u{O}@"Jդ>}P]?PSYjSMKT)))JR"ŚJy єRX23eQ镔_.)j' (M a-ICbfʊ*xUTX+axBaTTW4e^ɟWܬPT,j.fHJ'(K%ՄP[<AkpfpQpe2Bp]͠,V2/ĈFq˰kS(^VT0S|Ewޡw, I^ҼF$^*zV< 5b]Z x# P=ګ j7$WĶ/u zHCR1Q.r7HpFq .6d)x#9L+e3X)${Fkv#.J~FBBh*EN]6fPDxSG2ny,a ٩&K L*SL\K&,N޳be{tBX8wo]KztI+~XX6pG((f$eQLޙD#"FL33:` uA$R'6ْaee`_O-',ޞ-}"7mD%Of3_ PvP QiXËV\y7􆑫uL #UB++fa\!o(B\sPa.iY.,jquκOnI-ͮ5d 4'jӻDJ>Q4Rk@TD52Q^UHt|tށ 1EV`%dOE/*gAN'H%bGOvNRGu(ChQNJJMia߳ۄowbj^1^ZwS3dTgp:?c]fz afG&z-"&e?5itxavƲ"™?}@S%-yVbP[ػJseL;|*#n5x搆9^OiM&S֤9*^?C&5c2iܲr\Y[IƦL>&;${CvV ٤L=%Jezz\v`LTK%咹Id1ۄ%qsoEIސ|!h%HESiG Km_Fd5LqQ_`68}Q;> Z{1+"y/FU=z{jpvPxRFl־(`H >ՖHuQiil0feptDwΖ"1Krdb ?F 2F# dZjEۭ==hJ Aat]yb,Q'ğ'zU\0"]) >nE#&00.̃`,]ōGs儠?m_d(r D>7?^&հ&dxTSs33}Tii!-iiBtM.GH LpBW>1\! ^Vy |~HVg RCp uHU)*^>T &"[Y$.Wv&{2$GLIl+ÕT%%1T ڃ 3&PLZ7A/pWgʑu $`z6o!$]qIBYG0l 0%/WqmTG/x$p3u/#x&|9 ل ll񗑇@B/K,&rj)jYXZ n铵;ZEٳdlBCā^(9^o632pysήkxhIK"O^}syrj9`*-_ ʫ a7l[Xa#\Wm{.#4C+4~u07phAe'20!3DBB<+K(}+]PJbW).-* sGA8/\ s*ƒ'JURaa. "y,[q1yIOBJUxe1e5V_ƫy&2{7my'[ K=%ANE+=E,|EEx^^O ♽S=ITg::\@gfLj&H]0ZEI-^Z.#:!c 6 $d4lr 8ō7U|t& = xŔҴ_CtsUT^qU $Anc:Cċ$*)gϝ/vl2n QkSQtRX(1 PCfS)fEG$DHͣ./}w$WL:gY՜L\zO?Ϋ/I0QlCs9-gH &ؓRN0^DDeG1u|.X c+4F9!@vC6٦ErD-:}3R2 eFP8/8j2D's 3yyRAmÒ-p%  YV3p:6]o/boVW͝!mWe'%wpdNNHp͊V$Oe4N04iB-ɩʩr,gH+&BqTh[zinb5j*Q[l75,ro7ko#-Ļ՘x3 Qݨ5qnN}ـ$(S 4e&A0wUJ%MdqEH=y.I(ɣ{ⴌ5'H,}e\L^[nI%$1IEM9E$ו;7%rvn},l.K"gsܴ\86L"׫<,Rl;Y%%ΜrMi#MnIN~,ɓxa!\d&"}EgqPY⡬1V_',f+zcS2Xd[f~)$QwUhϤ#w[{wZV{Dߞ>&ʉ)#?GޣrnI;>YBo_q';Y,\|xt?Jb!;*F! |MMt+9i:I[UY9}ڴBo~~ia45,+&)`>X~ ,kaz8N1=fQʕ%f fe8 kx~z?iO*N%${yRRH FpRdV~㭹iEnъtVU*q*% p?pq*-A ۂܪ*iVkV*[&4ԫ 7ɛE]́k4Q.Dn8r5C8*P|;yʪm9Ԕov5bi 6vp#Isbvʱ tSJ zڔ)m0"W$ I:of3Pj7j[AEJ'4"s>]/ t-_ֶkj;"~yۋo_W/ ;r't29%Oڱaɶ8To7'r@xnCx;$\j7'0vj6jhק^W}'L[@IA+:Pr!7Q6I###25GUU^o0$y\X (T'kg߀™<܏(O"P.G8{BJx8/De +죍92$by$,T/CQQN+] WZx7m/1pZIYB\BQ3 .’`PV#qq)I>ދ {KqBYY  FpA9v6e۳ Ϥ`BlޙrJcȡgD ʹ&OBޒgѳĦg$#HP:1j:I6RWcLFrtL"}94jH@i qAŎ'`zP3DuR=xEzj?-cߋ(sv /,lE[|B_afW_.\<] uU ' ̰[(\Ce/6nc;A'*P6&ɔL$gX34CxTA.PK3i:/ӥT&ڴ ̙OgCodͤ3P&QK ltlJMgĞv$#ţU .%G:gdYBs-O[Yh "ROK'&)򉶐T~OᎼW>80>,o% "?ym ӨҊ^QMvCdi-NmPD3z"oS=%}g>a0wwo}m׿7[<ܻ X C!mKŸDyX&}D<xHyy L"զEDP.=jO!z, zuc7k&T*&UDi\.K+ADeb(\\+8Uŀ4U P[.*6%PT= w퍡f5S?|./莞 F 476X!ή^o,_VH0 y~P wQ 9AGF`Ν/Z//1!.pCl'΋* 3{9+gf6@$?pmGERya˖}KN|wS{#Wғ.9d)C1kgs"PhN^C';A@8sLN֥zER32lX,i; T\6ێat&} hR&~ ґ`t4eRruj{@.iPlI)It*sjZ͹p:)IN# ze4;[!ɞ9q3T 4s0|Rf\bi_Tu\gS ቏O2bWXIʯ8-RdOk!~7H+5D~j9ٺ\M^~~_Ar%}h䟑_Z%CvI2jgQ;u 8:D?1tILVC(ZCDy@{ 3%HE_FypY e-YFN' 5JO&JRskAM,ï ,i?A?byyJ2KSr+eP&6R/׼nхɦ6sSVu?KВr7B1!~5:xk ЊX# S4`@,m%H,?CP,OLXC,%X0pObQ'zsh9Z *(BySV!w@Z"v!{DdټO6Uut.]ݕgXyolS1 !oյ`iPHwJ;_kŰ.4zjC¨;w2J^ݽۼy[[ 7zy/Cw_lm/6 14>/?kF~or.]9 &.muVumeɺkSoNw[$gZ_o ?I#ձ*VŠXXX KcXX Rp:At?#C~4LvU%rqIp;n6| b [bX E~J\l\D6µ ۶b-~Ш+0j|Fod=FmDy uf&ۥqiRjCh4V'W(YLI3%”ҊTișU:Ơ).,I/qJK%cDSW–%׈úhfceX!WfѶ53W05Lmè1l U-\4IVq1 l.WR@҂Dv$-@3޻VG;^ήYΩi365l CWSqO 3ò8 ?$Jx"6 endstream endobj 82 0 obj <>stream x}QF{?E.[Jљyg ,.݋Ӗnozq+tU{߾>_N L~d~_>t8on?|9z>~cx~6eڏ?C^/Ʒtۏ.?n3Ŷz ;b=> k9vq,ԁH'uMmtVg jҽW~5QozK??A? ?A? ?GQ?G#(?GQ?G#(ğO ?O'I?ɟ'$ŸO ?O'I?ɟ'$o~7&7 oM~o~7&7 oM~ß?gY?˟g3,Ɵ?gY?˟g3,_//E_ "_//E_ ";~w.w]~;~w.w]~_]CjPs܊_m0W~bK⯵;umuⷧvW%kuo6oUܯ}bwm|ǟƯI=ֶ:~,}s/h.4~u/o endstream endobj 83 0 obj <>/F2+0d89a7d29-f4ab-4fd6-9469-9f8f6fd9feaa<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 84 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\201\204\205\206\207\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 398.594 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040basophilic\040leukaemia\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.076 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\212\213\214\215\216\217\220\213\221\222\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 439.094 978.589 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Acute\040panmyelosis\040with\040myelofibrosis\040\050APMF\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213\224\225\226) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 256.709 899.389 Tm -0.079 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Myeloid\040sarcoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\227\230\231\232\233\234) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 820.144 Tm -0.019 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (DS) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 324.255 820.144 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9d9e9fa08b948c8d81a189> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 547.125 820.144 Tm -0.241 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Myeloid\040proliferations\040related\040to\040Down\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 135.036 778.564 Tm -0.089 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (syndrome\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 699.364 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\242\243\201\244\245\220\213\246\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 699.364 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 620.164 Tm -0.111 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Transient\040abnormal\040myelopoiesis) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 493.995 620.164 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\234) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 514.155 620.164 Tm -0.925 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (TAM) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 558.105 620.164 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\235) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 578.444 620.164 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 540.934 Tm -0.019 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (DS) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 207.75 540.934 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9e9f8b94878889> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 349.635 540.934 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 461.734 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Myeloid\040leukaemia\040associated\040with\040Down\040syndrome\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 382.534 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\247\250\224\251\207\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 382.534 Tm -0.056 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Acute\040leukaemia\040of\040ambiguous\040lineage\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 303.334 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\247\223\207\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 303.334 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 224.269 Tm -0.064 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040undifferentiated\040leukaemia\050AUL\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 145.075 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 383.295 145.075 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0509\07322\051\050q34\0561\073q11\0562\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 570.165 145.075 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\256) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 590.505 145.075 Tm -0.064 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (BCR\055ABL1\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1840bc97e-c2dd-4fcc-be6a-948343297631 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0d89a7d29-f4ab-4fd6-9469-9f8f6fd9feaa 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21410\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0d89a7d29-f4ab-4fd6-9469-9f8f6fd9feaa 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21410\215) Tj T* ET Q endstream endobj 85 0 obj <> endobj 86 0 obj <> endobj 87 0 obj <>stream x |Tս?{d&y9afG2CBf$Ab0 BI1URxb0A(P ߪJ{E H[k2;L{Ͻ73{^{=MF)Q/QKcG]K#8:oNwV8g 8Vܽrcԩp\}}O@UZY?븊2B=̛e<ԹR(`%g}+VY/؆!._xsEmV[hg!X2you yhqiE#~yݪ=mjW%›IED!q$}|jTDE4E1EVcqÁ8{Rߢ,1N1b%y"33B $ ACI10'F$EY7kVT`{[i=2HMf,Ȋr ¨PD.FQ*DEy1yڇ(Ƣ 0RT(ơrTƣJBըբ:T&j@ MDwIɨ݉]h hf( a| ? ?yfLi?PVW6uB/Z }|49A40ga.>^F0jzĦƆĄ*.^9|\,ZV c~ߘoqQaA~r:칶%l2:U ,K*¨iu5I:I'tk!1ZI7tMI}˴CNOXeRcℇ:L|ݍsӜn=ᙤfiMRym[mJ-PKe9GBuNsdhvɣ@'"6Id ծEQU$ RBkȟ$. w@ ?E0]ZzF 4!H nJ<\V㮙'$C29I4}+*uQHӒ֑cQ{Z7ugpd<6ҥSN$5IIInN=8TrrC vz]9%9P%sZf@ ܵ‰,ncIN8kɢkNB&] j=[Yq'4n%BOϫ[xgf3CL)4tzrCs!<-w~v;ȝ;7tZ?A:b~aqە<c&F3˭F[L$%HƒdN@Jn`ݎ $MjVLwo$k@^pDz6+HRAӦ(ܼI< }Xе n5]_u%Ϋ'duk4NOo$W #pDMRԚ"2޿9u6}'w[½MoOZo&vm-ACn~!sƴ`w8ַM0UY=M;@J)RJ IA2 CkTo=2B{#L:Z݃T-IqBN~/o`e!fD"Ԑ%4PQ4_фW;6!rŸp R~ʏ7sRKp#F&h$Xh3Y `70Bgu7[Ɠhxer3Թ9QݔG9S51?qRSwPKA'ML vRA'(¥ DەcY1VpOicS$$6`,al"4"Me#E"DJfh2Z^S#iLdx=  V/.˳;TXmr9ӴASbS@6kJBF_uiB^!o}đp%FIɘ[WwW<>:SW?X_'6_!c4) }r\Tp3 D©pމҝY`Lg,ӞBO_fYNtGz+8dBCdtP4:ݑC:G̊ ؠGnW=gg!}c7\]qL?8YG#KN;a*}_ ⷠ],:A*dAٓr M"1 hVK%bf56tiYJ4 ָ5iBNM-`f)>?01|o=znFT3 ^X[7[(77dRvVЊjj!۹SMfnt4! { = jj@(F p r tzaɪnG_ lOocٲ?|_F>:]yv9N>arvHb^,Q#U^S $BW ](mݺ&Fh>qpqb*eMOHrΡE[jUUPO*BL``}o/#tBp@266tNڍC::ֆ=gRm5˕"2O+;Sh#`v;*rm6,AR&݂-@=dYȻc0࠰i%2nIkt}򭯶<:ߎlyȃſ.bo>wlտMݗX]vv i " :l T9H rmtG%C 'v:b n! 1C/<_Ooy| < g㿞-9t 70oRVT:YʂTI&$8_ŝ1?&% /Oͼ1Wc|+³VQ"X-l!ٴ.\fQxf`y@egߎaFA h hUjE<N`5~# pAOwɍՋ K>X)ĸk oBN/YͲzoiLfh~҃ `x6矡jR%Rڒz]؛Orxήcɂ^kH-T%fX;Lr\ .>튠LfwBCӡW#~?ޘzVw]SۻEhjmEc#=HU\s.+zL,vUJԎgjmvT̎c;;md .Csa)u(6j]zv; ( 6־Lj_F>iH$+tt!;&)Ž,`#e Js<~S]x)N\>XO=T<+a:kFsE?Ұ!g?j25"UFeh;B؀ق3\gpH Xttif eN۸y) Gwk<n<` (Yr`0drJ AAql¬09t%ph*F5@!{_?Xc7_'8Y|G):l2~fif.\MnzTɐ"#Tb Fi*PL0/tfJ##||/`/)I0<ßq7L_0Z r!t:k6~T!.۳Ŭ8[Yf`Mї6*e29`i蚄 _ >[|+._}=ш~Ǎg7=@7QOūZ9 d UPwr8OlGv۵X.ReB r%;(x 3fi}x:B4:o?]z:7udRg\QXVVQaXڐ]$bA5]ەFv*'-@ bDE[Z,Mtnџ1\p?ݽ@6n:Sx_c+S<;/M_蘻4z)e)XW2`2|f;[Ò>h20w⛞n=SIؖ!Y~4-i~++K~S]2}>P Rub\X ƫB-Kujv8bZTG},6yRnAY!L4cǪ'}fX}9 qLgUdD@;VWב8T&snwxhy4p'kDȋ2&lm1@{P jĐ M|Oxa:*q+P%' ǪbE=[?gRC5^ex:*+]xes%UY_^c6הWA< xz/x/z7弴wp$0f'-p%u:*H| բl$5'544 tpNaBe!2VfV1K$ܕ2 Q~r"+5 SJܾ*8B+W"Q"wCB<օX_t&iph2(ч2#. vBRl"ϔ救;3x;χQ\MvXfl޽~0O5?L]L7kuh0Ts=ajk&QP-w4?6Z]}}[ssw'g73p}`Yh?|*1b4tA hFK.+Qe*~E+ xLaV)nVJi0f$!4Y?,f F.wxi1S\l'sq?fԁ"wi*=N%AhAL-  p;̜ibߊ4Q,}rvxt( C"CQB/P@c"'>h 9zh@Mb j}jbN my3*)o&^ȟ5eA^]J*R>|kF?Xa}|N_rdxvc˶׍k 2@%Ghjsx +-VGK㐾ub nZͲ2x R1(xqJE ݏmf3!Ba}>!eO[CD@WfLqQ ;pK3 ogddBbZ8ё(,/7qكbirB|^|M,.~kh)hhեV?T-n^Qz[8\MtS.Is'['S7&cdvɔgrxr}&,>=O.=+Pj`#8qO< ųi ~:U\S|ƃk=]}w=_y$8xh=lOyN^_K(T }bKm=6Jnn[kMwVڶ٘Z[mv:+$/Ķc6d=OZPKزB;, XN[޵\H(A Iltu-yq䆸݂bFdo7ś:64mj$gN4o˦&eYheZ,ҤŲI(xd63 ^eN2,M YlۇBA@`eAy E1o' p ~!dhrs (4Ӫ;u P.oeB& yX0~?jcBLP2 - <#2~WbARDƩ9u62`'Zp'wfޟ{H:>^Q44R7X媟O Y3k90d'Ru3gWՔ6}0ƍq|у^%:Ll,)WTZ ?_Ut$ܵßwu߱[" b?ى nTiklrk㢢44])wi"ƌJݠf;'iM6lxa{$D38 j x @ x7B%릔 ũt6٫$QnF4NdcٱcǏo j^ z2JE;{7gUJWe*6N*u:hi6.6aԩMm;:I<6!ѨbQ)@Fhlnm(ud{'/6^kJ':0aC8P}n (ZXlo777w4oj,Q7!s|H2%KK(%K>)dDR8:\"eY/zru_/XZ "M{ F DJ{ (8_U&'i s_mI/>QP5'PP4D0kH"3  j7~r.LsrA{PMc;Ro_Awj2AJ Z+ ix9 LMt_#x0VW3Qd,+եE -QƙJ@\4iL%.r@4+UVqUZѽwɃA)1⡒7..|:?J w竩[k׋w}/u*,K.I,H`*콸٭OJj u u?UR[sN+qZԮ%i~+^jl2c> oH e! -옟pzE@U2Uv66>?"Wl0>9q;r -X?U,:2l1 岹U,]fh"ኬDJ[tʺ8\38FJA<4 ͒b}vWl]u!bPqnnqF25+ZekFl4TrTj5BcV&TYja EY8:1n܉YT"Klղ!?0X@>eh`J}}B}r]\ak.m̓6q}H"|W3iѦ(\upʴ: K~tƴ aj(I>=ȍhöS<ʗ>2n]˃+K{=¬]7qc չ^/J])W -?[w%.9ȇxGbR-vl~pqwKtVEˈRV2@[ B)7`kHUl@6q)u:cH$K !gֈZR"> T 虣F*"06(wYY&Jq M f*bB+ꢊRbh 51(/e)q.@-"b K|nD(Z"@✂Ȱ.oQ 9}/'2_>D>o}}}}Ay);=h5`Ù1gGJQ!H#zZ?MkA,*WtjmU } aX$K*d0 sIT* +ď,2كEXlyCH YRJ'.~3/>Cא Dq}ߎ̙A4wD"zt>e+WcpcA@hW5>Z c JhJH(4( dJ7A&q /"(J˜g`ƙ_@<+U(Km W w$yjŏs(Rݓ>9[кp)-tŷkJK72J>(~b5ЊS?Ըwq`x#}}gR+VMK'O\2+U8Nt e tuN9'вlVb]SiY]gLVvY`8NN+L8vvc6[\BT-d A~)JM (ގMl"FCK|#CZx$6Ne@,j 2[ %ǥVQSDIjCj%2S[ʒ5~. jpY[qxVm.'> >¯k[q)>(ʏHArƠ&@oн Gӗ mԩYE1i _]=+WFq8n$,VK0+5&>B" ,O;~[=g S,V)K|dR$m~0;NJccY&lS+; kSSBMr\vvq㍎:>CbyngᬢXQCE/-z胢ϊ-RM)by6xlvvin覲w/nQ~w}<-CjDnVUU ZUGWU߮寪_5evf ?X{Igؒ%,aL_sKؒ%S,\’KK"+]Iv+oVf,Z9}+Xsdb+n7V~߮TV.BJ>Ҟ.jPQU"UjV}OTW);qVIv1Iۛ3fߴ]BRP('&` ~j*ZTuoCUOV=]%WYʡ`&=]uͪV}Q%wTjڄ:/ _TݨW$YL#tiPAat }BpAcͱ1Zƚb3c={:&%^ر؛ƾ݈=ph4RL,Z!\\3ŹsM+(J}&}q0]twK߈O.8J|z-ihv%+UY(6ק-qeC٣<<w+{^%V;R) Q,80\:͔QB$utSIESqPdop6qrIqqipZF L!& / 6R/K |f::v]hKpq~2``G!v(p# 9Os|H99icQVf-maf~ $xmޝSt)މޝv׹uLyLb9Ɇ]."W!gut]]E#jb??8ܺڇ'-zo,d,QT!x'RN'K|N ƥ _ND\RzEL[ FrRU6UF#Jd H1`LNNDG Ur8&vACO(֚vl|w1 Љ9e flTpw*KqCښƦ VI4Ss' *iJ'jHc."Er|^|(?X~ K =O n:bPȦU^b\CI5tNjsٮ`笈f#G0E5h,);)eKU L) Lħ 9h2Wly/ X@,zӡﲮ a9ӱ(ڛ`z~ fNЎZ1oMG:FYQ` ~~ OkenZ}É&y']vܲ1? N ~_Dw _̡_X1Fu7'=ZPӭKRxKۈ)꬞RTsk^1?3-}k(/WadS`QxG9׿7iբ3@ ~_^~uj.p':So II@eb\(F(``\Leš{-"-neÀsWr ?WbQ͑W$ ,/X]]j m.c0] Acl<\V-fIA9.t)p[+mRHQ %c⃅_(,6v.-)T`BUnӅ#Y$"oO.6v.={"|$xrk/cP#v }Ci< PB 1R@7$0FA@L?C_tP5t3^ wI!-͢[xgZb}K?%U:>Ʃ[+%K6z7;J%oR%7DQZVq7V^Z!^2Z'SU<$Lz,LKs~%M]ݗb;*__k8|qCkS5n~#]@հ$˸LTrzǾBϤppIdicwdF~KJbN4bAATơJTG>Oe~fu:AD\]culTBH$_j^r ?&dow&TVN-iF( h0]kd c/(("« huu5dǤ)\DO]b-<ᜌ%P_Lb#!=Gbe妬@'*V]IٗetDHڤ<_I9SUf+/))UB"QO҄_HZIr.QqQCc:H 51EE)EXȔ~ $ۼpMD{3|UF P$+%!ʐіQ_&!4t%d"󝷇UFuP)npQ׉Z_&s\E>yLoU'޿{¶e$P$\Ẇh\WlSw֯gN,Zɟ3Z=ďDkU).]}(ښh ߟ^sFE?P]Ȋ\xaSQ*պaq2kV;dk@nadU YAA6VQ^Ur„逫JN\FT 7%J$XH$;J~Q1i@失 ;G1UXAj4 eݷU! / Sin߆cIX|%l3ޘ#mZ;_ځg;бt.ۇkSo_a)VwWuUco~{}!h)#:ɠ^4ՠF|SKD#3k EUWU++˲l .Th'x]mɘ1B,N^V6Q]7%yk][pj[{bZImmlѨ՚JqÄaDP6b0/6ZǑñ!9Riĩ^Kp&X( ;8X\7N7R4UA Вz'&'g|{_*&W/?Y[Xu5;! /2ȑMITPd$*$*Ʀ1/6nP@$Afwiib'I'J|=yeFăMm3aEuλ]W7wW]I~ZPu_ԥ\~_5?O?]R Fkb0/߸f*1C/=57E+/13nZ\Ao0ƍ[٦5@U̚zo\?}oOrneLry$W\Tγ}CA\Nm4̺\LVṀDx۩V$R,)(q8e/u:M `ؗb,O..%OW'yc_V*NgQ{5(x jl =^7dX2XR+PMere,% z$UAV,3 e}> VS5dGS+ԸKdN >CMW_Mŕ~N|`;~s_k.]&^*ո~|Ə+/3(   E2qS I+8י7.X1~|\ 53gD0^G87WDs5 -;g(,Ă klBxƩbRKR]SSOs\PTRZ9cEKM-ZEgo'.X~Iewo;= '" >,!,c =FB5h­SCOD9)Q> PMiY~qN"* ѧO}W})ⒾԹRj%.E+S8K;e`?{dQùJ WnzwM0Իx/Igg$ytC!NzLj *ie?mmJ'V~*Gv.<_< o sŵ܍$v8@z?J9R>O% rDē_yH @"s /ȱR"&as-h9h4K p6GBB,Ƙ-1A [A0YFT+e$W)W˭ri6&`kQVIzRMQX&嘲Ir#&MQ'*Rbŝ{db{Tse=Uٷ7u\Җl%K^dI-[%[d[Ul]ʡ0BC_Pץ!Isrc4!nnnJӔМ&)p4i6NO~,YvYpŕ p+`EEL>a'>[>{Yb\E'$-Ned>HLK\dj5Pʹf/jR;XgX%A&ĩ3qP_sq4P=6ވqA_rAa7d'- Xx˅${yxj0H%K '#E-yFx!lhQA S o\ /w8K\ӇDKz?klٲ(C2b5o=sn{ϝ^ϥ]ڼ˕ܟ\++dH(znB A@\nЎƻ"AFQ+7* 6G@I.縹ƺ:-"Zmn0TqΥX̅+ƚj[tj+Nd t.g,3lMy%.Wtm571U*o Z T jb0jzSV ({f_GFyq=ݍFqQHIKLӾ0:1;AQyyP.(Vc'5f\z|HR) ld3:#ַlF|#$wEȪO&VKRQYJaEU>> ?Eʴ1$;:"IjMPV,>7$#QH )w4HixѝXԽ$14LM7`LhhT)q"0M(N.4lAۥQ\x]S?|u]ݳg2}HrRL]"}ks敨}hj"OS`Wfǚ[2wp7jk =JYbah: `-WK̳utΝ;wjײ>kC֌;gyq*gYSS:]lˉJSuuDchu'T@"3Tf3I34/P#q5ۣF5Thp-rdo": P e;ed/ eeĄ(# ]nPMPKB '"T\D&E6+BRk%R % B2fe#.0 3Gom|Fբ%.7lXM m/ζ\*ko5 ae测{/.ɿE}pWi8c`6+OBά3wEbK@+;S{t?-yS@vtܑ\F[ooY]hgh~#Fe*zx`JR=w $ N ?+J{F؟5Lxx-&Q;1]}Z"/1u _p}\tc4專W =_)-ad:<1hؽeA@ v):'mҼiLL;^ c>-UTۥL{}LQɊ%WJXAn,-QJJPZ~QQ`,%2T<_UvJe\J wNNӨeh##/)|4T?KLbϚ@@gyc8g01}[o2y ]ϙf {w譏Y `/zrSG̟U&'G}EGlJn"XN~ǒPkLFNN. lDkc4jڝ+-'tDD \ayCr2܅e29~$W#ٗ,n52JШYxI^ӶbD3-,J={}M5U==XZ}wrO^?*x2w)?jH_ [kG7ɲ)Xvޞ̷F`Ϟ ʮyo[7u >ᡧaO]YF&|a] lbjbVgNKJΨk$WrQV0Me4]֠54)~ΜIAeT.ϸ30e" ^ɺU;+b/#RaUhjBbS$r;vFEPwyݏ7l$\DxE*d)>ՓH.RC"hP,ͥˏ|qIOFڒE YT͐hJvSQfwȮN|-D2NiD ERɳ$[᭜A 5Rim$-<6: ;*&w-_t Wdm;?&5NH6C翻nxg<;vmbw.L8G[\C-wuAHdaR%yλZvtEzros_ Bc0*ZBp8}.DD&f.b0"SZ)]4a=%4rΙܵ 7Ǒ,ΌM+x5ւ9 +0섪ftdM1\)݆{ %S J'D^"C֖Z<^ 2Rk?nhEO(Emm&79MAgT0v sy% NbōDIя2`fb{`ԚzSo35,z}2j7N310{M.ѡ;$ *1E *mgYމD&69WP_M:QS\= $yB٢[o ?s?zB>Ԟ?Uׄ5MoCm$"G pOX-AGlbA_]XvthhyurdXkS`Guwm2MX  'E7?_kX3wQ~0dP1Fҹ@CFӪSnKc"pi<K* :OÅAD&R볡{1%&Mb5`&@R[^v%^yx+lTV )ua/Choa8ohZ^ۡhǵWMQiжkP')a3PK[Jd褼*1'D\M;X2E&Y|E3%q!IP8చZ Uo3nePnUhfnP8TD-wyϢC{9){>Ӳ={:Q-| ׽4^krWTSȘh:eNV4JT]I`9aI*ZYYM(*[t"I6 HnOc +u~堮2ꥩ%`( D'0  ˃&}C7#7,gP"ا8`w궂)[<;=/e Ks慪/;{ڮ ppk }7|ZGZo빫yUe+l^ފH}Y(T8eEY!!pbRiku1B0)B)ziH2Uz6ʲ2?p_F!'0@Lɤ^RGӵfm:F"b/T8# NpE PDA5р@EU?~^o2K1Kf=jm0qԚ6vSck"fsw\ >VeӨ fa@4ҀyY<))DªYQG9c!Y[kX&`nȥ±Dj`vEZuo ~uO8ַЂ'`ߣlm.^ܚG֢s-XuuY ‡}dbq)b?7̿g[*[C&|]#Р)t"MөϷ[\Zg"f|\q6V]cuz Z-tQǔJI"D-q1D{ɋ{i)9@$ffn]K&s)pQ`ͨNltɛ 7aciSS/1C¯ 7 EsCBߐ@ua:.J`53 V%Tdz/gC8.n/mLx ^^p**>^|97 8Gl.92-{py^ٮ]ݨe^j{\ƹUN&9k'(I6o8)"_vi@D~'Ⱥ+DrD78$5jm᣽ ;ZGo?ќxp64ۯ& U[a/zst) ЗKB[.$7 'lvarj;&"lqg4xT*-."qS$X.$=ꅩn + Ƃ$ ,0⵻D'Fw_g9&?KEzRaE*3xlDxQ0 LLd&E/$c ie?ǝ%EL/ IgHEC{`y.Vr/iٛg:cDc~ n >ssY¢~aSZ(,x{7Z8zUx gm襣禄3YŶ-X-%g/ܤB wnN-fObz%QbeI5I*&y"Ӟ,JRfe$H/nRKKLV*݁sM:EI 7N Kwoo/ʘpLxIGHp6aMO@ N&wMlyfơ~ޖ.QmȽ#&Q&s@HqsS/ 淶wC1IvR)#cJ˪kV0e,R-¯6]'x!8MZ"䮅}|Cٙ ՆZfxy]i9r>:>6ho6%wvZ-9< xS29,kIjPבG* _qbqxՀ9\s5jd zJ !Rǫj<jkT"z7wwwûpp8nW bUB42Ș|ZUDe4DTƩZ>ĪTM4HZ(#b9S1NV`%,Sj`v8BzKJ^UL1%L a+F7̞?W\l[|dB,J/ k6O,BŽ{۳m6d?95`o1qҼC7,j\ w6#z[d{ g>B32owٶyvQ61K Oaj(d^T(.d. **rՑP ℆vך vÁ*vjOj9'P Fց$Bl"gɷ:$+żl8RֹA'؄]C5(*..j*!ĘMLii { ɜralrHF:R ;%9#v4$c}18 91i::>["ȱĠ:xQB㳣C_%!h0pUSyQښoB U˓o _ Li'SCLY41M}kaѲh.ZxтUf`0 O=WXHa+[|Z|^m7ЂtTnXl 5@)5 d*֙/SgR 2XbۉvUVVG:5Хqi:LvPQtD0p02/ ftRGx4 **둍˘Q٤ 5eFau mZ!{JO MyO;E_\*T~@MaIB%YG)J "'f$DIFe.Q Gz=wyq1/oo;=V Lr`]ŽX>/\};{s AM'\xj;,[!!,9qe. I7qK繝 p\fאk 8Μ-瞔u@\a\lE .\ޔOKJ5ފ lĆU1xp}k6|} :@7=aܲ3x__y[O9XE x&84(CŌ0Q,ceQو#y@^~c B+S*+c.uTra?̸Ƌ._=%J&4Xf"+O&UL \J~I/ms 5 5`^ T@\owezTuRQ&fv,ǥ R[_WBVW6Fx%|g/Kmj-6Ԗ`>ſ)ܚǺi>ȍ` 빸ՍlW#ܻnL$n|~ɶWո^xۅJݱh4}޸f{MWny`ㆰ{_awWwo]݅_>=#d>Oϼ=+F|F nl܈snu7|7 oJly{+ޥ7li}jw,uAX2Zbo޺*@c7>a|܉p439v;xW-w~70Qq{#x&Yo`?agm? Û5&굏o>l>?p3 &+ՍR=GynTKuT:k8cB4 >}.2' 'ɜukհ]>ZWz\IIzT/eRT?3oзGN{K/n{M5QPP]`* Tee:@p;peg`!9ǿ{O(j=1pZGc_7??/wݵrΦ'߽{t:ڀyo%N [G pwVwQ7 endstream endobj 88 0 obj <>stream x}Ok+7?,[JHYܶ4tkORCcȷ PJ 6#&ry<t;o][㧏xz>/o߮G|O0~5NkZw6ؗ-?wq߃azӼ;L꾻to|}?]^9*GrRN䬜ɦl\Ur#=yPQސ[g%{G֪777ֳ/n}>w?SzegM߫O֤wsocc}zee_o;e 4|>~8u K}pssoٌeoO\8nUg@}AxٿzʋʔiVr]Z? endstream endobj 89 0 obj <>/F2+0813d1cb5-b26d-4aec-b1c9-e00b88bab0fa<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 90 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.053 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mixed\040phenotype\040acute\040leukaemia\040with\040t\0509\07322\051\050q34\0561\073q\04011\0562\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 755.79 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 776.129 1137.019 Tm -0.064 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (BCR\055ABL1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201\202\203\204\205\206\207\210\211\212) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 383.295 1057.789 Tm -0.031 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\050v\07311q23\0563\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 497.055 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 517.395 1057.789 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (KMT2A) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 592.844 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 633.525 1057.789 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mixed\040phenotype\040acute\040leukaemia\040with\040t\050v\07311q23\0563\051) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 676.725 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 696.885 978.589 Tm -0.071 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (KMT2A\055\040rearranged\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201\202\203\204\205\206\207\210\211\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 899.389 Tm 0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 399.674 899.389 Tm -0.179 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 440.174 899.389 Tm -0.041 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\054\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.975 899.389 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\220\221\222\204) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 532.155 899.389 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mixed\040phenotype\040acute\040Leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 514.515 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 534.675 820.144 Tm -0.043 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\057myeloid) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 633.885 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 654.045 820.144 Tm -0.072 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (NOS\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201\202\203\204\205\206\207\210\211\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 378.255 740.944 Tm 0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (T\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 398.594 740.944 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217\215\220\221\222\204) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 540.285 740.944 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mixed\040phenotype\040acute\040leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 509.475 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 529.635 661.924 Tm -0.04 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (T\057myeloid) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 627.765 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 648.105 661.924 Tm -0.11 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040NOS\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\201\202\203\204\205\206\207\210\211\215\220\221\222\204\215\223\224\225\204) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 560.625 582.724 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Mixed\040phenotype\040acute\040leukaemia) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 509.475 503.494 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 529.814 503.494 Tm -0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040NOS) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 580.605 503.494 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 600.944 503.494 Tm -0.086 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (rare\040types\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\205\206\226\227\217\230\207\210\211\215\220\221\222\204) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 459.434 424.294 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.063 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Acute\040leukaemia\040of\040ambiguous\040lineage) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 552.525 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 572.865 345.094 Tm -0.129 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (NOS\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.07 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <999a9b869c9a9b9d9e9f9a9ba0a1> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 459.434 265.849 Tm -0.17 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.043 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Blastic\040Plasmacytoid\040Dendritic\040Cell\040Neoplasm\040\050BPDCN\051\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1f83d7978-2850-4896-ab93-2037930e09c8 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0813d1cb5-b26d-4aec-b1c9-e00b88bab0fa 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21411\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0813d1cb5-b26d-4aec-b1c9-e00b88bab0fa 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21411\215) Tj T* ET Q endstream endobj 91 0 obj <> endobj 92 0 obj <> endobj 93 0 obj <>stream x |?<3XݶCSƒ%Klcmls9P  1HR8.1y?$PJRr hCI桹Дu4~+ɿ?yWvgfgggw}5!=B jp?Бl-| ա|[Uߴ-u^El߅?wӱPBH{A&4Bϛ3`6:RdJȷC;ޥi Ͻg]V2 q⽳:;t? d:] g;;9!E?Z:4݇Џ%s: OO2BK.#}{Tܓ\jϤ%8BXB|cDcw˅r*V'">XEz4DgKGtHK/O6҃a$ TH4H{N͏LiŌ,Ȋl0>RP*J=pt2a.Fe^rQGPP ~*EaAe(bUJ4UjTF:ThԈP3Ƣqhv;$5r(w;咦8jBCEES8qJ,l@Qe<!%ql:-ql]#mgbxÌݜyFݮnW)$Nm>fg  hDK }XW՗#H3߂X$]})qfT؇ycZA< ~m\uҁU? yZ :JϛFyzԔGǜq3&_\9.~ݽ媛 Rx4Vl76Kw^ ެawwqݷnnLNe{0# G~Ap)<7{x]O8z/w.? CFŅI MhOfMM%+L+muSeCո2-*sV>׎(3qJ}S}2RǴ()P)ј=cn`m,j)η!ihnۺguxO>%I>9 =S|<\D0qLr۝< ydeQqGn:-rR΀臭uo:HNWU/q>Jzr$ CN*)Ԝ''10Tݖ,Fn*C h6d]M.4هhFb^r6*eO&K/I0+Ѹ*$eI)dhJUw需=Ӟ8ssVNu&Po4Ԁ=yS݉|WƱ#ХJgQxy\mIuXI>_ So2{ߒTZRS4PYrSㆋ56)wͣĎ$50ykqٶ:˴3pû3upw\(XIZ&MIRԙ"&:^1u3;[ڕEo)p;r~yk{/vX\NA/\rą ZJ iE3h J<"R#L5\]D.r Inw>#qI*bT}/BKW=/Ž_{pw?Y$ΉwS܈uHf <4G |&Vj41ڲF˩6W{Dq4dL]\88%>([(w L#!ۘ6vvI X]/_q5Im#i - \~S#s~2/ ]7:b/:&j3:]V X*<ٹ5EceM?4 CTbV0(U2>=Vjr^KjDaBk ><Vܕ c08jrR"[q t%Xcz/))a lxpSF-?<>xal"|Q!c Ek06V-9AYV؆u *z30G?XzůΈd|?>tM> @ҹyޝ(Mչun@[Qj\u5R[֬TVzz [-JEebD)Ȅ$N.)-P0ݞpe}9[&Y';OxI'Eߝ>~3l-݉hh)<#k~cꇳHEt5=U2)0U0c1* jХšKA Lo~c18d MeN(& qF!?tGޖoylhz̏r9)c+Rou*0N4TV#Y3K%,q,DlRp) AJ;;bR]qk2B81+?b?]3n3nńugqx _~*Jv>Ȝy~`03qR$qdhK}pSsiylFrG6JhBp+ h:<:>o.|ABd$0nƃC&7hpi{M"lR紆 x8El&k5&V`'Y("Vfdp+6۔R6L̤ndώ5$2!+%~e=$͘d>7VoEY6<#~|rg/wN77CttG{6kdGy"M Z_ɡ 6f4$`piASXTe$tyR-GvItr=R2,c/ ~q >~ߊ (|{ya%տ.RHR<2wML`xn`ѬFj)LϕG~,L86qٟq#(~Ћs![ܝ'Z _<yvxtXH^4MFFZi`T2Ք6&z)wަ[Fpsvrh;y3'c9BO93ɎD2W6yv5& K#HwN ]7U^'jl}ȮT2x3r> }NfLAo0CGdQ:*IQcҬ"^$sB67JMR=||v}{N *.{ ظl2ZeUf0jm* hræw?VumDjNCgoQ <vbٜ[./Y{dr! T~f|'{>W$~H.{_zEA܍<&D`Uy&hNGP\$Q Y0Sy{O&7~UNF%^Q9*&-'/)C!iH!0ҀjVfڔUFMeݠfTI} m /ƾHvӑTB.tQ5zgꋏmRm~f}O;ܿN.=QfsJy<:uZc`l6 X7eQ/\O,8 b)ސ6!)Pwvn^wㆆ廿؈#?+9wH|_:QjP3ggݷ`Ʋ~CwвC+hMHt &1@|}wb(3ܝ}@֡d )L乇 wʃzUoˊdgdIY`Z6fX? g|3O'/y'*&]aC,XMPR%!su)Ժ~eH'KĖHȕ=a5a~aL5#ϼ{_~tEowu?,P{`&Cx>mBu $ tWfb!EÑeCY7\& ֔s)%?&T$6*y-Ćt8bnσmbN&!{{{94m06ZfVK &bfMs Ij((pOc^X@W`Ֆ{~?Wb>_{ x>(9!5C86qvF0)'%Y %0KF"avqw>ޮm~ջ@'b3' xho~K)̅~p)!ř)7)THUMF$ATAPdg $.Xfclу)k\3Gz?pG|s v~}6Yz]{z^DWy(d@~Hct^GiRpڄ$t7J5BI磞 aP(f,mTS8 ˄~̈_y퓂ܫ9wUE0W)( 99vzHzgYao$q8}_KMMp8~pi}{x'QJT0r֠Sq*F¨@@Q v/$v)S̃)fE%R̹5HCàHDgð! j >j(V W̹0m_ej!hVuLMӦߔ[ffx@`uR(r~D3Yn!NRP{<-ˢK8ԛ݉n88);q}&VɒH&Gޑoc'O|Uc|DZH։ADF9M=|6nuH V\xM(;w~N(ٗai0 !9zpgӿQ"٥z\>[Ƕ"C #N}d3]"he(R7i$^l*R6TfoJ&/2(/=?c,<BcBw>ȲfrrQk@W)nfx&DA`wQ cA$ >x mڿꡟ޿g3đ5WO7 ǚ7?2qTmsy{쭁] sOm-ZCU(X2(6)JFi4@:i\gH+d*3Q$ pW_ 'זh=މ5UbĮ{gdG`'ʺ()wCJި22`|`a x7) .:/:&]sI|lN<"} 3 ! _2Z#cCgcn8CIǑ-Omg4I6;q˙¤L4%*Z#`bFިFc9iFŨ5wЧ=*OvR?Vf,"7"*zc2'oIéX4 5ߧ}dTha׷rdwڢr&,z|}&!YbЁ (5b3+L,FI2@܌"Q =&7zos0eƝsX,ֳH|-EB~6J6j-bVH8QUY&x QSc<̀xy$ T X;`w 0b8Ѿ ewf35R adH@pj#9fFE^ڨ@RxӀKcʚ칞ͥcƔ6OU5)̅(Q jD_t/7f4ajHm8GC5N e%Z#qc^GVݏ BWP| ^4 _/H5  丁qd8\ml7X59ׁWq%X_(8rTF\qhF10q]yloٲ2N٧eLЛ@, c`{6LHL7mV&v 7ΫsB$DZyؘE.DO,im]bI~u)/[[CiVYOFI֌7eP_vW Cta*DF 𛜐~[Pp6kER<M)Q}] mE<3CYoa vЯ~'lkfJ|{-|;|Zp#!':'Nj|Ϥ;2ǯ?vaULƉ ė}xڹ3c_6vJUndqm3j\xTl2s;ד'7F6.G,J?WW<ҁC/ uJ?[xU1z֥ynw*P[R:RzS@J $RNp-)8%ԏ+MogM"YvJx;Z4^Fz~ҟJF+ndGz#piaANڠy{c8! Zc#<[BRj/GCQbX JtL|JPPiX̓Tp FnɎv0Sx<ɯ*O<_IJ2)6x-O=ܭU.xJKۦM|zX}"^pt g(HQ6P՞:$7sDIaVl87}& v*N*{q+ y }~\_yΣ(!l$qhV j& eU.ԅXWԃ(Cmt0y,% XҜWPrX$[a&MQ!jaJ/%%"ȨD֔U*@6 dRBr %-H('KRټdv B+<(xaXaPtFjQ9pLW@|4 % Y5ȤoǪ4>IV8i)'ζg>߈-Oj{w}Y8l ݡ|l(Vbh$ lVdٹZHbG^n?ҕdz#zr $ # Uc՚W$kc3lf})t_?+)A?r̀3 t^)&8QX8ݏ?)BV~cJyyTPRVʔ.ĹTs82 21\ QuV *YZd2^Z &%QJ.,I{;"KIʸ P=RfܦɪTRXom ~sOMG,Nx+ӔvnW'-I&aڵbZq"#}A ۶u_w+Dz؉Ǔ'xxrb,SиO ,q֦1aGșF9G;Q-؏[, >OKOAԈ!YK]AG%mNo3WG0M* #=MMsct31 l[/O S2.39}3UKk'.NY޽|hcCm ͸%w\ йqxk'235Ϙ6g0VE斾3NJk)`+~P!*KPKylOciҠ5)wq~m.ۏܟ zk)4gZSL\:Zma< >EEBNssZu1|>e6wq2Ԑ)CIy4~y,=Յ g.*d ht#t܏4-Bfe.݋^CO,B@*! uR/=oEe-gK:;}Vb9Z"عQ_l!d8Iܔ u\YI |~Lơ/BuAŠ/7Ϟ8ٲ=ۉ!5>/֋'hJg6#SAoit%!xGeXrL 44bP{>ܑ2GRl t{Fv]kr|u]W{zzxɶ}1U}:}-s\ 1wFA~]a:b$(8NB0I1@^*i`XAF %[I 4.Q[RA4>ظyT.=EƳW%8 '| a-vmž^NCJY 5!UOI'JYQ)!BG:'ǒp\;d-H{ O?Mlj<2 $MДzL4 ֌FՕV 55i6%6E"Gbb1& >Q b`o_#p1%EoqS-LGۋ^zO_(UzXR c2! h7GОy<|3}|Xl-%qou|M=p {|Hf+ŒzQD)6~/M[s4@6jMn=ԅ-V1h Ee&7X&rj!\Ob#Q{N;]'ܼ?6M/i^m iVDxdphֆ~5qƚH7=ܐ)N2>or@Ɂ̵O$2SU`ZFu[؅=FׁO_B9bVX40͐C铃dZiFO?:dd s ˦f:vb[mcvNч+d6x@fE r5J* 3Tm"L3ML{M8I'u 1(N RU^I\pYrqiIJ"PrC"Q)qIB(HQ5I|"4*tV VK˜0,M|L;Nu;=XصkZܱ {Z۳7n![-IHq ;ؕǟBl/l|ǒO^„B U>!0Xt}龴H3jc%<N/xAnH_49:7IEjy HRX/vݬ)yKP4A@Y@Q:Ç\@Hr;$XhU@K:dF/& Fc1](::!tY~Mfi^kˀ@TcW[gZI*XL:`%VmڛV(tÞ/p.|$s/RV%("]:!ޘ#{mnT8XN%RșV@n/1"WzZqg%KSm*gp)ӓ\K(+-d'>IL"s)(Ͼ隍v7?ӪF]:+z6 ;_|El}^zٔb(?Q[ lk<\6wbd]<+œ8m8;-'NMWhf/rʼjRG'\VB"""VxV,K~2Y5T X>+邑j`D [z"PTiEh7 #tz@N#y<_`*oOӍُ֖P(Fͅ;Sя')l?΢KxJCx ;tКW~72L{NjJD x:{֫^%Vj̏'7v'柙Z6󿝯?qLdjK-ZY6$RP2dn WRB~}xg'ɓoαus3|c3yu>kuV /xH|Qp@[)h(\;ڂ1HMd::cj:r;:&Ccv:wu'.u6uN\7:کlyd;ݩ c ޿-X8uօ,dc N^8s ,T,|_v2Ѳ]_ƨ.+X6u]ufb˚n<Ȳ7}eWbCprR{/m34TR`ÏiX}S֥DfYXe=XSY ugɢ~QWY׳ ^(E/HʬF aF ZSsw5gs -ysO_6mv3>iK|"nJ p>>7Xv-3D1x|00Rڢ]̤$vL*+SNꞞ{iVUе>MЩ>g疥kȇ]O`w`_]]xș2YH4 5}Ӏߟi  #bt)9-Zd,d L]ؔgW@Q hGMCv#"|l-+kTѼ Zvԝ;[7Pk@!hq&^%,[c N baJB?tv={x"^=QfHKo- ) ],uU:VZ6MApF5G]S[;Z0f5.ЀoD4p_t!)ev)DC'C­a/.AЌzQr]2I$M^:ݎ)CPT͡ 7r9sgEH)2I aD?o ^ )!]cu)~10{=m?/]xw]&]wQr.S/&p׈<  !| ̢S [F<|ަ7*/D6oq4)=ozoFTGךIC)3r\8r aS&N0*bqG.kzF;+g \i8--Eǂ+[դp,lyMFL"#c4]DgĥaVkݖKQ|,/Pdda Ғ'sw\HH"͉dz^W ro/^׋3*V~%'h >%8j%>y-t=Uu o~OGMh4Hh<`f 4&x!M,QOƠhfUFSRP62NWJ`m0\ oSss;8<232FVPP0zt.2KR%0Bmn&Rқ|I[IG@ k,]%JN0\pnG [S]ijHkƁ<Z<uIhCVGc^^Z(gu9C9lu΄Os9 Q>LHxκa/oæ풴jx1n.ZAdȅS+JD#7xSt a9N4HexaC Ԥtx{AEUCGvk/薮dۤŀkwN;3o_j㎥yu{QV?DaqF~ 0ב d_׉_:!|}'I*?UT&%աˆCm.[Hhh{EAMkk [I*``M:YsF%t4X6oP72 x\!Pa\ifAG@jҽi,)(3LʺV}>%^ cŤXڗFiu1P)QL2r^b-^o >Cr((% Iclo0ƿA/}QFJLumI[ܸTf3&x]fɂ͝tM ~?".Ox(s b4?;pM-5SĶTK˛_)*~ /pfdxR\".V0wʱ>Ew/@(Ol˪P6M:Dzli0L„lA'4̬iU*(1TX%-ݗE'MZ'8.Ki xW]z1oę<̳oU[I4qx?ĩFKnW%Zߕߐ\-~|ril ?+/*~SGaTwA6@#l%Z (TeHʯ-,,*ҫ ';;P;Rs%Ba>܏F-> |FC+=1B겲́ SiZsڃ=Bـ٥ f02:Ψ+9,55ӵTvefڊw8!m 闳1 _+|1,Px9)9ylK*NU agp@8[eKJ7cPj$򟴶l5%J'0]آ" e(-DIVwn %5hIncd) IN$Iiج%!qc Mˋ]ʋeWAo1%#d>Ӳid7{-60OHRnŷvs{Vc#6tյLǫzjOWg7ecZi<^V5t}ߛwh= lYl7lYhj6fe ڌ Vtd2zpRZp:lfjKWXoDs5C}.:ě4}ittjSk>F yP!(3i|$˳y 6`tn9(D}]APٔ. (eK٫<<zŎWv8LwEc2/@M_vdgQDXe0XSJ urY>dXlFR`}@Q?=XgPsdSTEۥ=eV('(@7 #B@`877 "tM|ҺnIL0C:/ԋK ;Cd%&mfq21;A (LFV 3Q_dz%^6s V Uܺ;T<+v p/W{ښ:bΝbGE2IJM+爻Ί/݌4+AFLv!D&枸`OdZe(?V@_yiď9o2r%wpXg)5y^o+c*KGVYAQ8*SABg # ُp Q psa%h~0nwYtdpXlt!24Pi(wDq.J#V84L(ծ]ኻ"D\{MZ[d9m9ka,4gEymHK?OW_ol'J(bpbs iIwEyI[8~DI %F%Sr3HܫS{xws,-lۢ^毽p7Gc4-y5K}b gd^WV?V>>=hy2@ͻ;gj۷<۱ ` k!7Os8MF[ QHqK}bf4Bv(E^%vǶtTp%@N#"R4~+ѝ*MQݠ.*,𛤝TgjƢELPSZ ^DZh=N2΅.{N7v;]WEzyg.bZHT)HiX)B1/AybJPv#$c;Br@QPC2$3QX1˶ M:Sߊ'rOlyGF5mg$EN?S%' NӃx2?wsg'_fzǏ͏lykŧ+)gvY y3q_; oiNc_LkjDcQ ^NyPV %mGNzitJ| ƁX 4l優&DSWW|fE-(P$i7f&daAI0 삣X 34: Y%a M3 7Eii^q,9(+q(jhDZN&8 eB683%K !h HvNx` @r%b)l6\daP|8Qt~/p6mIbrٌҾfaUqαsSO9f)W7T-uI ޹SŸ_{d;2VS FqD)Tu2uT_a?͵FF׏*/GUW_C9j]t:GFhxl ? fk&Ξ\ϝ&+F]ŗRA#9F56nj T6S19z' 2suդZrt8Lus"܏l5j- ~q%*GQ\$?yTz@0Xao$f]B= '{L((2J0HQIl9!xƱ #gddm]QKw {څy ]] [ɋ7,헽I{'%]}I-%Gu$8>,h16K[L ݲg! 7s~%[uB6##HzqEځ +,( YjeN O5+J|&fssǻܯ_R%ϊ;]8Ѱd_ߒ/⺶yxxi\'F@ux13M^E~dCUĉ5w{VppR:B{U{IA t8v{"mzqχa{t)둙௽lx`U)iwf:V/;+Wp+e0(v؏, H6A_>B gfz\%t#3bzZmQt-6-jko5 }[jDq1 Wʞ+vW?!d "@@ N 66`aS2%ŜkKR >7d֖ Kx8w\')Ls/C3kζiNv8 ,y(Xng~(; x)Cr֖m>ŻN/|0pGId\||%U(jJ}x]=rהǦmiTރ3?,Ć `ʎ I܂D5}`R$WT8ylr!.|᷿m=6?Iaji\3rԹi8=[xZ{Vڗ޿4~b|o7ѩX*$񐭶:)0i^6aTX^%qEǛBpo^6dL6&B{v./5Zi6J#}ZZ‚| ׽3,Z!}cM?iN2lU܆Irfr֩kk[z@ׅ].ILQ'+jEղsOrb) r?QU#+%?'XUdJU% 5*euiRWʰIJROScxwwuT,Gh`}jrzӟ|{X=GMm3WxhʕSڌml:mWp2s\l_I͏qʧױ>-wo%f8~ tLxOXy"_¸& WW&Pne6h}/,|d4rVi_y0d+;ti[R#s߂e;?"K*G~NNME")sIϰgsI9i34ZW0:FlZ_I݁yɀ)T=^'Xɨwlbv\ah˶lsdch la*V#A6d?01&V[H5bߵkC[%{?ȁQ,"kryY+G 6׶ŵHZ\iaм -D[ ˯?=SFGbV!&.>7?љHHnIOɔzDd%P S 7Zd …1XNd̀BiLeMG\KDCT&IH1R)(FD""FO\ ŕJ0^B (m9Gs]m3@I:TF?tP~Y`[X ,b[^vU:^e K`- 4+%_qsFG,Jք )̗.%rɫ%\of%`UURz_f⍙f;%kٱnޅJ$pI{rRɨˬ:->|M7"|&1|WE(xh4lDM ԆKC>'ZSS$lTeM[@L\咄LnZswp'o߂u8DjC 6I+M>Bt:l;< yFK wv6;PqU#$.W#΍"UGqISUYs1T[HxUNSE+ǜE7K:\\ F[B&Kmmb{!8I{]#;ʶÕɶHTѦ"C#BJ Aj9G3A:Tn"C e%,-QC,k .c@HrH:I2Oxo$lh$D9'sSsSzF8vx3joϪ'WPtt @GBEި|8N_겵{v#a8 `d!%ajY0Z~~WS8M=(No8>_5u2zFC #G\Af t1bwC2 }C Uѡ]gʼnUOK'K/CC5|qqC.\Z UN(JԺ;"~p9d"J}*y=\~q"Sz F8: )eZ49HIOMBKԯ%Ɖ4DK@:j(M2/"BT"M1 Ř(F]GU~]r29  h 6](uBKLO 9ѷ-Ar@ʄT  {vk7yFCŰ:i=ӑKB.^it:EEq2uSF`feTUK*Ѵjhk/kdDS袺uSR_IJ/G>3b<ϞOGf|5 _de4͉sCy|[)J"F[" s"@O8FDsY~7ɬ ?AfvɄ37?˥BOcqw۰gsDC,Mp+:v ֶpsB3ȅ%ب }np endstream endobj 94 0 obj <>stream x}OkrG,[J<3fK_=IF,5wx T0\|y<tƷ4 q8Wuwo>ޮ<|Nwq?4t<ϐu<]lb_vw0y2Bχۏ2p x:`Qs>McA討tR':3]ԅ6Ѯv+ԍ^W^FVu?A? ?A? ?GQ?G#(?GQ?G#(?O'I?ɟ'$ŸO ?O'I?ɟ'$ŸO ?gY?˟g3,Ɵ?gY?˟g3,Ɵ/E_ "_//E_ "_/oM~o~7&7 oM~o~7&7 ]~;~w.w]~;~w.wſ͖V%u⯵Êx֟j>[n}nxyׁuRMo C߼~?A Y}mݻu7{M_b_~Ά|_ ]luױ[_Uzs.Vosf8퀰١Y4~;\frc endstream endobj 95 0 obj <>/F2+09e81c5e3-5080-4bd8-9abb-8756f3cb6f6c<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 96 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 1137.019 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040Precursor\040lymphoid\040neoplasms\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm 0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 194.25 1057.789 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 356.295 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.935 1057.789 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\215\216\217\220\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 527.115 1057.789 Tm -0.042 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050B\055ALL\057LBL) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 632.625 1057.789 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 652.785 1057.789 Tm -0.048 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (NOS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm -0.053 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 534.855 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 555.225 978.589 Tm -0.013 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (not\040otherwise\040specified\040\050NOS\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm 0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 194.25 899.389 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 356.295 899.389 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.935 899.389 Tm -0.083 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\222\223\224\225\226\227\230\231\232) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 608.145 899.389 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.052 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukaemia\057lymphoma\040with\040recurrent\040genetic\040abnormalities\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 740.944 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 740.944 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.255 740.944 Tm -0.041 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0509\07322\051\050q34\0561\073q11\0562\051\073BCR\055ABL1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040t\0509\07322\051\050q34\0561\073q11\0562\051\073BCR\055ABL1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 582.724 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 582.724 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 582.724 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.255 582.724 Tm -0.039 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\050v\07311q23\0563\051\073KMT2A\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 645.225 582.724 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\223\233) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 685.905 582.724 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.053 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040t\050v\07311q23\0563\051\073KMT2A\040rearranged\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 424.294 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 424.294 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 424.294 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.255 424.294 Tm -0.032 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\05012\07321\051\050p13\0562\073q22\0561\051\073\040ETV6\055RUNX1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.043 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040t\05012\07321\051\050p13\0562\073q22\0561\051\073\040ETV6\055RUNX1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 265.849 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\207\210\211\212\213\214) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 265.849 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\202\206\205\222\234\235\236\201) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 526.215 265.849 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.077 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040hyper\055diploidy\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F11ffef7fa-5586-4cc6-85bd-3af0f96fa7f8 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+09e81c5e3-5080-4bd8-9abb-8756f3cb6f6c 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21412\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+09e81c5e3-5080-4bd8-9abb-8756f3cb6f6c 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21412\215) Tj T* ET Q endstream endobj 97 0 obj <> endobj 98 0 obj <> endobj 99 0 obj <>stream xUMh\U: QSFL̴ M8{L^q! X+qSDiqavYh]tQ]J2prs;w瞁Ћ:t,/ vҤ^Wr>HQ Ȉh,K?}2Jqemٹ{d||TȽ뇯= ȟ- N'/ɇK 3w#V|q?H^]5,LnWs?-R-{AGWTo6%w|&39Z4# B)24LhT"pKf PXbox\_| >h޺On |Jˮr#0^F6M9) NτΝX 2Aj?nlƏ:{!=CQd6Q"Hl c#w2bKfSoDɉXF'nFn׿s? Wrwlf#"+DvCĐl #9$_nv‚_yTa1(l )lWES ˚>VXG76#61(b [Y5PF%dK8y delyPg^=gʏ3V+Ktr̉윝^)䃚W-繙]ǡ"cT8_f4,+g@oxL+k+e1e%gYˁW 2^X݄cqgu\wz3e a$jejO$;> endobj 101 0 obj <> endobj 102 0 obj <>stream x |Tչ7{L>$6If2&!DD$"JARDŘb hZBxCzAZkcZj-Bf}ޓ}}{eݞg !B jk.Y9nߩUe `~7BnG*2n]r-_{S'.yBۺGZ_$E6B?`ܿ".Yz{u*B}.e~m~8w1_u.ኑiNn?Mw.Sk;"I܋8paH-aG4C .D(0TM{lks#Zźw(Cu'q k4hai)pڅ(D*ԐҤKcxO <2# Bp@( 9o5pAKȃȇ( /BTRBaT"kUOPC T*xTQ ެChj@ MDhjAt ZQMC)BMB KcAoSiѴȎ|sU 诧ϓ;G>e\S2W)F~(T鍕Ow'WImha;NoJo }ܓ>5g7 woBh %e7Z` yOblwhWOܽ9V d ]fyЪ@-Z u|(1h4E/Az",=Ӯ2eRĦ uBmMuʊĸx<) JKEyqrYj1Aj*cQ1v$f6.NfNHj} >ޝN=M(LN莆fJr$2ONZfDBbVR-SL_t7&|}-& wcg3ɬ 3=g; .e{ao|SΙDm364q2Q3 f&]fJ> {{՜ Id9'v>*YކBIl*Il|uS zta>=/6T3ģABsf&pAMOfOn YPltOJrabZi3Yjj4WwA왍| C |Y'vw7*_ .ן3>t逦Kc% f7̦+ fyq[\Mߨ $-As ))|o,uL<ܚ_zn5utw7MFܼV4Cs9M=|"\ Li4͗I8=YOzrO?u"9M^I>AjrLЃ$v˝TSY\ ƴPܻ6 /x=4$pv|F Ha:#W+]WX9&_+3+BRKp0yd:B"J-̰Z(K+G#@>oޝ---&o+D@t33kSϐO _)P C1E)A!cc')*;*(tRF581rƆ7~g~wbN>PdڰF- c\ Z8ءWhQggM(p ʘ%D1< }7_x뷾z=q9s\'{/~x6AsBJyOg{0Sz@Վ p3P4ࡦO~YIգ ^)8JU6ѱ6ۢxbQ֙.l 7]'v?/Ŀw_[?.~f[|1 mo  ԟf!3 !a,&Na6R@־UZ=.@F!>'ƨX>ΧPbvR9.aY}[;u<8;T+FG:?gȹwTYDW aQfgBɝ'iUD32:0Q!7jcԉtŻ6 +/pF~@>a/T#O"~#/%x/m!ԻIIH rjv}T:ai ;TmyQ,KUR|N+GшTuo?wߎ S̊IXlOV?k݂q)!G8 n#16_?ZLz,a@dx*ŚRRܺ:̌|הx욖DŤϟܴ"6<2%UXv@A[\Pp!-* et 1C6HV=>pL1܃ޙ{w~qgx8Sn!riK14&>&(.dkpk3V1sR96fdnBˮH ~e#5Y)Fi~0+ڷ房$~.>֋[U 9 :R!:mfBm&z3iKXn«,mlˌ+)JKRD`(]gB&Ot:"b0ԊuJ=biѨbESɈN :8q89x.KÝ8$Jr$`M)TEv2hwP.-&v& nܩR` 6DT5n~\}QyM۶\-^Gfh63 csVو #a|䏪:=.aׯH'֝yxS+/up΅w1R޽8zzޥ҉ց*ױZc2H[;&3!TO]'ȝd59be{^ ~ YJ Y2ar%YJ*s`h WGӊݐ݇??9JkаƪfYi,, eE5j0 bAjՀTf(82^1Z !12*xZ|\kW0b?pd>,U&-UI5ä> ƫ9%sOw%w ^Ţs撆`rIE.+| OGy'*VMaE[ \KX,XsY:ئeh2)ĥR1ǣ0\_yXHT5~pQ~^On/nxk眮YVqN*)b٭ 7.wthHq3G*{\##ȲUo㲶x >NS qΊxg2nɽzWܜ*#Xi38x9@n~ ڊbSrVSoh*JlR*S2J6G':ws >k+gct: ŐQ!No~aKw};>otw8(b$.^yt]ʡ/L(׭Tfg&Wܪ[3"SڶxvS]/~ e,2J;H USǞ{tσې?~s ѓ6σ8"nvr=TOQ(ւ>LrV˸OWkj^KQ;4S*y9z{ [9AM(*In %ZpQw'S\(Qn'0#;GrN?gI?{3?٥W@B `22sYHݪ)lH.5+ 3i~U2˃.M=gsElϷǎv<ø=5/ފ-\-v(o/^OridΈ 7Vu_qU +4WH:"ԑu[9Y/Pq'j*?zIQ>A'׀Fr4Xv=O  Vj @v`$*} ӉIb&1MƋsiFhH&ZkU}+6(7P]b_y18{1ſĚBqZ-l9às MYR%pe 5iGSݣc* ^':jmVVo6PEjGY1Hc&R*>=ٵc_w4n_>vr࣯vxi^Yc̐0"-;˲c?ʎ\~8ȏG- ;홷(&2Ftދ 9֭g=;wtoždrc/@jMkN`ʫ}LȰCP._ڥo;?WS*Z_a\إC.KuY9ˆpap I 9Ʈŷ.agnO> ;8l-U>ϽV< bo.ՊjI\IxA)n sQ 2`gPٌ}-ߘgz}?u_e`@hP{Y֫v7({ :V df&(J-6 H:}~ ɿ.1twrך]ygw/o&\WѲ;Xb۴ -}o?Pu-4QCt:pb mJRVL2MtY:ᓈW8NHnKflˌ2O"`u8'Y?w4 ShwLXFIDO;bҵm/ lA{/tcCgM+PWrsHl9.vN '2YR;꤄ib !CMjs"8 Ac3o>%ۡGi@i!!16ѣ"!~=2s ~k8gjEߣudTDQP¸2lJ&&Y u6 נ1ߋ5- NqZfHBkPme$: q:OMO@i]O"䞋ꞑI{„KrJq'm77V2uT(,~|GqpċB(ơFjaCGo6=;H`_0֑Ȋo O`}P7@1|ɇ}>Fja?t7Lv0W%x\q8ñ!\!#$CG_/Ź dygMsҥeriQ2Qp"GDBj9 Ka1FK2xLQm 3.\U("b 8O|O|qωחVG"#2/{7mo-r`8e\ـzvqQoj˻xq8]!e^QRtM g ut:s ⨳N5&q5- ;Xr8`Gcjģfs#MH|z f-O[_,䇖{-do[peeeeEc 6Z,-L-YY0Xp2C 3rZx\kLFrDG_ko$LOIϸP`!FLƷWFlld5.34Ⱦe/lW2 2੨:#%EŊx,f7f&NCG̓Ϳ73fA70rsyyY06+̽fBee 5&6eHpJHUo,•EQxppTL0Zx1Z#]me籄pv5{^6h\Զl6`k頙u &+lj0|kwso >RsT Sjwpr 9{9tvQ'(%jod8;`KoY.D$ܣY ڥ$<>o9JyK4ʴ]& (2Bgp#*v6Q!́i Y; i)fJd3+#L^`T)Vn^| ob,gؽ,'lxjq=Tbrs9-os-S;_X;lھpm/osENx:.UM{S"_ziMW+.5sō'4/[+i̹KȚ{,#f6ը, ByyIg"[=BrVÑ0PR_WW[S3.hR^$xOlP\RCx7nqI |=w66 ][ 7(&4T"傦rV<}!C9uȖ 8vb|S A76Q9j+r(U0GݵZb(/5E.Mq4A'u}Dq?Ŀ_[}חwoXI=\qEqcaWnyvSźk;zQZ7q o2KW]:~k0,}[rZ ֜f[f~Aay߶iUk9J{^MMM{3]'sf][>yR&~ܨEgQ* U}BÑfq ̀P?2R[s(;*〿8W?!oy:4F*ko4k7Y*GTrQJ6J,kHC,EVq>Hj|P3JϜ@YB| RgOEQxG92{~,gQc-$pH a? +wm!E=SUd%.~+j6-ղ9"޳sK#2c-Z)x87-v0oP7d8Bө5xwNHSs<^]_?ܶyS_SS )}/n^pD1~cq]M[ʅ%E@QQpd23g>9{#*4Ȇ _0 |<ݠQ~\(b!*s!\BaUTyn$[[ΗYZK:=JPfV6 PPj++䏄YD x <"7Vrzxpa=qnȈ+V]6%jY;Z.++)- WE(CnBw?rsn۝t)⹑+=c8ZyD: .r0IrBLot~:ʟ]Pj+t,Йt 5ep; D#t&!#I[zGcBevs! h)QA=ᨒ`fPFUyzlO4Ϛ[>߮i7}>K';߲s[6a~FzgˍS fsui&=l}O0 ?O5SnP< \C(r7:9Tz gR?Ai6[,9auMmj~Ч.@.=!4—P2L"QPx22?Сz= T}4zQ\T tfFx5o(-^WDřGJ%# Fw_o3=#:l͖ M'i.I?4ZC5fL:"1z?+toY"1aJ \5'jI t\(;),x()Q~6J=hȿV!~+u߷[o&LbSkgjħ4=܉g CqsꔂqZ[|J.îxE<66nqRyqP֜ cЭ MAmx'DP6;7wqRtive5 ";¾Hjk(]Uk$ʹ U(hR{s~tb`Gޗ15wP}[VxwőVO]0 luҼI= Oʢx"Hw؉} V J\ ؋!ٹV{$>GmLTއ[n w{Ê0$G'\2|>LizZ6ARjOD)ˀlɖDixE6)XAeKD]R3]&<!t 94|rgbp-v |&1\3Qr-yK֊{mR[N"US){R#; .԰(kR/aZGS6hSg7K:OVh10YO#h);;g>m̉x%Y]^J֠O {P/6bP+E:dDVYXV^C Poz22Z',=A6AwRJO4:g)ژ#AQ1oJ` 77Qob D#@UT1|Yih'FW ̯^l^q3y}ҍ]`7 = VۜbȌ8|3p120 zϘ 83өlǩ@&=ФjhVD7 tKIdTHL>t^tVO2h 'L rOtOT|{og_S׈Ry Rt#~Yd|Q*KJHDᨯv{ҼT8*g.Wy).P!EyBzr_i0'6%6Ä B]]mjN;VqPP| Z9?:Zob..X}<ߨ}3յSYX0vIia ق Za0`DBWT e3so3#|GE_ &Ve*ٞժ\ d \5ɦgY|xp3E3`Љ6ps)2:'0ϰ g)5^KoPz< W0Ē֤#4L8$G̣T@(t-JGMHmx#[v_#[RIKjY{wţǽ^WBpo/؋]ni ʏFh2~Cp~sfc87M:VWW s[·.$4Ta"tѪ'Ts@=I1.|Ti QRPQ9Ar:ݙ*B!\#hI--o:6Th|iD#XY&O]vD; ]6x| KFRYGYg2Pʎ,c:7^jk? :`8B~[>OCY9xbo/ӷf. < G/l@iH0)\vƶ/[6cGѥ>l4q6DYg,MF/7F@viPq|+҂# TGS+FHxTeX Y?p|MSWgoŋ˖+o!ORv?D"? >5\~+zu- Y}igq1Vn#p8`P kuو 6?FWSQl1u.߃\$wAvף&Ԃ!dڵ^gkfBM.8QAb@BȨ')4T!?E(KLZj;T"aN+DiԻixPj iŨ}4_*xϔ%tv4+}ؿOBtIDH))ؼRfRz٘ 4@pNg(_s6=gyB%E#2#Q%H +d$'jfAkE0ֽ=oo-VoDoU/_|etGMm#}`K'lwvAee% .KktA2PN`6BnA2blN(o+(g\wcyrܡ#L/iL;]9#PK`t.AΗ&=B7)\')L:-,++ )ipP3a&qxzb8\^Qt~At_{{NoK\)` m l⩷++^&X-~խ,^˲Sa>S3RS(/}{. tF͘SP7>Vi98d,$/|{yF#o US=Xػwܑ}w~cؿkCvܼNeo{ۀ ) ޻x=أ3V;<\ .rBnQyn&â f\b?gTqxq8U+d :)#iĤ&~K>bx CdxXRJ2di2a uGQ!U'LtGs"xxLNlPRҌf! ,>bC4,MM&v%ujRת[ջtZGc6PlyBo,LrB,Ajrx]=v!|7]|'׃3Ա9ldIi E:^'wCg*$M()nxdHRcSKiJ7gR*r!u^lwky[!0=+ԇbJ\hcě05dNo@RVk&{LEM[CQ5\͂Aլjċ7m.owWMB򼗭z7b^PUnj$6*CI<[,--9z5(Im9yjlF3Fꨓ=cT"fP7ʿi4*&1rr +:Viw}wp{8S/`9)hmΪ}DL#Uy"ۛ91~~sTp>FV_jc/KHS/>+{SCSZD3P"Tg ؖڲ\R^0g2hgC<>ox(-vC],#'MQ_4RNpq0 i4a ||nӍnuv%lx,ڢ֢yEKآ"i.h|՘W!cGY=B~IS2c\)wQ 3r;Ѷ[DJrY\$xdƢ5MM M6.=bvOl+gS[6+>s;CR5| ~VpFJgbʪPѕh+6fd ;- [);2K3sR O`8hZ(3- `[0<dD" WQ‰ʬk`kk8YσbAٸ| /\,?23#O4 Z8CV4/Z0B8RB-8ZZ (ly`&^CP4 BR+Ř%ܗ琴&=Qᡑ4߈ ect۱;3K(I.6HOџQsl~0P(ـ?_IQxZ, (d’r"~SۈlH)'ڼ)J|iVc;zzldg%boSJE؇ %b-d6!jrfSo$;{^c"/m=lTY7x ?ٿg<0b( zU=Þmu8rrr̹:T % $B%Vk9-f%O9ۂK P):!,g U&sVr2Y:KmUϓR$ǹju.f ~*~ eŁ@(@^`t2!PTh2.BpwaPYHI-С .1P /hGt5vX`l6N0Z>uBP%ɯJ/<<7Re0]BvaO;2Ֆ hH=]TI؎}3쌿0TA@^\OoRN_>nx?Y!&֬\$ξ;|[r|Ϧw*AQ^КYmgj2E<C~(b`3E ;*kxΡy '4, nlK ^֓t,OЛ_) ZFB~(f\Z;# O! eAہ,m42ʡuł|;rpNWIr:EŌڬ֬YL@Wf]VbuV$%d r*&!x RJJBҤi˿jWf KOȋ~"{/,Gv[1_fScNZ@ڗ2=mb%3gx  -g6(;/fdeԴL-ZzN|-ċ[ķϰ tb9*.1}|qjǧq̨TByRшlgîCZL.0~ ~ɥwR,8V*ceVzޝM, J3 BA- %'OX9LH"eֲye#elkٮe/ \+˕ ywyޗoz54{iYp#C =z G ' ἁ5Hi87(y>)xbi:/[@nTj󂾴fʉhy:zHgr`]UL`ACx`>_3J8"\V~q*2 O P {%` у@_&q2eW6BBP=(5JBכ%mu08^z' % {'Z\a n 7y×n&nMfH*zXu@ŮÈUحµu=#hC7"(χqurpҥֺ,&Z,fp$u .?r|qH؜B7} 8S4QeDUyʳg$"]EĻeC%rm\BjU%WΪsm'+ȇ_ݲ$nMݩ97ٶ6<7ni۷]DEG?wfNRB3h~A|4]U,_h\q%W.^,|ò4WbUvsq^Qn]5ۣP]uLK?3:7_T bOmF9(+PYZZU\P[[]o-m$3*FQ5CU׀AAv;7.VUgRī9wkl^liyupVGn&.)%F:'WǢ:x⪙"tUr?ëčU1?.)U . ǏwQ,~jtGU}N wowXE9B>ރ;Ȍȸ!m3TsHM804`NEdԊ)e8,65s'Mj@ʿ5l|h4Y.in+C,ih6a5X,p_QKME9x<׮BWDHQ&06$MX8:iF(֛KJ,.ۊZPA*ZL_]{L罸#g G8Xs$[kPcL üʑ<ܚ@r]JH-u+;*˜]h&V*Y&j*˥U"ٖUmcoٖ߷bˌyl`ߝ>NJT\~2>2yO3ʩ؏Vv48ٸ:b|?F$~;ezeXAЋ F53%[wgR2/ON#.ݣ?֋P&P4 <\]EYil_Fj `͙jS 9({l FcQkt9ղ$1ZX6dtfMb y<IFY`r`}| Ͳ;}>/.CE-Dܙnqb:Zolb(,#b!;@{R䑸 ͋k d*$1yurqr}`nXb>ci5g{$PgVϬulMV)wOj;;<}y{à mw{a/5hzn93'0LJwtHΓc gPbbvE-e购?foF>K_[Zx F䅡{@>ωhmix=x#%1Xg1 ;N ۳ĝCs@@ C)rJA\` ZhQ-  /0./ YMMI?fr1f7b9^;WAPNaN_tnLPl78aęJL&]7_Jlbl{EǵT)Wǜ֛>1&E3dy(sy}nz vsƁF^)CBK жHH@XRA)遊D)-( (AEhкnvJ*+ptK* 髗X{Qkgz~P'?toC;u ~;9 AGwsEW̗K60X$jU+)VP,XFq+-NkX 2ތϳEme >6#w]>@!]/!0nװ][%M6ܪa+hQ|b3Ž@8o1[aFaG&~,B6kͲfRl"6̹>_6˖,9 VYʰX3 F L,ǛfLn]IdGKIWjfYnթTjQ*Rk7㘵W6a*bV)rML_۴GAc0q rOJGݿBXMe9-NvNk)LkD51eWq.7:nWTmLH04m>stream x}MkF?-r@o4ۖ.}m%54QE}'B)/e7;~֕?/ƷۺGzO%|v endstream endobj 104 0 obj <>/F2+0a27d2337-29c3-4466-8c82-fdf4fb58b29e<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 105 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 1137.019 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 1137.019 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210\211\212\213\214\215) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 526.215 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.05 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040hypo\055diploidy\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 978.589 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 978.589 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.255 978.589 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0505\07314\051\050q31\0561\073q32\0563\051\040IL3\055IGH\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.049 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040t\0505\07314\051\050q31\0561\073q32\0563\051\040IL3\055IGH\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 820.144 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 355.395 820.144 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 364.034 820.144 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 450.255 820.144 Tm -0.075 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (t\0501\07319\051\050q23\073p13\0563\051\073TCF3\055PBX1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm -0.062 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040lymphoblastic\040leukemia\057lymphoma\040with\040t\0501\07319\051\050q23\073p13\0563\051\073TCF3\055PBX1\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217\220\221\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 276.87 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 294.69 661.924 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 456.915 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 465.375 661.924 Tm -0.122 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 546.405 661.924 Tm -0.044 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (BCR\055ABL1) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 649.005 661.924 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\224) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 669.344 661.924 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040B\040lymphoblastic\040leukemia\057lymphoma\054\040BCR\055ABL1\055like\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217\220\221\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 276.87 503.494 Tm 0.026 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 295.59 503.494 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 457.814 503.494 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 466.275 503.494 Tm -0.122 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210\211) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 552.344 503.494 Tm -0.052 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (iAMP21\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040B\040lymphoblastic\040leukemia\057lymphoma\040with\040iAMP21\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (T) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 192.27 345.094 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 354.314 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 362.955 345.094 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\210) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 428.835 345.094 Tm -0.055 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (T\055ALL\057LBL\040\040T\040lymphoblastic\040leukemia\057lymphoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\216\217\220\221\222) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 277.049 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 282.81 265.849 Tm -0.122 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\225\226\227\230) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 368.895 265.849 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (T) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 385.635 265.849 Tm -0.104 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 547.665 265.849 Tm -0.08 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040Early\040T\055cell\040precursor\040lymphoblastic\040leukemia\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F1dc44b973-27d4-4c89-a7c0-b759b634ed14 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0a27d2337-29c3-4466-8c82-fdf4fb58b29e 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21413\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0a27d2337-29c3-4466-8c82-fdf4fb58b29e 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21413\215) Tj T* ET Q endstream endobj 106 0 obj <> endobj 107 0 obj <> endobj 108 0 obj <>stream x |T?~ι3w$3If2'd&3d\a 4"BT"bL(ARԭ0-E RKRK*PV9w&?{Ϲ{Bw[J/ҿ sg'hۆ*;@'52;Z$ivp'_8gԋЭKwZҩ1Bv-uo9bg ^<< ݋д~gNӓ p ?(^8Pc<%6#!nD5TL:0:nB"r +bJy/#{$^G{CrX>#E<|6kk#w 3rJBj^#uOȈLYaF6Ԏ4!r&j`.Fe9 eP>4 ""ATB(JP2T*h4UEǢ*TjP-C7z45|;-㋟Ѣ_G;4+>OğQ0_ws/D%y/{pOixi nK@+a̋麒aS}h vZيp2~&!@ :# PZ BW՛kf~x-hjYFz0g`^:4?z2,VՎ8q'oWC]uXrHI8T } y9Y +=-HIے(:FR*xeFW7΋&WEj'^E&ct}SG%jE9oG-Mͻ?21d _(YInL4vDI[0툗fz BqOhԩn/0'a6&,(j"(*^95bWQlb0wA;74mm(vuz\=Aʃ=~SnS=W H.@(hs7֎rhkvLtkw Frx.>(_U#*Ί\  hvWi59̂ U194 +8:\tk]܏n5vxju gh>SK8F2ܸ6~*/TGr&k=j&蝶SuQE#\C[TdE-^}U0~RsmC}T7>gwuz|q38t&\]y//]sxz{x.@֛䌫A;ja`m5`ȴ#pûat+K"Ѿѩ|U*WꎟڕE hw ^?=n6TKTۃܴ[knNϚ궪3^K.DRZH/\Q/` wY@3\)h #ex(FT,m%?L\qhJQ#ePQ;g _#􄿐v~%MVM|ćf;#IFlЮMn7C9aU KmS)m|d|xHRI~JZ{;ntAK՘G-|oa[[E,cs^XRKbBR(nd`|9}RrIOws}>MTE2QU1cy%` Kޓ}oCIdiK@%1c0bUt-3Ēxůz{/Q!hW,|F %ٌ0@eYQ¹&F.et5xiϱz~h06Z4#d|瓓F- cn̉ZTm+us@9S1+#y;<=P$Dn>4 9|c;ݯ<%=M=sW8:_ޏ&ØhTj݂v>qI&kZ7X]Y dszq#'f" Jy"(s Dڜ C {dgMV db\p=eڴdyLriiYG6ֶ6;9 d5ٽ٠(Ђ#3@*F ruKO0?ìExgy`{ rk?>f)b[_.{&("vi Qk*8q'z Oh( 7e~\(0l@_2LѤ@cB};]Af&C76DJ}|Pj+!,Q_.x,Ǭ78֫%ig8`WʷZQ~6A8 [Zw{7A3=w%@Jz1YX ERp@^y~F}^g{wgH$}!AEiPʫW`=1iUy^ͭ'z=F4Y5Ⱥ( ײzI=Ocx݀$%b>wh' HPhh때rz˜OgҸt917hjEf4jumv2BgF=S7Y\=*3Q77sCseAi8& Bw/$y*oo7C_+5b R+a+ESo+5AxQ]\e_)=gAЅ89uVx_4%ST*d]Ūj;8S\DkK9 F0g$}_kRs]]KML2PKC'wۯBgA:v'$7U0`-n B"`*MT+ߪL$+ЅJ # ΃Dkp-..Jկb~ب(w1+: }`C ^w僥5ٌK_q˺.-+Zz!W9xdt8+_ҁCS:k^՟HU2)M< gFN4ZL7 TPr| 99ͪX4VeQ&{K j  lg¨N}[qJ8G}m]yy@NEe,Z*% #"%$8f;Kl-73h+檁hf5l 5j`6`hUbZo(`.jz]yķҹZ|hKtu/oύo?>҅yi@V+FcVh@a$jq9N1n#@S¼bC\_1|dߎzj&.L/&jm) @ %1:bB(p"&/ Qul0W w?6kպ{^ (ynh={?c)Z@] Zm6;CZEyO٤>~$"\3 VJ#jM֜B CSCg>qΟQܻG/$ͽn~p+e2v*{ ȈrD Y\Ҳ05RY) > *˜嵋+XY'1c`h2uͲZ;`X(FYg#HnDTVp}Us* ^(A šq`*َro ^NsdaZU~fkjNhNm72QMF aقӥof3$i5%?WJ,v0(<9]ܫ7:<7ı` O YƝGDqϤJ1ơZu[M\_`G&KL բϕ,νJE=FWhg'~=Yo]O!}I^_4"tw,x?N{+;K^8ObGdx7A*(LڇdwͱJĉ(VPDz'o.`vHISggyޑ.Kps~8 Qa_p? ]pKv?J,v?4,L% z s ƣ;H 2kHCl${[>? Pv?f C9`3nn*z3 ]$j5T>p }:AiP F@ =1hJF ䷫3u`'t Mf].CU F΀fKK2 ^ȆD˿-`A8CJuUrm|\l=lxic/vMͥ o_7Mj(xW0 -n3a@:]ưU<Ϣ>6Shj`+Jj 2a"⁳U7ȆBX"L$GĻ?:6KTi{Duڇ0 Р5('ʑ@M/X dV JqťUHv7BBzJx1ilo1c)?p)}8ԏJhTMΉ^&aB9Iz cE1< =:f2rA͜_ $%^WA W,A(Sp5ZM4E Q2F%倫V'qnjN6Ŏ1i-70'|ؗV-T&v7FLuկ91f=ycϻ۲\$k$NE|p#%@ pu꟏([V䋀0-j"f.((S)tr4FB#g'jAm;L4HdD,d'Vz%I6EvNd#Lcg{(tyO&bK~ьI]M{/<0~G{ ߺs&\I-OЕ vT'OGu7=J;SZ#}Z Lio1Ĝڲ2:,[ˑ3=5AIywxƑ{ W¹7at -liiJ`eJ*-LhW0RP%j]p#0Q:Bscj2sN$f72@Ih+x;HCm`gEPn€]jK!f7v30eٗr=N4gΙ>үY.ױ +GaC'vlXs 1?#҇ Nk&=wblLU{-`abrȃr(uS J0d(zAOF.lXRbm(Y-yG*KKyJDUa"a?eF5.W8\2 ~XWjة=9\Tf ̞dGr@P ʂL@]\H`Dsn=pNp2+33<#+ɟԔԖ&%ÔZei~ZePŴ)e<'ֲl5E"#Vi0xbp>[ LS@pQ !s },r]ZV Fa@8$Y={ϖ#[$tĵz7d?s#62xD`H/CGh~OSx#Y.vɲyEZ GS[>Q!5ϰm$M(i"oĎ{ʼnMfS@T&&RT#ZGBtM(̣Z+'azX ep{PSCl=cA*kj*We23'%t4T o`I+YHJ#ТZc;:|@A>Uk,y{?{J=蚦 +A/JWd$d"ד5J, 1ZAd6[R~`K)p"δ4ˠAy@bs_T{"LxCX0Df)ǎLZi4\"~N1(No%\(oj`=w{T( tqW`?j@$4MCmVxee GW*qsP33^WqZ\4&wP2": = 6򴖢]j֬TkgteQn6X* &lfOozU33y8Rԯ)!t#(: Eq-h Ǯ[_[[EV1#N)­:&&M,#¯DD@ 7/&uŇh*P 0K}8 oGʓ{zڋ|e.x{nN7Ox: ;pUU5[F#@qEڧ~\ݥ~UQyjj+f3lVB;c:0u,~ha-Qa k˒ P5D}^((-=r$Hc{$TdB\D 'dЂl{xZ!E--rQ1J >>(=U _40 [(>Af2* 8ޥI6[uGc3r1Ks苨)y84z_dvugo%C*ۗ\9_5PfOjY<.׹,MZ6ણ ^(x43voژxPcepO.H]s,RZUu?_l$j̘ۚWp7.~-a' |i ?Fa4Ů;I{fł~O{y:TԨZ(e\J-A<{1_ȗ-<7sFI+e]C!PZT{5gʕGTHgk&1]clKg%jz'M\A.TDB *dW.C}%`ty7IL>QeժՅ6,;w-pe{33=))&iEa=tQݹ,^)]`m|N^増U,N~~.3!77nL Y5V[nby\Lw'W/W&'uPmA[ ךX,^#[t :U\ Hl郍8;(RXWIF\b^g8{.M䣡b]L(=XVg~c]lYV0|,OBʐx Uxwv)ĥ0N,'BnI)3(fq#2H3][B~A.|tst_;##Mh)dBt*zvqz)KLN#44ܔ֖FFaGhu.t, h˭`ʿiF /z.ah(oap_}V &adq,yUCę"O(~^$Z?&d]J6HOvVXR^?q4&˓JMW6J-jf^H<0_>eҤi~iէgȗ8%=4T} YGY,K4> Yi$Q4:%Ւdd G0jUNP'$N6Е+x6 _د YLAQURW~ %/'@{ 򭬆^M._K\6C>8 g+IzյT(v=6-88|z h(M\Ҏsʞ5|PZtXx)-[Y-'mJʗq)ĥ*)k>>[2h*Qm8oZ N O*ȅPug8هȾv|[`LH2< PRSdWzƲ&)V8 dC_0ު3]CaSLS?S?4!.Q'-RE~Xfw[_6.\wJu5M3ުjzi} 'W/8K=eL! E[$ &Mck6щ,ӵwqQd'Q M{42o񂘄ߐ¤*vhKll8w_4\D͆=iL=Oլ–kJzwD}-^iұ5+ +La6|/p\ݽzV>5VoTTsaN_a^eȂlR|J 1RZSX_JeJcʊS>Ni=e8XRP2u~^ xR7򄧱rф=?}MDKJ^8mY݄sndg.)2xe%6JI;ER3C[v핮nά# ;T#K+?", *Aա xKWjnͯ뽅L:Ij x~t瞐( Tc 0!dJbZĔHE:,eV2$lmu5?VsZ!=Hm6ow7=%Tx+""1 '&;#Ԓ^xŮ bEWpJOz|;)y.xm z1b#<,Ll ȠOK<#BrD:K:Y*?rm ,1uAQGW}_}vǼN$򾱀2FxO))ɬצ&UG M`zr2e=RZzj#+גYT}>pj!,bSY'tq~dNcp轣Qe t8(w\~,d0w'd^3Oȗ aGE„#Xubē{0VR޷Qz9CZԸZ>I$(J}+6+,#;2/cįd4{zu%'Jh ܒnFĸu4ٍ~f7hMK;&ǎJgU-_6a4͛?wqtR6a񏒊!}_ve'֩d]ױtJkֻʶa'MV2 -cKߗcԦ, ~4#أA1E,֑Y7%tqPvW` ?P*kp>lKi (hBp: ޶Cs 5 QW n3N f`)c2=u$᪪eR Lj%Oj7eafӕG=Ȣ=ҷamk7|x)6py7+CҔ7*r.W?/Kǥ+$/m*&{18stP+])]V+>q쟊 oG$9影iVҖh36|3-91cac7>8禡v6t!5j8W RH7!/Rs]`_\shqtb?vqIPzbE *{ 7dϑSpdÑ 7(#-q w@)`[02! ~?-Fh'z]5Y9 r)czY-[c$nw)Ebb2C9[IyHWe#jZToR|fSIatТO*e^|r\HӺW\2xM@>*߂fzZy(\?JGG~Sdݝ Bcܚu7.\eΑ?ÍCGI6eI%NwuiB8ݹ q])d:ocnE)w'-Nv0б&ҚDZHD*&D:&N剴,BJ {Xz8~G[o/BdӴ]t64tf"mI3t0ޞG }_{cQb֐Tl5ڀUUdVgE}n!߫/2)Tyh~hAm[7𿭎FJʿsjT5>Gh.E.*e endstream endobj 109 0 obj <>stream x}["G{?E_&EU 0\n&!:SaBN[7m<[w8p=6Oqwxwdz~ OyMxOn<_χۧ?ǟ'ӯ~v=[7~8e:tcyzwv70yC_k|;ڎcgA討tR':3mj]tQ+ݫ{QH/ z^+^Fw?A? ?A? ?GQ?G#(?GQ?G#(?O'I?ɟ'$ŸO ?O'I?ɟ'$ŸO ?gY?˟g3,Ɵ?gY?˟g3,ƟoM~o~7&7 oM~o~7&7 ]~;~w.w]~;~w.w/E_ "_//E_ "_/%s+~[mUX2/%V/ގ_ΣؒUk֫?oڹ_u.ZWiͯ6o+~Yۢe}f>n{Jk[[znk&-?wӏ]}Kmyh44|Ը/+^7 endstream endobj 110 0 obj <>/F2+0540eee26-e094-4810-82bb-015537abd50c<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>> endobj 111 0 obj <>stream q 1 0 0 1 0 0 cm BT /F1 12 Tf 14.4 TL ET BT 1 0 0 1 0 0 Tm 1 0 0 1 531.615 1183.076 Tm 0.086275 0.086275 0.086275 rg /F2+0 13.5 Tf 16.2 TL (\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1137.019 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\200\201\202\203\204\205\206\207\210\211\212\213\214\215\211\212\216\217\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 560.625 1137.019 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 569.265 1137.019 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\213\214\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 630.105 1137.019 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 1057.789 Tm -0.047 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Provisional\040entity\072\040natural\040killer\040\050NK\051\040cell\040lymphoblastic\040leukemia\057lymphoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\222\223) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 221.25 978.589 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 238.89 978.589 Tm -0.061 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211\212\224\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 320.07 978.589 Tm -0.058 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040\040Mature\040B\055Cell\040Neoplasms\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 899.389 Tm -0.068 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\225\226\213\214\211\212\216\217\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 357.914 899.389 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\057B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 384.375 899.389 Tm -0.104 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\227\213\214\211\212\213\214\221) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 546.405 899.389 Tm -0.051 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050CLL\057SLL\051\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 820.144 Tm -0.054 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Chronic\040lymphocytic\040leukemia\057small\040lymphocytic\040lymphoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\230\231\232) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 241.41 740.944 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 259.23 740.944 Tm -0.091 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211\212\213\214\211\212\233\234\235) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 441.614 740.944 Tm -0.26 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 661.924 Tm -0.042 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Monoclonal\040B\055cell\040lymphocytosis\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 582.724 Tm 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 193.35 582.724 Tm -0.081 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\211\212\236\213\214\211\212\216\217\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 396.075 582.724 Tm -0.065 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050B\055PLL\051\040\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 503.494 Tm -0.062 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (B\040pro\055lymphocytic\040leukemia\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 424.294 Tm -0.078 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL <9fa0a1a2a38b8c91> Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 337.755 424.294 Tm -0.045 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050SMZL\051\040\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 345.094 Tm -0.048 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Splenic\040B\055cell\040marginal\040zone\040lymphoma\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 265.849 Tm -0.073 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\244\211\212\216\217\220) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 297.21 265.849 Tm -0.052 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (\050HCL\051\040\040\040) Tj T* ET BT 1 0 0 1 0 0 Tm 1 0 0 1 175.53 186.649 Tm -0.012 Tc 0.086275 0.086275 0.086275 rg /F3+0 20.34 Tf 24.408 TL (Hairy\040cell\040leukemia\040\040) Tj T* ET Q q 0 0 595.2756 841.8898 re W n 1 0 0 1 0 0 cm BT /F105eb298e-baf5-43e1-a70d-afbfe74271c2 12 Tf 14.4 TL ET BT 1 0 0 1 74.41 37.86 Tm /F2+0540eee26-e094-4810-82bb-015537abd50c 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21414\215) Tj T* ET BT 1 0 0 1 74.41 1224.14 Tm /F2+0540eee26-e094-4810-82bb-015537abd50c 16 Tf 19.2 TL (2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\21414\215) Tj T* ET Q endstream endobj 112 0 obj <> endobj 113 0 obj <> endobj 114 0 obj <>stream x |ם?zΙHsd[%K~ʶd,˯/dCcbƆ8!K %\BP`iB M YMili6Ms4Bi@Jy͜3#4h1m Cq p5zX1_EߧKw T }gIB+B3-sQ_O! 4 C '2Ȼ]U ? KVܱhE6VA~罋 bw,_toI#V|kdO>٩ƣHehq,y&Mh yL!#*C CZ/B-o|CxyHB EO`t\!t}\#YCz s ò C=Tw(zo+ x§i#*)s`=I#e֖iB]mMuU2RrS\TXv:9l[VfՒn6 z^ըU4 [ֆ޸qKxȐtTGqS{!$D97gN,GS̓?W뢾xaGſu~.\lr:$Z Z9|;;%-qEGEsOeG| s3t?#3mv):^聁ql86Cf0M}K]M}wÌޘKu:]$AψJjS H*@*(Q!RRh` tM4.< W#oԌO eS)c2Dk˓pѣC%LJGyףs-ZgACkfσ" ~܍ҁ.1 yڶF(뿳 u5B]ZC#YqzO\4k?bw;hvxG|/ Z'=XaM. nִ.I'-"G|h$-0WՁ+ SS׻y"MKÏ)=h@G/G]M7:: pxqQ>9d1~Y i uJk= 禊R hMoܹCӸ<Y1L(ϋ͊7̍8 L魹cFx|<͎EIaQrFSmS> TTȊʦ0ۺhV:̆gQNa5=;5A@)rT)<踀C&>tkW2@ƐҚS5hT{]V4}3=]GWIŏw3^r,J,_qG Ha8󞸬xV\MCiNd:i9Y*thMQ͏R}٠ J\ %kLhRyמ0ެ.H[O;mܬ'6RCMRd ~SPwGuDžbxG+5KѾZ|,N;+E3~gW3ud~'l[A:(w7$"W ^^}F 9ɟ-$qL~$N28!G%pΛzr_vaD䏜eOZn-.踃uqszZQ݅:49/`8ɹr7 l VDZ[++ZñPuPuF(8c#CmqAa~ ;[@gl@ V>ߊ`ѮUB~H.Hs;f;6Xt杧/ {^pV뱭OEvl~7ber-&ϱpvU* m5fQܪ(h*R5[q+1J5HkE 9鷘]R2`L >~_ Eܳ[t7 n (@|_&Nq*d'٣kA罝l:QW ^(I7U& CHL7E7 kY L=ǯa_xW=! OT0O?=CO'% d=ꗒ\ Ybr9f7A|yTex+KMN3D4ˉ 2M.C2uOcc!H5B=qNIc 9Ɯ)g{9|o08DCΙ)51&a +ٽR^It.a*@,Gv\TR̻rX Ә]x}Qi+<ݫCMc`K -E#^OnATY<*jtj3u fp`7UVw0P fӛC ؎kq>< *V`)5 dSjHPdEImŠ_b|BTsskylaPxy>Y%=J rncyHFqY@uίZ@W9NȅJ{H42vdYf+oʩץhj |r͒\iT4[ r|}`hepcų%y0y Wߑx83GnЎH;_|Jo;؎xAC Hmq\l*[(H6$~}w+~gg~dc"^_,{?rWdq:?_7Rrw닻wqmVy1\ NrA^=$PJty9١:yR Pv 1C|͌~s q×:g%4S(Y6WpTno3rh;Ґt7@7{=D=.Xg_wh۶ }qNaveֻ~ph{wc-=zi4*C80񠿵JTuR&7r)[%)BC/)'rBWW_6Zԗ\lx +k] lGR$A|H:FC.J 'm *ۡˀwys}'0N#WF-[1BE<`kXFctTQW)'ɔ8 Hcs:)=tY0SKM JZR):PZHjLaIItN3@wh8FrQ92 =T8iq\{wO|~N[+04T+2rxJY7r,ݪk!{:%WJ"KR\fd^XJL,L|?Y01Jsſ~ȋt4)dj &wiSVVp:ܶmF=G P 4@W&/:܅BXQO[cHYnUUecd Ԉñ Aд:kgơh0c핆\cP~TT+*kh*T*R Og Gݠ[y c3ݕ'{-VV+GOQx PS{/F*++"]KA> 2]!N^9C hpr;hKjy~AXO &S6gڛ+#^|w(Oo۾}ZwθY;_ӻ}֚UXo*5OhYE<ꕓ8:LO򏹃J0+dljޝƫM<B%&aqDK 5"'"xLxrgIaaYJ ,G\RJ)%4Q:xHJҐ'؇k_qNE{l+lfKIn,1Žvw\@K7]Ji$! ф$ HB(-.teς2Sl`<itT[)3X˟&~E1ɵ6/ʢmUf-ڱ~l'ř/3;w/oY]/,ny>qӹO?s?F [B ?2 /5+Y*/ZY ^UqqIFa6e\2>+Z?{ Hl8W+ÇS( /H3y&@2  w8Ǖ \%fVE>CSW7ZKq<ͩ!9m S paK%0>y0DCDCe*[I;.>YZ;Ō.}2ʴE`Ċ ,Ѩmp%  i8Js9owRlx/@$9~ou)J'ޕ#0(' %ʤP.C 'i$">'w3D_6:xH8 P2W2ۈsb' %|+c Ox^=V^}i&#ās}[.S86恵O-~oxٺo xHy#z,RT?z晡^{l_'szw,37wnfs[B!?gŽe3;wψ_)̊_~E~qeu ksH8V_pد,~0v&W#K|m,50{ئl cUk_8CqNL$ѫGYHXs [bh&j6mʊT .eG2fXִ4mAep,㰺B5ecc54\z!PY 4ԣt#P2!>wnnы@X dJlZc҄8ZpK&b%tIA ̤$HIV/ D’Yb-|T| (%'Z\z}>!}8(a"/xWzhn :)K sY9TL~QBxI? #Ɍq5IQdD 2WJT$9o6\4e`]9vzݶBƮPŧ(MG?! .QmL[,k%&D]x {xXxJ~ >(9O?̟p.[;qzj0`m\xU߳f|랮q:s5%k޾ϤP7;i1"^|u/]+u2d"?0`BԠrA0Y:F"XP*- dM&چp&dr yPrs8ٙ.ZT !Bf£%a)P wbք&-Ӄ&b0wMaZlfzt}q鐉)7l7M_/L65ebLMl / ɭ&kĭ_'_B o|~0x=io3t{A=&]=sYzVJ!pKO^\ZP\•C!xd5>ad~f|oF(*#Gg#7d5(/Vqvz,=]$5N:T"ŪBb-EXi<5M=2jZ]+7ot䟟FMr_1#r'I=K2*0Tc׃_ϕ-8]D䂱wMoW4vvk^ę6ڿm:GdEpToF^ke9$O4>I+H̲[uu߮]kQkjςV2 &dh4V*$BWT(ZpKcFXWR]Y<^ޛKq \ r "L^?q1Ahw5446i2fȎ+ݿٰM(,gr&id*+CiTtp , c`M ZY.<▹Bz*;qcMЍ;a z"K߅>] kV&m!X(a=I+mOwOge iuGmG.\['#S6/Ly ,7h$<<H [[SoB1܂- Wq>r>CK'H@.!0OjjBNgpGu)_4lDn'.mH:J׽@G5!7`mj تMMWic&MS4~K8Q: VYMiiS\贸8_ٮlg.FG{}Sb^ʑi2A&K”!>Z'h cu@J( No2M%@#t{ )#E-#'$Y@j#E_>Y~X@0!8dr`O-"IqS2'4DP_vlVF q/ۏ9r(ij;@Sowo\;~ Al]۸lO ui8-f\B6￱=qN -ӽ6oS+up5w͠>=>-GF2 $02܌ʾ;qXQ9/x775xFK`y\˯;y2+)}Ps7Ťs̷6Js Hpµ6-{-\zkEpױ{B;A3o^ۺ9Պ;iD=zwTiW/FLA.=▾qHA{{K,!%K u9%K@֔i6 }gV߷*I]+澯}h)Z}=vllցAEkA = N/FSsͣ5LK\SQ] "W*h00A;s %[k0'7Ni2j@S5%!4j>!]v f6ַV,-O[]_J,c׏c~ヮ ~MoשOcLP^BnPȑ5 7 L,KO 'f-av]>oC}̣ jF_^ÿ8$Nصw|C{,s蹿vo[V{ {(c1!:#󔸱, ;Yl}Vf_7l]{׳;zfsM,{@:CAҬV-SiF.XF܇m{)3B-(6͕é-y>׫5jnK0ANEtr@CS$)}8Jq4@>["J9r^pXi"rJb.fro y>x3s>HӼ,_#'7Y(2L nX77D` 8)Lzh[%N^*ڔK9,|b;>1*]|{4QK[Bꁈ8Zŷ?j̉W?&"p͉^׻MWr3gbTX ?KFF\8^#BQt(,J5. suuFԕged(ajif*mjFMplEQ@yBԢ:,[ J/q:ilQ3h[tfFޠRu4BX]4Z֐]]|NJ.N7ڜ.یF$1J5T-mM- Ӧgfu]s/nr rbrs:^?؈hI|:"'Ҿ}jxd@#rOG#fsQ oG}>n ;ͭ,ZuF"aAJ;շRduQ(^@m#+$yUVb#֎t2!Ǖu97nZv 9!5U9ؓs:1qtbF*X;r:Μ,͓ /M2")/ iCiNi.-^;>ߡJ{CPGSR&_zIrK&5)zPm#RL~̐Ǵ)零hxdH Ǥ.i㰤=5& ~Q\^ҧK&3Ed~qX;=Ow>l/s%gov[~1+įŽe Ƿ^n#u4>qrIݧUVMO|*o'Y߷-9Kzj]|ݑumgpzYC##Z woypQFgDXCm.i)j{-e US_1IBeN9XT\]kFU+Y7CPrCJr v g3:MG,X<0SUE7NS1AL+eg绊sNNq"6ZGY's6U ׂo̍ 3Ǧ57j}l=W~,?#ͤaF96 Ew̔ "*trb{VV|Tu ?2sf5c]('DB KdfEk5jX?By6 1,tUҡ<*JF9ڔJ܇u#j%~A)?`VvKQUup{?fĩpmu>os!ۧYRc+/P \*` l8#x`kd{mx]1m6l-Rе{~F˫TƔW-c9 ehKISCHݲ%Htޠ_b2{ڃWhTaBIR^[$/E &Ks JީM?+Q) |")av^wmw7FY҉/':ĽZw5)撥́DDqƱ}x96M3k6g%\p3WݹPzk(L~6Nԇ>5.  c9` +nJuZ,:,Ye}ɲ$˲,K,ےO1G_`0,dఐPz&0dSYP!'xS ;B,Mlv&rpX_wːjjz?>;^/{ڏ؏߱dusvu9{]rz"#V\gM! =t=)05W Xb|KP4bt}EpZz4_{ޤNP&/yt~ɒO3|'dY<3T]io\A3wUWدOvOu5[8^+^M,Ϗrjm턋X[_C 5N=0c_ B[P57!|71r5Pi8+zNlHRWay).(jr \Exkl:\\K n(nEAVX=MV/ΓNI®.:+ y-Bk.,;f8 !FZb[\1AjDG̥ޘ63/0}B c,r 22c\S- l[aG`TbrL*Tlw % wp-!:at e}j݁IQɏPwy&o׿lloLCɉÿ>͓|OafWO@;bw(yzw,絛 ]]֙Fg0$R3,{wg+s%1*hvG5{^J)LObcZbJ̢̝f=;&̑ <Us-&:e23>ZZ |RL98M$2KOSZ[сf>UJD mte=Y\T}TCGٴHX2lˑYz=b!4Ft/X1n#Z*u,Wq "\;ˍq4wŹ0'Y0I@"5CTxB`t ?ΟT{gg?!Yn+|߉GGޭέ+W98iV"þi ae=k8?9ɋ.:ِP-~?b+vB,/pT4:]Mt9Lf a-A0zSe+(+*НptQH=M8I{,DL#1>^#!vFGB}&FÞc.1#YcH_P.Z\QL7ԴZ: ^YJ=TiA (#2X@uń~ msq@Yp8J 8H)ϊH%\^޹%JG1LB"0o1yP9?r2䔦pIFp>IN&!]7+$Q%膿OCeMBr*y:q&-LQ+~O V=eZB^ڹ|Q/9 S歔nVOq>8>HJ)&l^ ]+ęQP̃)uO]0vSY$#>{n.O[( TL)Ҡ$AEdx5~b_l!@y9;A9rRFFI]Hvt7cztĚLi֒MAt)NJ3Zi=ڈ]۫ݦ֎iGq֭u\e:*8Z@+Tp.0 Fiv1\Ĉ*brj.͕ P]HBra; TyJ!љ?'g*+(Ҝ "V.+*,TBBZF Agd/S,h/ҽ;ΤN̥'.y=Qć|)?x+a<'&cd_'a\~Etmƻ؈__p S{@[*_dXmO~~aa[_w2P`e.XFH52V*#ע 5DWNP=@` AB+aS w%6/n#3dlV5 HJuMMTBW; >Gw;4]/iownLy"}t_ZUE 'bf2PVx'i]Dʗ=c#FܨAxt:JGE(y#Fx6F=:yc'+g|+_AP~\~K4gg]!Ă38Lٌ Lk0iPG"Eg]鉈&>I ^`wJeu׃uiH>YᏂԈA V]W դ+UU z`WŮA]x~.DV#- d~W,L푑l~ ) @ \u4aK-/޲f~{ͅ ݡ .|+,f~i-Yo!Ι}7jzg'F7]]KKYM/^ *jH?bˏli' 70ǩm拑?ccmzOśbeRîM#[G[\fR{#R+k݉Z%uO*LtGgibCzL1q#bU3Z}7[Q?~Ԥo^g'jG%K#;~|n:ode u=?p6!|ș$O_y$%wS2a gh#*bP̂34g~UtC?fV |ˌՐN= f( (L?6$%vx:hF9 _5$Rn 64 Z 4j#64:܍'9|jRS^@O10eYlLvU!v{C,?(TC)GS/.eMk4}u g̵f>k[w1ͅ+<폗sL:w,;U#>+8ӽ(aRO 9ѱCOr;9/\{mpWJ%/|Q֝̓C9ÅoxJ=^_ n3ƽ[cV/Y9gn1y??%3 ߝyz n ,l5foٺgȼ2 a~,7fdoܿݜDCV EᏝIld$HNd$CIsZ`~D9ҏ Ex! v&O}¤N"5\#:=d$;%Fv!~H{ ?;>57* :! R @`+VۋN˙_.,H檹tVLUrfd*)U6I3iMfHsa{. 燹56 a]8=ft+㸮.1e gi[:[)WUPFNc<Ό@:V<ٿ@xkgV99>Uq/ɌBqxvA|^ۚ⎦5qWSo+wnb7Kx\ʷB}i}k\R긹~~*G endstream endobj 115 0 obj <>stream x}j+GṞ !Huٻt' q&HmGK-_˜@Hu2_?nO0u:|<>rϳau[_v~lt<_.:,fa|uewy:O?.uz>o~vqvXw|?O nyn,}o9(rT䤜Y9MȮ\Ur#/V^7y ?A? ?A?(?GQ?G#(?GQ?G#$ŸO ?O'I?ɟ'$ŸO ?O'I?ɟ',Ɵ?gY?˟g3,Ɵ?gY?˟g3~7&7 oM~o~7&7 oM~o~w.w]~;~w.w]~;"_//E_ "_//E_ ߽mh/fo^_CKTş}ú_<oֽ}}_RozW -u[y[z~ךۺ/ >G~ }6+[mZ|W endstream endobj 116 0 obj <>>>/Group<>/Annots[126 0 R 127 0 R]>> endobj 117 0 obj <>stream xuSN1y-k o1bDAߙ2t.A ArVB4`s {^ۀnG5hL_259q㘝Q8˜" OgsŞQ EсE:Oa;~?֩"'r 8GRU>w8#5Zc*]ݹvvs1b:.Ze[垶s6l7հ 0(g X!qX[UMb Bfud.lI{t*:ΰ>q1|,'[BKIeKOG^@%4RuoTF7~Ov/;yD endstream endobj 118 0 obj <> endobj 119 0 obj <>>> endobj 120 0 obj <> endobj 121 0 obj <>stream x| t\ug?샅  R PIPȦ8RvqΞ8Uؤۜ*&e+9n9vԱ↉؎&`H)n{ړyw~ !ۈAG:?:@i~խQ }uU"B _tW.Կ啧/1QP{W..\?z4E)Ps\]}ObAh k [|?qWsI}0?Xz}~}"tp;f|#ht8 =( c`CΏ!TG~kͯ"‰E鱊~FjsBP~4Q 4y.+qt]CM:@Fᭇ_9cW}8{݋/>{?#ȿ~~왏'o5f$'\'Ϳkw5֦ͿmokW;͗fsnNy+Ч՟O~~G{S [V;WSZrmٸO^_hIZ6SO2' A!}{JfNdJ>pc~bOGz`zva% HN|@0yzps s!DNT['hJ&_3'Z5*A>kVlTp`˘f tceeq_}878(^\*Ǽg„Sk-alycG>NQ~Ο(J!78K r<(hhNX4K Tͅ{dawlւ[,MAg8jp.S]<[z2(ADp mt_׀@ڸfk_D@-}ӟ 1qm& ;J%ƓOq~N(mBZ5,YaggG[]» q,!FWցxߠOF!t`0ՉW_%o(O>*HXB7XC,l2al7<a)?j!*l"9Sh|-/86_: Vs>in//2Z81F JGirvL>3n ={/syH*#n\^GA^YqԚQ!6_ t $:@'Z^\[êm%T-[akhKB nNH &퐵h4a7{OV[C$RQs4:ΧsPiLII֏i*=lL }1#S*xl˾ JYB}m:%@)-=pqÀ3@-P#*k9F i({m+!Dbb;4q/Tµjkl oHGc}S`KҠ ud5ת tY{(P.aSb(5px"F|?=0}j,A `KsmYf.TU4yH'|ߴiͷ!h|7j  8_z|C^ }EG>* ՊCю_4vfCeӅK"m儅f&E6ߺhƂB}/t1\D_j.hЅ2-ʗ"O<{qn󍺄'y[vBþ:^^i-:h6Rē|%J{[MQ7jU9"Tq~'0BȻ"2$7Ü׳z:ÖdǒXXR\9\aK/]Xb JV\Ye -x~B*ԪIڹq쬚/%|TFZlբ^Uo{Z FjC;iݨ W cLaybie,OS}Vr9y4\yf'O=a$p4v2qNo,p00H N٢mtױjeY^rbJfKCA%*WStLiQWh$~YuӦiL&cd&E'T9B|-3z296/^YUT<ݤA:TGc.rW79oCF`%s=ftӴ8oWRX5MLxI\m&VQS 2F%nt63"Cjr32v8=(=8Jk\kdp&*Mfԩl֑M֩6eNc񈜌zd c2ÞmI4 id,, ٬gK;L#dL,+oY92_FMƲ1d\a T!,K^"Q-}"^=haWMs9(gUO8,Ts3H]M)4NMab=6 { C3ʣ_4Z=߿՝UӚ2gSʗAmrlZZ펪Ī:lTR@cɠ q^H' r+lKA絚HmSo="DF6 !% lxB)kqQQ-NQ9 gr1EJ%l:H`jB)OUA=[n a8 M+Fv1F-´lӋĎbA@z+aVSM9+ʀD=umi.bu-3#9DP:j$c e-!Bel6Tz5J42VA6*h*D e.Go"H"?UOMMoEIE㊊!ʫ)r\uдmcpz@Ip-h7:cC uƊeT'XQTB3{c5>AG0}V|Bd|>=b%QHޖ~YÃ6/ աuF,:-e*5Ja\5 /rdU RUGIV]^J33)>#(k [ͳ ?l_WQٟgX 7=H=ù-^qPEuM ێ(Z,qх kwhMDr؅\)?wȑ!b83 O[gC=Oo\٠0Ѝ赩Z>F2L,2%gtS7UG6rEjЈgԸX33m|L肺xHP[UE-0\I3'qz)^Xδ,,0E??1{t d!cL3RbؿN i^ RUΪvgI?(mCi=6>ӓ=p+)l6>^JPfS]oEG-kG͙fwt֭;N1S"Wh#zjATH63rIãc)h904GmAb)sqh](Kec*&PEzGA3lGЩv`Y0E",eR)С1f1)f8WMVJ]eEC9U2l_ KX%9Uuba@KX<;u.m;6C;VQ%ҟ˥ӕbwcYmq9n"B6ڔy-,慶1#5GG=:m-EeEI2cT9 q_[As'q8%dY8E3%͞dlhN;R[F e=cIuYF4M^צ`AS[`)V^ ˊ2UŪZL%e.JHɚg-Aqik rT@\ m2bW,~ĵH؋r%,^^5@xz%DʮR]g/NJ~0RbW^rbEˬ5>s0AAc$ѣ G{)`D(u&HPH-_:wVV6}݋tvxG\Zrg/1浇dG (h$XYeydbݮTODC91/, T_*cU m<41*ǸV[KwKlB ,w@+`)H=aT!/_7Lr򶸸m7= t< 酁T H@s;!ۡ1^ K`5^qud= ۷K U< dǪ2R?#!&:F\tIb\ٻotqAa=WDG4Jͽs)V{<1!\:[:ųF:`e ٌ\$WD;c\BC;PnA鎤R۷mww"Ta-XpI oP8|hS?X &ZV40hgA'U%rV:s| ?fVQlhu`;O0Ri)7QߠHī utFFwkE7Q՝+1;l|VAteyQ\RfB$.KnZ,60qxlujClif*+ te#r%٩,21`S;*ryuN0!c%UPUV ǍIzWM5ƳZRdE07䎁wnFY4 >QJbaj۷wǺ!`yF#|_D_mF75_X!/VIjb\`__DaΆ'936FŁֽ#QBGVJmWʎk>:S4V`.Ey#z|:V5$ -k5JgO6cʬ@Uylf^|Hʱ"k?!4$w`a*u[+H-ja.8PFZ5S}0ΩyiQtJ%)ԓ;vASg}c:eat/g?D/uR-|I18N Āl=&rwhl9~B(D_kT5(B7KbR:6NȌbFA  -A_ |󎢣NUh.ΛK:wq(6nª\&!S\nCv#Pr.,+V₡.),ApF-UYZ_VyȼU#|;Vs}WKZ;x!r+ cn),1_O)e"wZNBc徊>RB=& ԄDB||.[qj>z'!9g.%R]+rxZ} ڼ?Sju {P/ 9&NMehK74wvuYSiݶcSac T ?\zLL`RuPDO $6_ǹ7n*^,"`jHw?[dXҵe[_]feF#E'n_s k'σ#Zz| >",9 Yd i $OLNd*9~O&)@f_W{0܌O*R$ Gp^>k:pyy|N|!T9`n˪u{Z!fkyl!/ @wCD#0 H >9m𻥽0z1 ]!r3%Qi!( '`3q[7DVVUI1LXM#˂c.Q)˂D <9Az{_67#vW" 6FXadx-b{/D9-5=P{1IiS6hŠ`FWlD2 ?zpoGl ?CQ2N14PPԿF(5* z%! 80`wOUQ=d(cw/,m r{TfWs6* wʼn0RT.-WKU.e~fG.Xŗ4i׊0R tPfb.(? ʘaaZ469ҾU?ʙl-г *蚯>[kD(Pʎ/R 64]sd,k?d"kT' ~[7:;23E, `yz %*b"G+Н*Cm%5$0 QhDsTV^h;jY/u +-YHŢJt~1bZ{!;TG~M_i^r5W[ ~-N.η..i H3T`+ +D9Ѐ4%M0[R5ntIY/Ֆz%?\H5DUCbqrOuY ܲ w0iٶ'[82_~mثh{~RvZxl(^mO e8# /1t7M|7HpatBNz; Y%rQjotT|I% PeJݛ.8"}E,4'%yZ%%`_dhM`iny_B&r90nps'f'ΝUSؚ[`梗‹12/zQ;ԸX )'ԁ u'4Ž Q2?B:nN⒌{E*큎ΔnDlϪڹD.ax:y%ݢ1ڽX F汗,z Ĥ++i`W T6]^;=ymz`6pM:fJ$Tm699ԍ 2Mӊfq}n"x2͝%fdoi&^-UJSF1=8`@Ԋz ́;v.ض,Z,W;eXۡv袰Cf[sˡxԧ%\Lxp(d0OxS YMP4h=NPeaWi(L*,ʒ$a7xjmA f',}Tن2O<.I3N8h͢lVC5'k$>qM%WRu<*bFtW HP-z""bEn<ۛҌfΝoz0#-ĽPgvJdy=qm*3Lq(!,|Xe!,$l}bh#n8D?@)axGS$} ?mB-""ƀd;H\"m~&Y!N;|@լD։v70=:@NUbwP7)0`jAZtiS"@=Mu z<6t4U%O8X:ӑ-TŋVw n.je*}&8PS#?i7P\=KPi: G%e..)DNfOp_%d×$rtI _j&gЁZ`?-̝MlΗ$* 0::K$SvFOŴ C1;g؍l";//SxRԨn7=[O* Lx ,2G,0jA;`uD0"!8ENPU GdE]챎ͣ mQc15e=7lX.]GX(Q{")cb%j D唖0C+nK>ז(>nMԪ2.-|*}@GXnF›`6(HQ3-Vt n&? UWx]ƶ"%>6ο|\iCkT?.^a|%gB!h[ 56M+TH]4Hb+yH2$;kQG}gȌz(oh] @2܁4Id@ \nxBR6&ն\jY' BiH#>(B<ԅH/6&LQ"2lrtB6c!Bȥ!AA(XLPOJC==o!]@GC so"TJw!5A5{`;xUjSv5Ǩ?JLԏ`Vcrԗ7h^Ah/xQ(HXfl[|Ge .Tb\F+Q_4ѫQimeQo hyT_FegE [b߉4_Lm+o+n7օvpbTV[eăٶm?f~̶m1cFo,]irkO,-Bc?400xb[Oxo\?7X;ycū 7]G&w_\Z^z2,HBOh ]FW*ΐ}hpMY/EhHHC ?N*\oA2V9 `]h8F'.@UqhzZ2'`9(io!_-Aه5,v :/ N\\ dlW*iãΓ9jx[CX}a[mBJп rѾy'ξ96>`2w:AkkF$YVz NY/)rk߾',<@:עkx| j'}2rksz|?# :}ny=ȫgNOx:4@[Y5$}ȉ5x;KýW[#g/߾Yc+'Z|ȧ9r-?C2wps͍=3f޻1 Ο !Wh-?[Ԛf~vvz@3j?̟c}ўfHO5?t5;j~_Ur3?Yjo@:f~; o7f~K͏el3?3|_|ovKf(b*h n3 Ѽs^3@t?>%wá;d﷚){ΜC)u3n맔C)2)}NМtH<OsOo cuG}+4lG6Z?v?@Μ]}~ ewl| @uslve>:wEjTn]T&:?(J!>stream x]ˮ0x/OG`RIY}N"d0> x. CX4n"m:Ns흸8)0Gzn !_Ouy.Ÿ`~lKq_ݴ(8}o݉\O;wkqB/^U?t[栐"o*/O~v@cɤTĤ_F1}#|lfj"'x`NIEl5}HiҧyFi֧I%ˀBs]a7@;7NW  endstream endobj 124 0 obj <> endobj 125 0 obj <> endobj 126 0 obj <>/A<>>> endobj 127 0 obj <>/A<>>> endobj xref 0 5 0000000000 65535 f 0000000023 00000 n 0000000111 00000 n 0000000146 00000 n 0000000351 00000 n 6 122 0000000499 00000 n 0000000575 00000 n 0000000889 00000 n 0000002633 00000 n 0000010096 00000 n 0000010194 00000 n 0000010860 00000 n 0000011060 00000 n 0000012083 00000 n 0000012858 00000 n 0000013758 00000 n 0000013990 00000 n 0000022074 00000 n 0000022939 00000 n 0000024129 00000 n 0000024350 00000 n 0000049131 00000 n 0000050154 00000 n 0000050375 00000 n 0000068356 00000 n 0000069226 00000 n 0000070960 00000 n 0000075479 00000 n 0000076645 00000 n 0000076866 00000 n 0000102516 00000 n 0000103545 00000 n 0000105279 00000 n 0000111223 00000 n 0000111889 00000 n 0000112089 00000 n 0000113112 00000 n 0000114262 00000 n 0000114483 00000 n 0000136705 00000 n 0000137688 00000 n 0000139422 00000 n 0000145987 00000 n 0000147182 00000 n 0000147404 00000 n 0000173148 00000 n 0000174177 00000 n 0000175911 00000 n 0000182162 00000 n 0000183257 00000 n 0000183479 00000 n 0000203710 00000 n 0000204675 00000 n 0000206409 00000 n 0000212912 00000 n 0000213578 00000 n 0000213778 00000 n 0000214802 00000 n 0000216035 00000 n 0000216257 00000 n 0000245503 00000 n 0000246586 00000 n 0000248320 00000 n 0000255134 00000 n 0000256245 00000 n 0000256466 00000 n 0000272820 00000 n 0000273728 00000 n 0000275462 00000 n 0000281098 00000 n 0000282303 00000 n 0000282524 00000 n 0000307282 00000 n 0000308299 00000 n 0000310033 00000 n 0000313806 00000 n 0000314472 00000 n 0000314672 00000 n 0000315696 00000 n 0000316708 00000 n 0000316929 00000 n 0000332565 00000 n 0000333478 00000 n 0000335212 00000 n 0000340603 00000 n 0000341817 00000 n 0000342038 00000 n 0000370108 00000 n 0000371161 00000 n 0000372895 00000 n 0000380203 00000 n 0000381375 00000 n 0000381597 00000 n 0000403859 00000 n 0000404840 00000 n 0000406575 00000 n 0000413805 00000 n 0000414471 00000 n 0000414671 00000 n 0000415695 00000 n 0000416862 00000 n 0000417086 00000 n 0000437757 00000 n 0000438726 00000 n 0000440463 00000 n 0000447884 00000 n 0000449012 00000 n 0000449236 00000 n 0000466385 00000 n 0000467322 00000 n 0000469059 00000 n 0000474051 00000 n 0000475186 00000 n 0000475410 00000 n 0000498653 00000 n 0000499655 00000 n 0000499866 00000 n 0000500324 00000 n 0000500462 00000 n 0000500818 00000 n 0000501004 00000 n 0000513687 00000 n 0000513711 00000 n 0000514307 00000 n 0000514681 00000 n 0000514867 00000 n 0000515069 00000 n trailer <<30312D37462D38412D38362D39432D44>]/Size 128>> startxref 515261 %%EOF